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Abstract 
During the second half of the 20th century, Molecular Computations have reached to a level that can revolutionize chemistry. 
The next  target  will be structural  biology,  which  will  be followed soon  by Molecular Medicine.  The present  paper  outlines  
where  we are  at,  in  this  field, at  the  end  of  the 20th  century,  and  in  what  direction  the  development  may  take  in  the  new  
millennium. In view of the gigantic nature of the problem, it is suggested that a suitably designed cooperative Millennial Mega-
project might accelerate our schedule. © 2000 Elsevier  Science B.V. All rights reserved. 
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1. Preamble 
Every  disease  starts  at  the  molecular  level.  Thus,  
ultimately  every  cure  has  to  be  achieved  at  the  
molecular  level.  This  recognition  leads  us  inevitably  
to the direction of  Molecular Medicine. 1 
By the end of the 20th century, a powerful network 
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1  Gene  Therapy ,  which  is  also  part  of  Molecular  Medicine ,  will  
not  be  discussed  in  this  paper .  
of  new  disciplines  has  been  developed  which  can  in  
fact  support  molecular  medicine.  This  interdisci-
plinary  approach emerges  as  a  new  mega  discipline.  
Its  translation  to  practice,  i.e.  to  the  drug  discovery  
process,  involves  at  least  five  major  fields,  as  illu-
strated in Scheme  1.  
Genomics  (human genome  project).  
Structural  biochemistry  and biology.  
Biomolecular  computation.  
Solid  phase  supported combinatorial  chemistry.  
High  throughput  screening.  
Based on the soon-to-be completed human genome 
project,  a massive number of protein sequences  are to 
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be  released;  however,  the  biological  functions  for  
some of  these proteins are yet  to be  identified.  Using 
easily  available  biotechnological  methods,  a  highly  
diverse  protein  collection  will  soon  be  available  for  
structural  studies.  
X-ray  diffraction and  NMR  spectroscopy,  the  two  
determinative  arms  of  the  structural proteomics,  are  
developing  rapidly  for  high  throughput  data  collec-
tion.  For  example,  synchrotron  sources  for  X-ray  
studies  are  currently  in  use.  Furthermore,  multi-
magnet  NMR  facilities  will  become  functional  in  
the  near  future.  These  NMR  installations  which  
contain  10-20  magnets,  each  in  the  vicinity  of  I  
GHz  magnitude,  are  equipped  with  semi-automatic  
co-ordinate  determination.  This  development  will  
lead  to  a  high-throughput  NMR  set-up.  Such  a  
complex facility would be able to handle the booming 
proteomics-depot. 
The re-organized  Protein  Data Bank,  supported  by  
all other data banks derived  from the high  throughput  
screening,  is  serving  a  reliable  platform  to  establish  
one of  the biggest  challenges  in molecular  medicine,  
the interface between  chemistry  and  biology.  
Since the late 1980s, a very important paradigm shift 
has  taken  place. There was  a move from  individually  
synthesized (and tested) compounds to combinatorially 
synthesized  (and tested) mixtures. These collections of 
molecules are called libraries by the new terminology.  
This approach  has  been  initiated  in  peptide  chemistry  
due to its simplicity  and  the availability  of  automated  
procedures  developed  on  solid  phase.  The  success  
achieved  with  peptides  [1-5]  immediately  triggered  
the development of solid phase organic chemistry  [6],  
Finally  this  led  to  small,  pharmacologically  relevant  
compound  libraries.  
Using  robotics,  the  problem  of  screening  of  the  
emerging  number  of  libraries,  containing  synthetic  
compounds,  as  well  as  natural  products,  is  now  
being solved. It has to be emphasized that for success-
ful handling of the above mentioned multi-source data 
collections,  up-to-date  data  processing  software  
should  be used.  
In  spite  of  our  outstanding  and  ever  developing  
technologies,  as outlined  above,  we do have  concep-
tual shortcomings. The paramount obstacle to sophis-
ticated  drug discovery  is our  ignorance  of  the  law of 
protein  folding  [7,8],  If  we could  pronounce  the  law  
by which  proteins  fold, we would  be able to  proceed  
with  unprecedented  speed  and  efficiency.  However,  
this  is  precisely  the  basic  knowledge  that  is  missing,  
and  we  may  not  find  the  answer  to  this  burning  
question  for centuries,  unless  we change  our  method  
of  investigation.  
Until  this  point,  in  scientific  practice,  scientists  
have  always  started  with  folded  proteins,  of  which  
there  are  literally  billion  types  in  the  human  body,  
and  tried  to  find  the  rules  that  govern  their  folding  
patterns.  Although  some success  has  been  made,  the  
problem  is  far  from  being  solved.  For  example,  we  
cannot  even  understand  what  forces  determine  the  
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way  a  short  polypeptide,  containing  for  instance  10  
amino  acids,  is  folded.  How  can  we  then  expect  to  
understand  why a long polypeptide chain, containing, 
for instance,  1000 amino acids, is folded in the way it  
is? Clearly,  in order  to  gain  a  deeper  understanding,  
we need to launch a project in deciphering the rules of 
peptide folding,  yet  even  this  smaller  problem  will  
prove to be a mega-project. 
2. Computational  background  
Today,  most  peptide  and  protein  chemists  are  
using  one  of  the  varieties  of  empirical  force  fields  
to  study  peptide  and  protein  conformations.  The  
results  of  such  methods  are  essentially  educated  
guesses  of  the  potential  energy  hyper-surface  
(PEHS)  that  describes  the  energetics  of  folding.  
The  validity  of  such  empirical  methods,  of  course,  
is  dependent  on  the  accuracy  of  parameterization.  
The  advantages  of  such  computational  methods  are  
that they are fast while their disadvantage is that they 
are  not  completely  reliable.  Consequently,  there  is  a  
calculated  risk  in  their  usage,  as  they  could  produce  
misleading  results  in certain  cases but one would  not  
know  when  this  would  occur. The  method  is about  a  
quarter  of  a  century  old  and  no  one  has  had  neither  
the  commitment  nor  the  money  to  polish  up  the  
parameterization  to  the  level  that  is  desirable  for  
scientific  precision.  
In contrast  to the  above,  serious efforts have  been  
made  by  thousands  of  university  researchers  during  
the  past  half  a  century  to  develop  non-empirical  or  
ab  initio ("from the beginning")  methods to compute 
PEHS  from  first  principles  (i.e.  from  quantum  
mechanics).  The  advantage  of  these  methods  is  that  
they are  reliable  while their disadvantage  is that  they  
are computationally  intensive.  In the  1960s up to four 
or six atoms could be handled at the ab initio level  of  
theory (for example, molecules such as HCOF [9-11] 
or  even  the  isoelectronic  HCONH2  [12],  the  latter  
structure containing  one  peptide  bond).  However,  all  
calculations  were  performed  on  a  fixed  structure,  
without  geometry  optimization.  Nevertheless,  by  the  
turn  of  the  millennium,  the  largest  peptide  on  which  
ab  initio  calculations  have  been  carried  contains  12  
amino acids  [13].  
The  present  paper  aims to  propose  a mega-project 
which  will  rely  on  the  use  of  this  second  method,  
carrying out computations on relatively small  peptides 
at  the  reliable ab  initio  level  of  theory.  
Both  methods  yield  gas  phase  results,  which  
implies  that  the  intrinsic  properties  of  the  molecules  
are  computed  in  the absence  of  environmental  inter-
actions. Thus,  in order to gain an understanding of the 
role  that  solvents  may  play  in  peptide  and  protein  
folding, the effect of  water  needs to  be  subsequently  
simulated. 
The  reason  ab  initio  methods  are  being  suggested,  
as  the method  of  investigation,  is twofold: 
1.  the  result  would  be  reliable  for  a  considerable  
length of  time;  
2.  the  results  would  provide  a  primary  standard  for  
future force-field parameterization. 
In spite of these good intentions, one may wonder if 
it is prudent to set our standards so high. Software and 
hardware  development  during  the  past  half-century  
suggest  that  our  computational  development  in  the  
next  half-century  will  supercede  all  imagination.  
Consequently,  it  seems  not  only  desirable  but  also  
practical  as well  to aim for the  more  reliable  method,  
even  if  it  is computationally  intensive.  
Fig.  1  shows  the  century  of  development,  from  
1950  to  2050.  In  1950,  Boys  suggested  the  use  of  
Gaussian-type  orbitals  and  Roothaan  published  his  
SCF procedure  in  1957.  However,  in  the  1950s  and  
early  1960s,  all  digital  computers  were  vacuum-tube  
based. The  first  GAUSSIAN calculation  on  an  organic  
molecule  (HCOF),  which  in  fact  is  isoelectronic  to  
;  formamide  (HCONHi),  was  carried  out  in  1963  on  
an  IBM  709  computer  that  was  still  using  vacuum  
tubes.  The  leading  software  was  POLY ATOM  at  
that time. The first transistorized mainframe computer 
(such as the IBM 7090 and 7094) arrived a bit later on 
the  scene.  
The  vertical  bars  in  Fig.  1  show  the  hardware  
development,  after  transistorization,  in  units  of  
FLOPS  (Floating  point  Operations  Per  Second).  
Clearly  there  was  a  dramatic  change  from  mega  
(10s)  FLOPS  through  giga  (109)  FLOPS, all  the  way  
to the current tera (I012) FLOPS. However, it has been 
suggested that future computers can solve problems in 
30 s—what  today's  1012-FLOPS  supercomputers  
would  take  10 billion  years  to  solve.  The  ratio  (10'°  
years:  30 s)  is  of  the  order  of  10".  Thus,  we  
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Fig.  1  Development  of  computer  hardware  and  software  as  the  basis  of  blomolecular  computations.  Note  that  after  this  figure  has  been  
completed  (July  1999),  IBM announced  the creation  of the "Blue Gene" ultra supercomputer  with one pelattops capability,  to be ready  by  2005.  
This  makes  the optimistic  (upper)  growth  curve  a conservative  estimate  of  the  future  development.  
may  consider  the  limit  of  the  growth-curve  to  be  
lO12  X  lO16  =  1028  FLOPS.  Fig.  1 shows  two curves,  
the  lower  of  which  is  the  pessimistic  prediction  and  
the  upper  of  which  is  the  optimistic  one.  Note  that  
even  the  optimistic  curve  levels  off  at  about  
1025  FLOPS,  which  is about  1000 times  more conser-
vative  than  the  prediction  currently  lingering  around  
(1028  FLOPS).  
This  dramatic  hardware  development  is  paralleled  
by  a  heroic  effort  in  software  development.  Such  
development  is  not quantified by values of  benchmark 
computations',  they  are simply  presented  at  their time 
of  appearance.  The  most  durable  package  is  
GAUSSIAN  [ 1 4 ] ,  which  has  had  several  editions  from  
1970  to  1998.  However,  other  softwares  (e.g.  
SPARTAN,  JAGUAR,  etc.),  not  shown  in  Fig.  1,  are  
now  challenging  the  GAUSSIAN'S  dominance.  The  
dates  of  the  WATOC  congresses  (from  1987  to  
2005)  where  molecular  computational  chemists  and  
biologists  are  reporting  their  progress  are  also  indi-
cated.  Finally,  the  dates  of  the first and  therefore  the  
smallest  [HCONH:] [12] and last and therefore largest 
[HCO-(Ala),2-NHj]  [13]  ab  initio  peptide  calcula-
tions of  the  20th  century  are also  marked.  
3.  Peptide  conformational  background  
A  polypeptide  chain  on  its  own,  or  as  part  of  a  
protein  molecule,  consists  of  a  string  of  amino  acid  
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residues  as  shown  below  in  I:  
H  O  
1  !!  
H  if  H  O  
y 1  II  
\ r y '  ^c-- • s y 
II 0 R(MXi>\) 1  II  H  O  f^ KII  'H  
"-""'Residue "»Residue ""»Residue 
I 
H 
where Rl" specifies the side chain of  the ith amino acid 
residue. 
The  second  index,  j,  specifies  that  one  of  the  20  
different  side-chains  of  the  20  naturally  occurring  
amino  acid  residues2  [15]  may  be  involved  (1  £  y  £  
20).  Mono-peptides  (II),  dipeptides  (III)  and  tripep-
tides  (IV)  contain  1,  2  and  3  amino  acid  residues,  
respectively.  In such models,  the chain  may  be termi-
nated  by  methyl  groups  or  by  hydrogens,  as  shown  
below  for the above  three cases  (P =  Q =  CH3 or H).  
H  O  
Ä i ^ l H 
£(3°)  =  EltVo.tDLdsi.Wi.th.tlii.tth,  i/I2, <h,  tl>)]  (3)  
Clearly,  for a degree  of  polymerization  of  n amino 
acids,  there  are  n  torsional  angle  pairs  of  ft,  and  1A,  
(1  s  i  s  «),  two  terminal  peptide  functionalities  (o)0  
and  a>„) and (n  -  1) mid-chain  peptide  bonds  [a>, for 
I S  i  S  (n -  1)].  Thus,  the  total  number  of  folding  
variables  for a polypeptide  containing  n amino  acids  
is 
N  =  [(n  -  1) +  2]u> +  rttp +  ni/t =  3n  +  1  (4) 
The  rra/is-peptide  bond is  more  stable  than the  cis-
peptide  bond.  Consequently,  it  has been  traditional  to  
set  toi =  180°  for  all  i.  This  limitation  reduces  the  
dimensionality  of  the  problem  substantially  
£(1°) = £„„,«<„  <M  
£(3°) =  £„»,[<(>„ t/q.tfe, 02. <h.M 
(5) 
(6) 
(7) 
?  V  
I •  J  \i  1  I • 1  Jl i 
0 ;  I n ;  i  O ; 
v  v  y  
3) ¿1 O. 
tr>o<t«l  V|<9|  42V2  "2  
H 
Mu4|  VPitO,  <j>2  q»2  ti>2+3  IfjUj  
I I  I I I  
Again,  R,J1  represents  the  side-chain  of  one  of  the  20  
naturally occurring amino acids (1 s j <  20) given in 
Table  I.  
The  torsional  angles  (wq,  i/q,  w,,...)  are  
responsible  for  folding.  The  energy  of  folding  is  a  
multi-variable  function  where  the  torsional  angles  
are  the  independent  variables.  The  PEHS  for  the  
monofl")-,  di(2°)-  and  tri(3°)-peptides,  given  below,  
are  functions  containing  4,  7  and  10  independent  
variables,  respectively.  
E(l°)  =  E K , w , , < h , t M  (')  
£(2°) =  £[<uo, a)|,iU2,0|, 01.  <h< M  (2)  
2  The  20  naturally  occurring  amino  acids  have  both  DNA  and  
RNA  codons.  Selenocysteine  nowadays  are  called  the  21st  amino  
acid  because  it  has  an  RNA  codon  (UCA  slop codon)  [15].  
I V 
The  total  number  of  folding  variables,  after  the  
reduction  of  the dimensionality,  becomes  
N =  ncfs  +  nip =  In  (8)  
This  reduction  in dimensionality  does  not  represent a 
denial  of  importance  of  the  cis-configuration  of  any  
given  peptide  bond;  it  only  means  that  we  are  parti-
tioning  the  problem.  First,  we  study  the  backbone  
conformations  for  franj-peptide  bonds  as  this  repre-
sents  the  primary  problem  and  subsequently  we  may  
study  the same problem for any peptide  bond being  in  
the  c/s-conformation.  
Most  of  the  study  carried  out  so  far,  has  been  
centered  on  the  generation  and  analysis  of  the  £(1°)  
potential  energy  surface  (PES).  The  contour  diagram  
of  this  type  of  PES  is  frequently  referred  to  as  the  
"Ramachandran  Map",  in  honour  of  the  Indian  
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Table  I  
Structures of amino acid  residues.  Note that in addition to the 20 naturally occurring amino acids, which have both DNA and RNA codons. the 
21st amino acid. Selenocysteine (Sec), which has only  an  RNA codon,  is also  included  
^CH, 
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w I  II  
H  O  
Hkttns|H)(Hk) 
i  CHa  
•  •  
W i  ii  H  O  
Cystflfna (C) (Cyi) 
H  ^  
w I  II  H  O  
Lysine |K|<lyf) 
Tmaoctan  {W| (Tip) 
HSe 
V V 
h  n  
Galenocyatatfw (U] (See)  
H2N V 
i t -
CH, 
v V i  H  H  O  
•NH, 
sma|S|(S>) 
O 
V 
W CH, 
v V i  n  H  O  
Aspvtsla [D] (Asp) 
V V i  n  H  O  
Aipvigtw [N]|Ain] 
N' O 
PitSnn [PI (Pro) 
H,  OH  
•  *  
V V I  II  H  O  
Tlvannlna[Tl(Thr) 
V 
CH, 
V V 
H  ii  
GSjumKn [E] (Qlu) 
H,N cy 
w I  II  H  O  
GhitsnSne[Q)(Gln) 
MA.  Berg el  al.  /  Journal  of Molecular  Structure  (Theochem)  500  (2000)  S-5S  
IV -  1  -V  
J  8  8  ag"  g  g  
\|iii -g+a— a a —g"a -
/ ¡ \ 
j / g +  <  g X .  
\  :  / 
JOI US  7J1  
\  1  /  / 
VIM 
\  •  /  
—  1.16  I.2S — 
/  \  /  N  US  Ul  \ 0.00 / \ \ 
<t) ^  • rS  V  
CO. =180°  ^  ^  =  
0  C  N  /  \  •  
180° 
Fig. 2. Topology of a 2D-Ramnchandran  map. (A) conformational assignments (B) names of conformem (C) relative energies (kcal/mol) of Af-
formyl-L-alanineamidc computed at HF/3-21G level of theoiy (D) stmcture of a general amino acid  residue with the  relevant  torsional  angles.  
12 MA.  Berg et  al.  /Journal  of Molecular  Structure  (Theochem)  500  (2000)  5-58  
01=360  cos 360 
A  B  
Fig.  3. Topology  of  a 3D-Ramachandran  PEHS. (A) name of conformera (B) relative energies  of HCO-(«e)-NH-  (0)-CHMe-(i(i)-CONH;.  
chemist,  Professor  Ramachandran,  who  first  called  
attention  to the  importance  of  such  a  PES.  
A  topological  representation  of  the  Ramachandran  
map  for  RJ  =  CH3  (i.e.  for  the  alanine  residue)  is  
shown  in  Fig.  2.  The  various  minima  of  the  PES,  
representing  the  stable  conformers,  are  marked  by  
subscripted  Greek  letters.  Although  not  all  20  amino  
acids  were  subjected  to  ab  initio  computational  
conformational  analysis,  several  amino  acids  were  
investigated,  and  it  was  recognized  that  side-chain  
and  backbone  conformation  can  be  studied  indepen-
dently,  at  least  in  the first approximation. 
The relative energies of  At-formyl alaninamide  with  
franr-peptide  bond are given  in Fig.  2C in  the  form of 
a  PES  topology.  The  corresponding  conformational  
energy  hyper-surface  (PEHS)  topology,  involving  
both  the  trans- as  well  as  the  ct's-isomers  is  depicted  
in  Fig.  3.  
As  yet,  these  residues  have  been  considered  in  the  
absence  of  conformationally  variable  side-chains.  
However,  side-chains  make  contributions  to  the  total  
energy  and  they  are  also  involved  in  backbone/side-
chain  as  well  as  side-chain/side-chain  interactions,  
thus they ultimately  help to determine protein folding. 
To  include  these  further  degrees  of  freedom  in  
the  analytic  evaluations  requires  the  extension  of  
the  above  equations.  Labeling  of  the  torsion  angle  
variables  in  the  side-chain  is  accomplished  using  x\,  
Xt,  Xt>-  and  so on,  beginning  at the C„.  As  the side-
chain  is  the  only  differentiating  structural  element  
between  amino  acids,  each  analytic  equation  also  
becomes  unique.  The  equations  then  become:  
£(1°)  =  Elmal4>„  tln.ljd,  A  xi)]  (9)  
£(2°) =  £„a„sld>]. ipi,(X('Xl  Xk).<t>2. </<:. 
(*|2.*2  Xk)1  (10)  
£ ( 3 ° )  =  W 4 > I . < / - I . ( X I ' . X 2  Xk).<h.<l>2.  
(XI^xL-.xfrh.Mxi.d.  -.Xk)]  (11)  
where  Cg|,;g2  Xk)  ¡ s  specific  to  each  amino  acid  
and  its  side-chain,  with  the  superscript  denoting  
which  residue  that  side-chain  belongs  to  in  the  poly-
peptide  chain.  
Extending  this  concept  to  a  generalized  form,  we  
obtain  the  following  multi-variable  function:  
£(n°)  =  EmW  1 •  01  • (Xi1.  *2  Xk)  4>u. >l>u. 
(X",X2  Xk))  (12)  
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Fig. 4. Two kinds of  partition  of  the  PES. The central  square corresponds  to the  traditional  cut  (0° —  180°  •  
square  represents  the  IUPAC conventional  cut ( -180° — 0°—  +180°).  
* 360°). while  the  lower  left hand 
4.  Conformational  study  of single  amino  acid  
peptide  models  
There are two ways to represent the rotation about a 
single  bond.  Traditionally,  the  0° —  180° ->  360°  
range  is  used  but  recently,  IUPAC recommended  the  
convention of -180°  — 0  —• +180°. This  convention 
has  the  advantage  of  designating  the  0°—•  +180°  
segment  as  a clockwise  rotation  and the 0°  —» —  180° 
segment  as a counter clockwise  rotation.  However,  it  
has  the  disadvantage  that  certain  minima  fall  on  the  
edges  or  the comers  of  the  Ramachandran  map.  The  
two  representations  are presented  in Fig.  4.  
Peptide  models,  such  as  CHjCONH-CHR-
CONHCHj  or  simply  HCONH-CHR-CONH2  can  
mimic  the  ith  amino  acid  residue  in  a  protein  chain.  
The  0  and  i/r torsional  angles  are defined  in  Fig.  2D.  
The  conformational  assignments (g+g+ ,  g+a,  ...etc.)  
are  shown  in  Fig.  2A.  
The  names of  the  minima (Fig. 2B)  are subscripted 
Greek  letters. The  Greek  letters originate  from earlier 
nomenclature (involving a, p and y) while  the L and D 
subscripts originate from the observation  that L-amino 
acids  favor L  conformations  while D-amino  acids  
favor  D  conformations  (c.f.  lower  part  of  Fig.  5).  
The  names  also  suggest  the  combination  of  the  
chirality  of  a constitutional  structure  (R  or  S  config-
uration)  and  the  chirality  of  the  conformational  twist  
or folding. This  is  summarized  in Fig.  6.  
The top of Fig. 7 shows the symbolic  representation  
of a conformational  PES for two full cycles of rotation 
( -360°  — 0° —  +360°)  of  both  <t> and  1ft. The  PES  
can  be  partitioned  into  four  quadrants,  in  the  tradi-
tional  way,  or  it  can  be  partitioned  according  to  
IUPAC convention,  as shown  by  the broken  lines.  
\)r  110  
í - t u r n 
» 
m cux # 
Energetically 
favoured  lor  
D-enantlomers 
"ïoô  sao  
Energetically 
favoured  for  
L-enanffomers 
Fig.  3.  Underlying  principles  for choosing  subscripted  Greek  letter  
(e.g.  etL, a„,  PL...etc.) as  names  for the  peptide  conformations.  
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H.  S  
0 - H 
f 
|—  L(TL)  
diastereomcrs 
L-Urn) 
enantiomers-i 
(TD)D  ——|  
diaslereomers 
(YL)D —' 
J enantiomers 
Fig. 6.  Stereochemical  relationships  of  y-turns.  Note,  that  not  only  
the  ot carbon  has chirality,  but  there  is also chirality  in  the  twisting  
of  the  backbone.  The  combination  of  these  two  types  of  chiraiities  
leads  to  enantiomeric  and  diastereoisomeric  structures.  D and  L  
denote  the chirality  of  the C" configuration,  while  -yL and  denote  
the chirality  of  the  conformation.  
An  energy  contour  diagram  of  the  conformational  
PES of a peptide (PCONH-CHR-CONHQ),  present-
ing  two  full  cycles  of  rotation ( -360°  — 0°  —»  360°)  
of both  <f>  and  t/r, is shown at the bottom of Fig. 7. The 
central  square  is  the  IUPAC  conventional  cut,  while  
the  four  quadrants  are  the  traditional  cuts.  One  of  
these  traditional  cuts  (e.g.  the  upper  right  hand  
quadrant)  is  shown  in  pseudo-3D-representation  in  
Fig.  8.  
There  are  20  naturally  occurring  amino  acids.  A  
total  of  18  of  them  have  the  same  type  of  backbone  
folding  as  shown  in  Fig.  2  (i.e.  nine  discrete  confor-
mations).  The two  other amino acids  are  exceptions.  
One  exception  is  proline,  which  is  built  into  
proteins  like  any other amino acid,  but its N is locked 
in a five-membered ring. For proline residue  V,  d>  can  
only be in the vicinity of  —60° (i.e.  +300°)  and, there-
fore, only  three backbone conformations are possible: 
otL, eL  and  -yL. The  other unique  amino  acid  is  glycine  
VI,  which  is  achiral.  
h A 
N 
O  H  
V 
p A 
O - H 
VI 
In the case  of  the glycine  residue,  double  degeneracy  
occurs  in  its  conformational  PES  as shown  in Fig.  9.  
Fig. 7. (Top) A schematic representation  of the conformational  PES  
of  a  peptide  (PCONH-CHR-CONHQ).  Subscripted  Greek  letters  
symbolize  the  approximate  locations  of  the  conformations.  
(Bottom)  Contour  diagram  of  the  2D  Ramachandran  potential  
energy  surface  of  HCONH-CHCHj-CONHj,  presented  in  the  
-360" s i  <  360° and  -360°  s  tp s  360° range  of  independent  
variables.  The  central  square  (broken  lines)  is  the  IUPAC  conven-
tional  cut,  while  the  four quadrants  are  the  traditional  cuts.  
Finally,  it  should  be  mentioned  that  for  certain  
molecular  residues  molecular  computations  have  
established  the  actual  location  of  the  nine  minima,  
as  shown  above.  The  values  of  <f>  and  t/r  deviate  
somewhat  from  the  ideal  values,  although  not  too  
significantly.  Table  2  lists  these  numerical  values for 
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Fig.  8.  Pseudo-three-dimensional  Ramachandran  potential  energy  surface of  HCONH-CHCHj-CONH,,  presented  in  the 0°  s  d> S  360° and 
0°  s  tp s  360° range  of  independent  variables.  This  represents  one  of  the  four equivalent  quadrants  in  Fig.  7.  
alaninediamide.  This  information  is  also  presented  
graphically  in  Fig.  10.  
4.1.  Previously  published  single  amino  acid  peptide  
models 
The  topological  representation  of  the  conforma-
tional  PES  (Ramachandran  map)  of  For-Ala-NH2  is  
shown  in  Fig.  2A,  while  that  of  the  conformational  
PEHS  is  shown  in  Figs.  7  and  8.  Work  has  been  
completed  for  the  following  N-  and  C-protected  
amino  acids  containing  a  rrans-peptide  bond:  Gly  
[16,17],  Ala  [16,17],  Val  [18],  Phe  [19,20]  and  Ser  
[21-23].  Preliminary  studies  have  been  completed  
on  Pro  [24],  Asp  [25],  Asn  [26],  Cys  [27],  and  Sec  
(selenocysteine)  [15].  
The following  protected amino acid residues,  again  
with frani-peptide  bonds,  are currently  under investi-
gation:  Arg,  Lys,  His,  Tyr,  Leu,  Thr and Trp. 
)b ¿D 
«b A 
<*D A JL 
chiral  amino  
acid  residue  
Fig.  9.  The  development  of  double  degeneracy  of  the  PES  when  a  
chiral  amino  acid  residue  is  changed  to  an  achiral  amino  acid  
residue. 
Proline is fundamentally different from all the other 
18 chiral  amino  acids  in more  than one  respect:  
(i)  the  R  group  forms a five-member ring with  the  
backbone; 
(ii)  there is no peptidic N-H  group in the residue to 
be involved  in hydrogen  bonding,  and  
(iii)  since  there  are two carbon atoms connected  to  
the  nitrogen,  there  is  a  greater  chance  of  cis/lrans  
isomerization  in  the  peptide  bond.  
The  potential  energy  cross-sections  of  the  type  E  =  
£(i/r),  for  the  Ramachandran  map of  HCO-Pro-NH,  
containing  cis-  and  trans-  peptide  bonds  [28]  are  
Tabic  2  
Optimized  4 ,  4  torsional  angle  pairs  for  alanine  diamide  
(HCONH-CHMe-CONHi).  The  idealized  torsional  angle  paint,  
together  with  their  conformational  classification,  are  also  shown  
for the  sake  of  comparison  
Conformer  Optimized  values  Idealized  values  Conformational  
d> d> * 
t*L -66 .6 - 1 7 . 5 - 6 0 - 6 0 s"s" 
a„ +61.8 +31.9 +60 +60 g  g  
3, -167 .6 +  169.9  - 1 8 0 +  180  aa 
TL - 8 4 . 5 -68 .7 - 6 0 +60 sV 
To +74.3 - 5 9 . 5 +60 - 6 0 « s 
6, -126 .2 +26.5 - 1 8 0 +60 ag 
6„ -179 .6 -43 .7 - 6 0 - 6 0 "g 
eL -74 .7 +  167.8  +60 +  180  g  »  
co +64.7 -178 .6 - 1 8 0 - 1 8 0 g  a  
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Fig.  10. A  schematic  illustration  of  the  PES  of  an  average  amino  
acid  residue,  obtained  from  the  calculations  carried  out  so  far  on  
mono-,  di-  and  tri-peptides.  The  idealized  positions  are  marked  
by  shaded  squares  and  the  computationally  determined  positions  
are  shown  as  open  circles.  The  names  of  the  conformers  are  
given  as  subscripted  Greek  letters.  Note  that  a  single  amino  
acid  residue  might  not  be  able  to  take  on  all  of  the  shown  
conformations. 
shown in Fig.  11. Preliminary  invesligation on the  cis-
peptide  bond  has  been  completed  and  the  c/r-Rama-
chandran  map is  currently  under construction  [29].  
4.2.  Single  amino  acid  peptide  models  in  progress  
4.2.1.  Aspartic  acid  and  asparagine  
Aspartic  acid  (Asp)  and  its  side-chain  deproto-
nated  form,  i.e.  the  aspartate  [25]  ion  as  well  as  its  
side-chain  amide  asparagine  (Asn)  [26]  have  been  
studied  in  a  preliminary  fashion.  In  both  cases,  the  
iV-formyl-L-aspartic  acidamide,  W-formyl-L-asparta-
tamide  and  Af-formyl-L-asparaginamide  were  inves-
tigated  in  their  yL  backbone  conformation.  The  
side-chain  conformational  PES  for  the  three  
compounds  are  shown  in  the  following  illustrations:  
Figs^-M. 
4.2.2.  Arginine  (Arg)  
Arginine  is  an amino  acid  with  a positive  charge  at  
neutral  pH due  to  its  polar side-chain,  the  guanidium  
group.  The  typical  pK,  value  of  arginine  is  12.0,  the  
Fig.  11. Conformational  Potential  Energy  Curves E = E(t/r)  for cis 
and trans-N  formyl-L-prolinamide.  
highest  pKa of  all  amino acids.  It is,  therefore,  impor-
tant  in  salt  bridge  coupling,  which  is  part  of  certain  
docking  processes.  
Arginine  is  the  source  of  nitric  oxide  (NO)  in  
biological  systems.  NO  is  a  free  radical  which  
serves  as  an  intracellular  second  messenger  and  an  
intercellular  messenger  that  regulates  neighbouring,  
and  possibly  distant  cells.  NO  takes  part  in  many  
biological  processes,  such  as  vasodilation  for  
example.  NO  is  also  involved  in  the  central  nervous  
system  (CNS),  such  as  the  modification  of  pain  
perception.  One  of  the  two  equivalent  nitrogens  of  
the  terminal  guanidine  in  L-arginine  undergoes  five-
electron  oxidation  in  the  presence  of  the  enzyme  
NO  synthase  (NOS),  yielding  NO  and  L-citrulIine.  
N-methyl  guanidine  has  been  used  as  a  model  
compound  for  arginine  to  study  the  mechanism  of  
NO  release  using  ab  initio  molecular  computations  
[30]. 
Ethylguanidine  or ethylguanidium  ion  is  the  term-
inal portion of  the side chain (R-group) of the arginine 
residue, as exemplified by ALformyl-argininamide and 
its side chain terminal W-protonated form respectively. 
Arginine  can  be divided  into  two  portions:  the  back-
bone,  which  is  analogous  to  glycine  (or  alanine)  and  
the  side chain,  which  is  an alkyl  guanidine.  
When  a  planar  moiety  is  twisted  about  a  single  
bond with respect to a tetrahedral  moiety,  in principle, 
up  to  six  minima  may  appear.  In  the  case  of  
ethylguanidine  [VII]  and ethylguanidium  ion  [VIII],  
there  are  two  torsional  angles  x3  and  These  are  
two  types  of  bonds,  C-C  and C-N,  with  respect  to  
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Fig.  12.  Side-chain  conformational  PEHS  of  (V-formyl-L-asparticacidemide.  (Top)  Landscape  representation.  (Bottom)  Contour  diagram  
representation. 
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Fig.  13.  Side  chain  conformational  PES  of  Al-formyl-L-aspartatamide.  (Top)  Landscape  representation.  (Bottom)  Contour  diagram  
representation. 
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Fig.  14.  Side-chain  conformational  PES  of  /V-Formyl-L-asparaginamide.  (Top)  Landscape  representation.  (Bottom)  Contour  diagram  
representation. 
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Fig.  15. Conformational  PEC of  ethyl  guanidine,  which  may  model  the  rotation  (+,)  about  the C-N  bond  in  neutral  arginine.  
Fig.  16.  Rotational  potential  energy  curves  of  ethylguadinium  ion  
(top) and propionate  ion (bottom). Note that each molecule has only 
one  discrete conformation.  
which  the  guanidine  group  could  be  eclipsed  or  be  
perpendicular  to it. 
Fig.  15 shows  the torsional  potential,  as a function 
of Xt  for ethylguanidine  in its s-cis/exo  [VII(a)] struc-
ture calculated using two basis sets. For each basis set, 
the  global  minimum  occurs  at  180°  (the  anti  form).  
The  energy  values  of  the  ID-scans  were computed  at  
the  HF/6-31G  level  of  theory.  For all  four  structures  
[Ia,Ib,Ic  and Id] g+,  a, g~  were shown to have energy 
minima. The upper portion of Fig.  16 shows the poten-
tial  energy  curve  E  =  E(xs)  of  structure  VIII  calcu-
lated  at  HF/6-31G  [31].  
The protonated form of the ethyl  guanidine  [VII] is 
the  ethyl  guanidium  structural  ion  [VIII],  Due  to the 
internal  symmetry  of  the  N-C(NH2)2+  moiety,  this  
species  has only  one  arrangement.  
Two  vertical  proton  affinity  values  may  be  identi-
fied using  these  PECs.  The  two  vertical  ones  involve  
g —•  g  and  a —  a.  
The  full  side-chain  orientation  of  N-  and  C-
protected  arginine  and its  conjugate  acid  depends  on  
X\-  Xi<  Xh  an<l  X*  a s  illustrated  by  molecular  
structures  IX  and XI.  
Consider  the  diamides  of  the  two  amino  acids  
arginine  IX  and  aspartic  acid  X.  Under  physiological  
conditions  the  amino  acid  side  chains  occur  in  
the  protonated  XI  and  deprotonated  XII  forms  
x, =  (2-3-4-6)  
Hm  ^-Hr  
N  Q L =  (3-4-5-91  
I ,=  (1-2-3-41/3  ^  
H.„.  /  N5  
I ,  = (15-1-2-3) 
it. '"H 15 
VII (a)  
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respectively.  The  side  chain  conformations  could  be  
mimicked  for  XI  by  XIII  and  to  some  extent  XIV  
and  for XII  by XV.  The  potential  energy  curve,  E  =  
E(Xi\  for  XIV  and  that  for  XV,  E =  E(jfy),  is  
shown  in  Fig.  16.  The  side  chain  PES  of  XII  has  
also  been  reported  and  is  shown  in  Fig.  13.  It  is  
clear  that  torsional  angles  within  the  amino  acid  
side  chains  do  increase  the  dimensionality  of  the  
conformational  space.  Nevertheless,  they  are  very  
important,  because  the  side  chain  makes  each  
amino  acid  unique.  Such  distinction  can  be  made  
because,  to  a  good  degree  of  approximation,  the  
side  chain  conformational  pattern  is  independent  of  
the  backbone  conformational  behavior.  For  all  prac-
tical  purposes,  the  backbone  of  all  amino  acids  
shows  the  same  conformational  pattern  (c.f.  Figs.  
2,  7,  8  and  10).  
4.2.3.  Cysteine  (Cys)  and  selenocysteine  (Sec)  
Each  of  serine  [21-23,32],  cysteine  [27]  and  
H,N, 2*\,® 
hI"2 
2 5 ?  >1  
'  v.  1  
O-H 
+ H 
H2N 
V
C=NH 
CHJ 
H,C 
H  CH:  
?  : T  
O  H  
IX 
H
 v w  &  
H  H  ¥  
H 
OH 
/ 
0=&H 
H-.  K o  
n - ^ c t i 
O  H  
1 
-H3 0 % 2 
I  ,  1 
P-VL  /N-q  
O  H  
XI 
I. 
NH, Ufa 
XV 
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Fig.  17. Calculation  of  stabilization  energies (A£aaai ) with  various  substitueras  (R  may be CH rOH,  CH,-SH and CHj-SeH) relative to the yL  
conformation  of  Glycine  (R =  H).  
selenocysteine  [15]  is  expected  to  have 9 x 9  =  81  
conformations  [ 3 x 3  =  9  backbone:  tIAg*  ,a,g~)X  
rf<g+ta,g")and3  X 3 =  9side-chain: Xi(g*  .".g~)x  
X2(g+. a.g  )]. To investigate  the effects of  side-chain/  
backbone  conformational  interactions,  all  torsional  
modes  of  the  side-chain  (xt .  rotation  about  the  
C - C "  and Xf.  rotation  about  the C e - X  bonds)  were  
studied in the relaxed yL backbone [(0,  i/r) =  (g  ~ ,g+ ) ]  
conformation. Six out of the nine expected minima for 
serine  and seven  out of  the  nine expected  minima  for  
cysteine  and selenocysteine  were found at  the RHF/3-
21G level  of  theory.  
The stabilization energy exerted  by the  -CH2-SeH 
side-chain  has  been  compared  to  that  of  -CH2-SH  
and -CH2-OH.  The stabilization energies were calcu-
lated  with respect  to the yL backbone conformation of 
N-  and C-protected glycine  [33,34]  using  the follow-
ing  isodesmic  (same  number  of  bonds)  reaction,  
where  P  and  Q  may  be  H  or  CH3  and  R =  CH2-
XH(X =  0,S,Se):  
PCONH-CH2-CONHQ  +  CH3-R  
conformation  yL  
• PCONH-CHR-CONHQ  + CH3-H  (13)  
conformation X 
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Fig.  18. Spectrum  of conformational  dependence  of  the side-chain  stabilization  energy  on  the  -yu backbone conformation of formyl Ser-,  Cys-
and  Sec-amide.  
The stabilization energy  may be calculated as follows: 
s^tabilization  =  (£[PCONH-CHR-CONHe]x  
+  E[CH3-H])  
-  (£[/>CONH-CH2-CONHeV  
+  CH3  —  /? ])  (14)  
These  equations  are also  illustrated  in Fig.  17.  
From Fig.  18,  it  can  be observed  that  the effect  of  
side-chain  orientation  with  respect  to  the  peptide  
backbone,  going  from  Serine  to  Selenocysteine,  is  
gradually  decreasing.  This  is  due  to  the  increase  in  
the  size  of  the  atoms  O  —•  S  —•  Se  and  the  resulting  
gradual  lengthening  of  C-O  —> C-S  —» C-Se  bond  
lengths  as well  as the reduced hydrogen bonding abil-
ity  in going  from OH  to  SH  and all  the  way  to SeH. 
Topological  analysis  of  the  electron  density  has  
been  performed  for  cysteine  and  selenocysteine,  
using  Bader's  Atoms  in  Molecule  (AIM)  approach  
at the B3LYP/6-31G(d,p)  level  of  theory.  The  hydro-
gen  bonds  were  verified  by  the  existence  of  bond  
critical  points.  Three  conformations:  (g+  g*),  (g*  a)  
and  (a  g~)  exhibited  such  interactions  as  illustrated  
graphically  in  Fig.  19 for  For-Sec-NH2.  
4.2.4.  Leucine  (Leu)  
Leucine  is  one  of  the  naturally  occurring  essential  
amino  acids.  It  is  an  important  amino  acid,  having  
many  implications  in  medicine,  one  of  them  being  
its  role  in  Maple  Syrup  Urine  disease  (MSUD).  
Maple  syrup  disease  occurs  when  plasma  leucine,  
isoleucine,  alloisoleucine  and  valine  are  elevated  
to  very  high  levels.  These  amino  acids  will  also  
be  present  in  the  urine  and  hence  the  urine  releases  
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Fig.  19. The contour map of the Laplacian  of the electron density for 
the  (g+g+)  conformation  of  For-L-Sec-NH;  calculated  at  the  
B3LYP/6-3 i +G(d.pV/RHF/3-21G  level  of  theory.  Bond  paths  are  
denoted  by  lines,  bond critical  points (BCPs)  are  denoted  by  black  
dois.  ring  critical  points (RCPs)  are  denoted  by  open  triangles  and  
the  nuclei  are denoted  by  crosses.  
an  odor  similar  to  maple  syrup.  This  disease  has  
severe  neurological  and  gastrointestinal  effects.  
The  current  treatment  for  it  involves  intense  control  
of  the  intake  of  leucine,  isoleucine  and  valine.  
This  careful  restriction  of  leucine  also  includes  
monitoring  of  the  branched  chain  amino  acids  in  
plasma. 
Leucine  is also found  in some small  proteoglycans.  
This  group  of  small,  interstitial  proteoglycans  has  a  
high  degree  of  homology  in  their  protein  core  
sequence.  Each  has  between  10  and  12  highly  
conserved  leucine  rich  tandem  repeats  which  makes  
up the central  portion of  the core protein. The  current  
members  of  the  group are fibromodulin and  lumican.  
which  are  keratan  sulphate  substituted,  as  well  as  
decorin  and  biglycan,  which  are  both  chondroitin  
sulphate  substituted.  Other  proteoglycans  which  
have  had  functions  ascribed  to  them  are  the  small  
leucine  rich  interstitial  proteoglycans  decorin  and  
fibromodulin  which  have  been  shown  to  modulate  
collagen  fibrillogenesis.  
The  knowledge  of  the  conformational  potential  
energy  surface for leucine would allow a better under 
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Fig.  20.  Relative  energies  of  the  N-  and  C-protected  leucine  with  
varying side chain conformations for the  |3L backbone conformation 
retaining trans  peptide  bonds  calculated  at  HF/3-21G  level  of  
theory. 
standing  of  diseases  such  as  MSUD  and the  function  
of  leucine  in  biological  processes  such  as  collagen  
fibrillogenesis.  Each  of  the  nine  possible  backbone  
conformations  is  associated  with  nine  possible  side  
chain  conformations.  In  addition,  there  are  four  
chain-end  conformations  associated  with  the  cis  and  
trans  peptide  bond  that  also  must  be  explored.  Thus  
the total  number of conformations to be considered  is  
9 x  9 x  4  =  324. The results of some calculations that 
have  been  carried out  for the  (3L backbone conforma-
tion  are shown  in  Fig.  20.  
4.2.5.  Tryptophan  (Trp)  
Tryptophan  is  one of  the essential  amino  acids  the  
body  cannot  manufacture  itself.  It  is  the  least  abun-
dant  in  proteins  and  is  destroyed  easily  by  the  liver.  
This amino acid  is necessary  for the production of the 
vitamin  B  niacin,  which  is  essential  for  the  brain  to  
manufacture  the  key  neurotransmitter  serotonin.  Low  
levels  of  serotonin  have  been  linked  with  insomnia,  
anxiety  and depression. 
Tryptophan is believed  to be effective for insomnia 
and jet  lag.  It  is  also  believed  to  have  anti-anxiety  
effects  and  control  aggressive  behavior  in  some  
individuals.  Other  studies  have  shown  that  its  anti-
depressant effect  lasts  longer  than  that of  the  popular  
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Fig.  21.  Potential  energy  curve  of D(CI-C2-C3-C4)  of  eihyl  indole.  
anti-depressant  drug,  Imipramine.  In  addition,  some  
preliminary  studies  of  combined  Vitamin  B-6  and  
tryptophan  show  that  they  may  be  effective  in  
reducing  the  severity  of  hyperventilation  as  well  as  
the  panic  attacks  produced  by  it.  
Although  it  is  safe  to  use,  tryptophan  is  no  longer  
available  in  supplement  form,  because  of  potential  
adverse  reactions.  Tryptophan  supplements  are  not  
recommended  in  cases  of  pregnancy,  asthmatics,  or  
auto-immune disorders like Lupus or Scleroderma.  As  
a  preliminary  investigation,  a scan  at HF/3-21G  level  
of  theory  was  performed  on  ethyl  indole  (Fig.  21).  
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Minima were  found to exist  at torsional  angles  (D) of  
0  and  in  the  vicinity  of  105°.  
4.2.6.  Lysine  (Lys)  
Similar to arginine,  lysine XVI is a basic  hydrophi-
lic amino acid.  At  neutral  pH, it is positively  charged,  
with  a typical  pXa  of  10.0.  One  can imagine  that  the  
two amino acids would be able to assume similar roles 
in  biological  systems.  They  may  increase  the  solubi-
lity of proteins,  furthermore, they can provide binding 
sites  at  the  surface  of  proteins.  However,  there  is  a  
main  stereochemical  difference  between  the  two  
molecules.  Lysine  has  a  hydrocarbon  chain  with  a  
terminal  tetrahedral  NH3(+),  whereas  the  terminal  
guanydilic  ion  of  arginine  is  planar.  This  difference  
may  be  important  in  the  fine-tuning  of  molecular  
interactions,  for example,  between  substrate  and  the  
active  site.  
have  also  been  investigated  at  the  ab  initio  level  
but  only  a  selected  few  conformers  were  studied.  
In  this  paper,  we  wish  to  illustrate  in  the  case  of  
tripeptide  Arg-Gly-Asp  (or  RGD  for  short)  and  in  
the  case  of  tetrapeptide  Pro-Pro-Thr-Pro  (or  PPTP  
for  short)  the  medical  importance  of  such  small  
oligopeptide  fragments.  
Single  amino acid diamides  or "monopeptides" for 
short, have nine unique conformers.  For diamino-acid 
diamides,  or  "dipeptides"  for  short,  each  amino  acid  
residue  has nine conformers. This leads to 9 X 9 =  81  
conformers  for dipeptides.  In  the  case  of  tripeptides,  
for each of the 81 dipeptides conformations there are 9 
conformers  for  the  third  amino  acid.  This  results  in  
9 X 9 X 9  =  729 conformers. The  name of each of  the 
729 conformers,  given  in subscripted  Greek  letters,  is  
summarized  in  Fig.  22.  These  729  conformers  are  
derived  within  the  law of  MDCA,  and  in  that  respect  
rt^  J  
H-  \  
~ch 2 
il  9  y  ¥  v V Y /  \  
Structure  of  lysine  XVI  
A > 
\ A 
H A , 
H 'O/X h A / A 
H  H  
Side chain  of  lysine  XVII  
Both,  the  side  chain  XVII  and  the  lysine  residue  
XVI  with the protected backbone,  are currently  being  
studied. 
5.  Dipeptide,  tripeptide,  and  tetrapeptide  
Most  of  the  oligopeptides  studied  so  far  at  the  ab  
initio  level  of  theory  involved  alanine.  All  backbone  
conformers  of  dialanine  diamides  have  been  studied  
[35-38].  Analogously  trialanine  diamide  (tripeptide)  
[39]  and  tetraalanine  diamide  (tetrapeptide)  [40]  
they  may be regarded as "legitimate" conformers. Not 
all  729  conformers  are  expected  to  exist.  In  certain  
folding  patterns,  the  terminal  groups  may  come  too  
close  and  such  minima  may  be  annihilated  due  to  
steric  repulsion.  The  pattern  shown  in  Table  2  has  
been  previously  recognized  for  HCON-(Ala)„-NH2  
via  ab initio computations  (Table  3).  
Mono-peptides,  dipeptides  and  tripeptides  contain  
1,  2  and  3  amino  acid  residues,  respectively.  In  
such  models,  the  chain  may  be  terminated  by  
methyl  groups  or  by  hydrogens,  (P =  Q  =  
CH3  or H)  as  shown  for  the  above  three  cases  by  
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Tabic  3  
Legitimate  and existing  conformers of  small  peptides  
n Legitimate  conformers  Conformers  found  
I 9 7 
2 81 49 ' 
3 729 Not  investigated  
*  These  49  conformers  were  found  by  optimizing  the  81  "legit-
imate"  conformers.  Subsequently,  Prof.  Lothar  Schafer  and  
coworkers  [Can. J. Chem. 76 (1998) 566] have scanned the confor-
mational  space computing  11 664 grid  points  at the HF/4-31G  level  
of  theory  and  located  one  more  conformer.  Now  the  number  of  
conformers  stands  at  50.  
II,  III  and  IV.  The  symbol  R®  represents  the  side-
chain  of  one  of  the  20  naturally  occurring  amino  
acids  (1 S j  £  20).  
expect  only  one  distinct  conformer along  Xs and X2< 
the  side  chain  may  be  represented  by  a  5D-confor-
mational  chain  subspace  (¿Klf  Xt.  Xs-  AN.  Xi')-
Consequently,  we  may  expect  3 s  = 2 4 3  side-chain  
conformations.  The  total  number  of  distinct  RGD  
conformers  may,  therefore,  be 729x243  =  177147.  
In view of the enormity of  the problem only a selected 
few  conformations  were  subjected  to  molecular  
computations. 
Table  4  summarizes  the  geometrical  parameters  
(e.g.  torsional  angles),  conformational  assignments  
and  relative  stabilities  of  the  RGD  structures  opti-
mized  at HF/3-21G  level  of  theory.  
The  last  two  structures of  the  table  are depicted  in  
Fig.  23.  Note  that one of  them  is without  the involve-
ment of Ca2+,  and therefore,  it exhibits  intramolecular  
salt bridge. The other structure is with Ca2+,  implying  
"  Hjg^  O-tU  
/• I  *l t  ,"l.Vjl  
H'S  YL  eVS-fStPo  YL  zN-H  
O-H  «i^VvzO'-'H  
H 
H  N—H  O  /  
N—q[®  CW|  
/  ,N—H  O  hT  
5.1.  Tripeptide  sequence.  RGD  
The  tripeptide  Arg-Gly-Asp  (RGD)  is  an  adhesive  
molecule  which  has  a  positively  and  a  negatively  
charged  side  chain  as  shown  in XVIII  in  accordance  
with  XI  and  XII.  The  positively  and  negatively  
charged  side  chains  may  be  engaged  in  salt  
bridge  XIX  formation either  via an  intra-  or  an  inter-
molecular  connection.  
The  structure shown in XVIII is the amide of  the N-
formyl derivative of the RGD-motif  and it is given in its 
t l t l t l  backbone  and  extended  (fully  ami)  side  chain  
conformations.  Once  again,  assuming  that  all  peptide  
bonds are of trans  configuration, the PES can be repre-
sented analytically  by  the following  function XX. 
The backbone  may  be  represented  by a 6D-confor-
mation  subspace  (<£i,i/i|,02,i/'2,<i>3,i/M)-  Since  we  may  
that  the  previously  negatively  charged  side  chain  
(-COO")  now  contains  a  mono-positive  (-COO"---
Ca + + )  ending.  Consequently,  there  is  no  chance  for  
intramolecular  salt-bridge  formation.  This  charge  
difference  in side-chain  has  implication  for the dock-
ing  mechanism.  Fig.  24  shows  a  possible  docking  
mechanism  without  the  involvement  of  Ca2t.  
Fig.  25  indicates  that  in  the  presence  of  Ca!+,  the  
receptor  would  need  two  negatively  charged  side  
chains  (i.e.  two carboxylate  ions).  
It  is  interesting  to  recall  the  result  of  the  physio-
logical  study  [41],  involving  GRGDS(fS-OH)  (c.f.  
Fig.  26)  and  GRGDSiP-O-SOi).  The  final  results  
are  summarized  in Table  5.  
It  seems  that  when  Ca2+  ion  is  not  present  the  
mechanism  given  in  Fig.  24  is  operative  and  thus  an  
extra  negative  charge  at  the  C-terminal  makes  no  
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Fig. 23. Two conformers of RGD without (top) and with C a "  (bottom) optimized  at the HF/3-21G level of theory corresponding  to structures E 
and  F respectively  in  Table  3.  
significant  change.  However,  when  Ca2+  ion  is  
present,  GRGDS((3-OH)  becomes  very  active,  favor-
ing  the  complex  formation  according  to  Fig.  25.  
However,  the  Ca-salt  of  GRGDS(|3-OSOJ)  has  only  
one charge, a positive charge at the Arg side chain, but 
no  charge  at  the  DS(P-OSOJ)  moiety  since  the  two  
(+)  and  the  two ( - )  will  lead  to  a  neutralization  as  
illustrated  in  XXI.  It  is  not  surprising  therefore  that  
under these conditions  the activity  is  reduced  greatly.  
One structure using  Mg ion  rather than Ca ion is opti-
mized  at the HF/3-21G  level of theory and is shown in 
Fig.  26.  
E =  E(4> „V, ,4>2.V2,4IJ,VJ,  X, .X2.XJ.X4.X5.X1 '.X2')  HZCV  
0.yNH2 HjN^ 'q 
pH,  u  0  ?  
backbone  side-chain  
HA.  ACA  ANa  ^ CA  ^ CA  ANA  eCH,  
Ï  9  J\  V  î  ? "'H  
XX  H  0  H  H  N  O  XC^  
?  °  
XXI  H  
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5.2.  Tetrapeptide  sequence,  PPTP  
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Fig.  25.  Receptor-RGD-complez  after docking,  in  the  presence  of  
C a ! i  ion.  
For  a  discussion  of  a  letrapeptide  example,  let  us  
briefly  review  immunoglobulin  A  (IgA).  Antibodies  
or  immunoglobulins  (Ig)  represent  the  great  defense  
force in the army of  the immune system.  Ig molecules  
are  produced  during  a  humoral  immune  response  to  
bind  and  neutralize  invading  antigens.  Subsequently,  
the  antigen  is  labeled  for  removal  by  phagocytosis.  
The  fight,  however,  is  not one-sided.  To  help  neutra-
lize the role of Ig in antigen recognition,  bacteria have 
developed effective deactivation  mechanisms.  One of  
them  involves  a site-specific  cleavage  of  an  Ig  mole-
cule  at the hinge region with the aid of an extracellular 
protease  produced  by  the  bacteria.  
Although  there  are  differences  in  their  catalytic  
mechanisms,  all  reported IgAses  fall  into  one  of  three  
types:  serine-, cysteine-,  or metallo-proteases  [42].  The 
IgAse from N. gonorrhea  has been classified as a serine 
protease  [43].  A  comparison  between  the  gene  and  
amino acid sequences of N. gonorrhea  and H.  influenzae 
[44,45] showed that they are 50% identical and contain a 
fingerprint  region for the chymotrypsin/trypsin family of 
serine  proteases  [42],  The  most  conserved  sequence,  
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Fig. 26. (A) An  internal  salt-bridge  forming conformer of RGDS(P-OH).  Conformer optimized  at the HF/3-2IG  level  of theory.  (B) An Mg :* 
complex  of  RGD (3-0S03-).  The conformer shown  was optimized  at  the  HF/3-21G  level  of  theory.  
GDSGGPL  (S =  active  serine  site)  is  found  in  the  
vicinity  of  Ser 250  in  N. gonorrhea  IgAse.  
There  is  an equal  amount  of  anionic  forming  (Glu,  
Asp, Tyr) and cationic  forming (Arg,  Lys,  His)  amino  
acid  side  chains  present  [44],  Based  on  the  nature  of  
the  inhibitors,  there  would  be  reason  to  believe  that  
these  oppositely  charged  moieties  are  not  uniformly  
distributed  in the tertiary  structure.  Instead,  it is  likely  
that  this enzyme  contains  concentrated  areas of  posi-
tive  charge  that  would  enable  the  IgAse  to  seek  out  
substrates  that  are negatively  charged  XXII.  The  fact  
that serine proteases contain histidine at the active  site  
suggests  that  the active  site of  the enzyme  will  also  be  
positively  charged.  
Table  5  
Summary  of physiological  effects of  GRGDS(P-OH)  and GRGDS(p-OSO,~)  in the  absence and  in the  presence  of Ca  ion  
Biological  phenomena  [Ca2+] Peptide  sequence  
GRGDS(ß-OH) GRGDSO-OSOj") 
Platelet  aggregation  Not  present  Active Active 
Vasodilator effect Present Very  active  Not  active  
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There  have  also  been  inhibition  studies  done  on  
short  peptide  segments  of  the  hinge  region  [46],  
such  as  Pro-Pro-Thr-Pro,  as  well  as  longer  ones  
and  these  have  been  found  to  act  as  mild  inhibitors.  
They  exhibit  IC»  values  in  the  micro-molar  
(10~6M)  range  or  higher.  Thus,  they  are  weak  
inhibitors  when  compared  with  the  ideal  nano-
molar  (10"'M)  range  values  expected  for  a  drug  
candidate. 
Successful  drug  candidates,  therefore,  may  need  
to  mimic  the  heptapeptide  segment  of  the  hinge  
region  containing  the  negative  charges  of  the  two  
sialylic  acid  moieties  XXIII.  The  structure  must  
be  appropriately  folded  and  should  not  exceed  a  
certain  molecular  weight.  Because  bacteria  became  
resistant  to  most  antibiotics  such  an  inhibitor  may  
become  a  successful  lead  compound  for  the  devel-
opment  of  several  possible  antibacterial  agents.  
While  these  target  oriented  research  projects  may  
be  laudable  nevertheless  it  is  lamentable  whether  
we  have  enough  information  to  search  for  these  
highly  desirable  compound.  What  is  needed  is  an  
extensive  database,  which  includes  peptide,  cyclo-
peptide,  and  peptidomimetic  conformations.  
To  date,  neither  X-ray  structure  for  the  IgA  hinge  
region  nor  for  the  IgA  protease  produced  by  N.  
gonorrhea  are  available.  Until  such  structures  
become  available,  we  can  carry  out  some  necessary  
conformational  structure  analyses.  With  the  aid  of  
the  enzyme  structure,  the  drug  design  process  may  
proceed  at  an  accelerated  pace.  The  most  obvious  
place  to  start  is  with  the  tetrapeptide  Pro-Pro-Thr-
Pro.  The  scission  occurs  at  the  Pro-Thr  peptide  bond  
and  we  have  included  at  least  the  nearest  neighbours  
at  each  end  (XXII).  
Clearly,  this  Pro-Pro-Thr-Pro  tetrapeptide  is  more  
complicated  than  Ala-Ala-Ala-Ala  [40]  because  Pro  
may  exhibit  cis-  and  franr-isomerism  in  its  peptide  
bonds,  as  well  as  syn-  and  ami-ring  puckering.  
Thus,  2 X 4  =  4  isomeric  forms  may  exist  for  each  
backbone  conformer.  Up  to  three  backbone  confor-
med  (y t,  eL,  aL)  may  be  expected;  thus  each  proline  
moiety  may have 4 x 3 =  12 conformations (Table 6). 
Consequently,  for the dipeptide  Me-CO-Pro-Pro-CO-
NHMe,  we  may  anticipate  12 X  12 =  144  conforma-
tions.  However,  even  if one  disregards  ring  puckering  
and considers  only  rrans-peptide  bonds,  Pro-Pro-Thr-
Pro  may  exhibit  3 x 3 x 9 x 3  =  243  backbone  
conformations.  Including  the  3 x 3  =  9  side  chain  
conformations  of  the  Thr side  chain  moiety,  this  will  
lead  to  a  total  of  243  X 9  or 2187  conformed.  Thus,  
the 243  backbone  conformations  may  be  best  studied  
on  Pro-Pro-Ala-Pro  and  the  Ala  side  chain  may  be  
extended  to  a  Thr  side  chain  subsequently.  One  of  
the 2187 conformed  has  been  optimized  in our preli-
minary  study  and  the  structure  is  shown  in  Fig.  27.  
The  central  Pro-Thr  structure  turned  out  to  be  yL  yD,  
which  has  been  previously  identified  as  a  new  type  
of  (3-turn [36].  It is  interesting  to  note  that  several  of  
the  oxygen  atoms  occupy  a  region  of  the  space  
creating  an  electron-rich  domain.  Such  a  display  of  
high  electron  density  may  play  a  role  in  the  docking  
of  the PPTP moiety  within  the hinge into the cavity  of  
the  IgAse.  
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Side  chain  dimensionality  of  selected  representative  compounds  and  their  corresponding  amino  acids—excluding  methyl-group  rotation  
(proline  and  glycine  have  no dimensionality;  alanine  has  methyl  rotation  dimensionality  only)  
Model  compound  Amino  acid  residue  
Dimensionality Structure Compound Di 
0 CH,-CH-(CH,) j Valine  (Val)  1 
1 CHJ-CH;-CH-(CHJ)J Leucine  (Leu)  r 
1 CH3-CH(CH3)-CH2-CHJ Isoleucine  (lie)  s 
1 CHj-CHi-Ph Phenylalanine  (Phe)  a 
1 CHj-CHÎ-COOH Aspartic  Acid  (Asp)  
I CHj-CHi-CONH; Asparagine  (Asn)  2 
1 CH 3 -CHI-C=CH-NH-CH 2 =N; Histidine  (His)  2 
1 CHj-CH,-she Selnocysteine  (Sec)  2 
1 CHj -CH : -SH Cysteine  (Cys)  2 
1 C H j - C H - O H Serine  (Set)  2 
1 CH,-HCOH-CHj Threonine  (Thr)  2 
1 CHj-CHj-Indole Tryptophan  (Trp)  2 
2 CHJ-(CH;);-S-CH3 Methionine  (Met)  3 
2 CHJ-CH,-PII-OH Tyrosine  (Tyr)  3 
2 CHj-CCH^-COOH Glutamic  Acid  (Glu)  3 
2 CHj- tCHjk-CONH; Glutamine  (Gin)  3 
3 CHJ-(CHi)4-NH]+ 1 Lysine  (Lys)  4 
3 CHJ-(CH !)J-NH-C-(NH !) 2(+) Arginine  (Arg)  4 
mensionality 
6.  Cvclopeptide  conformations  for CsH9N303  and  
C8H12N4O4 
Cyclopeptide  structures  XXIV  have  not  been  
studied as extensively  as their open chain counterparts.  
Once  the  ring  size  increases,  it  is  more  difficult  to  
optimize  all  stable  conformations  in  order  to  explore  
the conformational space of these types of cyclic  mole-
cules.  Ab  initio  MO  (HF/STO-3G,  HF/3-21G,  HF/6-
31G")  and  DFT/6-31G"  (using  B3LYP  functional)  
computations  are  to  be  carried  out  on  various  cyclo-
peptides (C2H3NO)„ for 3  <  n  <  4. AII-cis-CONH and 
all-rra/u-CONH  structures  were  considered.  Typical  
optimized  structures  are shown  in Figs.  28  and 29. 
PrQ  -101.7*  
Cdi = +160.5° 
Vi -  -36.4°  (XL  
1  \  il = -53.1° 
u>o=+173.2° 
Fig.  27.  An  optimized  structure  of  the  tetrapeptide  Pro-Pro-Thr-Pro  (PPTP).  
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Conformer no.  1 
Conformer no.  2  
Fig. 28. Conformers of  all-cir-cyclotriglycine  and  all-mrnj-cyclotriglycine.  
in  various  classes  of  natural  and  synthetic  drugs,  
although  they  are  most  commonly  found  in  classes  
of  antibiotics  such  as  "lantibiotics"  (lanthionine  
containing  gene-encoded  peptides  with  antibiotic  
properties  such  as  nisin  [47,48],  subtiiin  [47,49]  and  
ancovenin  [47])  and  the  thiopeptide  antibiotics  
[50,51]  beminamycin  A,  B,  C  and  D.  They  are  also  
increasingly  used  in  the  synthesis  of  enkephalin  
analogues  having  different potencies  and  selectivities  
from  the  parent  compound  [52-54].  
The  simplest  ot,|3-dehydroamino  acid  is  AAla  Fig.  
30, having no substituents on  its beta carbon.  Because  
it is  the only  unsubStituted ot,0-dehydroamino acid,  its  
experimentally  observed  conformations  differ signifi-
cantly  from  those  of  the  other  dehydro  residues  
[55,56].  In this sense,  AAla is  reminiscent  of  glycine,  
which  also  has  very  different  properties  from the  rest  
of  the  naturally  occurring  amino acids,  due to its  lack  
of  a side  chain  [16,17].  
Through ab initio calculations,  it has been found that 
rrans-For-AAla-NH2  can  take on seven  ([inL,  8„, 8L, eD, 
tL,  -yD and yL) of the nine theoretical  conformations of a 
o 
0 
For  small  rings,  such  as  diketropyperazine  
(C2H3NO)2,  XXIV,  only  m-peptide  bonds  are  
allowed.  As  the  ring  size  increases,  the  ring  will  
tolerate  frans-peptide  bonds  although  for  cyclic  tri-
glycine  (C2H3NO)3,  the  ring  is  very  strained.  The  
situation  is  somewhat  better  of  cyclotetraglycine  
(C2H3NO)4. 
7.  Conformational  analysis  of  simple  
peptidomimetics 
7.1.  Dehydroalanine  (Dha  or  AAla)  
The  a,p-dehydroamino  acid  residues  occur  widely  
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Conformer no. 3 
Fig. 29. Conformera of all-cij-cyclotetraglycine  and  all-frarw-cyclotetraglycine.  
? 
NH2 
Fig.  30. Torsional  angles  oro,  <3 and  i/r of  N-  and  C-protected  2,3-
didchydroalanine.  ru0  is  approximately  180° for  rrrrrts-2,3-didehy-
droalanine. 
saturated  amino acid residue  Fig.  31,  whereas, even N 
and C protected glycine,  can actually only  take on five. 
Furthermore,  it  has  also  been  found,  by  means  of  
relative  and stabilization energies,  that although AAla 
is  more  rigid  than  glycine  Fig.  32,  it  has  a  much  
greater  stabilizing  effect  on  the  peptide  chain  as  
shown in Fig. 33.  In fact, AAla has a greater stabilizing 
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Fig.  31. The  seven stable conformations  of  N-  and  C-protected  rrrrru-2,3-didehydtoalanine  as computed  at  B3LYP/6-31G-.  
I Or 
Fig. 32. Relative energies of  the various conformations of N- and C-prolected omr-2,3-didehydroalanine  (solid line) and rrnns-glycine  (dashed  
line) computed  at  B3LYP/6-31G"  level  of  theory.  
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Fig. 33.  Relative stabilization  energies of  various side chains for /raiu-For-CHR-NH;,  calculated  according  to the equation  given at  the top of 
Fig.  17. The  most  stabilizing  conformer  of  rrruis-For-AAIa-NH;  is  the  PDL  one  and  hence  its  stabilization  energy,  instead  of  that  of  the  yL  
conformer,  is  given.  This  value  was  calculated  according  to  the  following  isodesmic  equation:  HCONH-CH,-CONH,  +  H-OCH, — 
HCONH-C(=CH,)-CONH,  +  CHj.  
effect than most of  the saturated residues examined  so  
far,  except  for  serine  and  deprotonated  aspartic  acid  
[57]. These results  can have great implications  for the 
future of  peptide  based  drug design. 
7.2.  Chiral  pseudo-peptide  and  selected  derivatives  
Due  to  their  newly  discovered  pharmacological  
properties,  pseudo-peptides  are  able  not  only  to  
substitute  peptides,  but  also  essentially  improve  
their  pharmacological  action  [58-63].  In  order  to  
assist  the  search  for  new  compounds  with  desired  
pharmacological  properties,  conformational  proper-
ties of  three  model  pseudo-peptides  were  investigated  
by  semi-empirical  and  ab  initio  MO  methods.  The  
three models  include  the protonated  form of iV-formyl 
pseudo-alaninamide  HCONH-CHMe-CH2NH3.  
Af-formyl  pseudo-alanine  itself  HCONH-CHMe-
CH2NH2  as  well  as  the  formylated  /V-formyl  
pseudo-alanine  (i.e.  propylene-di(Af-formylamine))  
HCONH-CHMe-CH2NHCOH  [64]:  XXV,  XXVI,  
XXVII. 
For  compound  XXV,  which  is  an  W-protonated  
pseudo-peptide  derived  from  iV-formylalaninamide,  
both  trans-  and  c/s-configurations  were  considered  
(i.e.  <u=  180° and 0°). 
h A ; X c 4 « « i i s K w £ f x  H j v v V  
ii  ft  ^  i.  k  *  #  J  
XXV XXVI XXVII 
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Fig.  34. Topology  of  a  Ramachandran-type  PES of  the  simplest  chiral  pseudo-peptide  derived  from N-formylalaninamide. 
Taking  into  the  account  the  dominant  role  of  the  
peptide  backbone,  it  was  important  to assess  how  the  
backbone  changes  under  the  transition  from peptides  
to pseudo-peptides.  To characterize the backbones for 
compounds  XXV  and  XXVI,  four  dihedral  angles  
were  chosen,  namely  ID,  <p,  t¡i,  6.  In  addition,  
compound XVII  was characterized  by a fifth dihedral 
angle  ID.  The  conformations  of  the  simplest  pseudo-
peptides  were conveniently  described  by a 2D-Rama-
chandran  map,  i.e.  a  2D-conformational  potential  
energy  surface  (PES).  This  surface  was  defined  in  
terms  of  two  dihedral  angles,  ip  and  i/r,  varying  
between  0°  and  360°  [16,17,57,64-66].  To  describe  
pseudo-peptide  conformations,  the 9  expected  legiti-
mate  minima for model  compounds XXV,  XXVI  and  
XXVII  were  carefully  optimized.  
Both  semi-empirical  [67]  and  ab  initio  [14]  RHF  
SCF calculations were performed on typical  backbone  
conformations.  For ab initio calculations,  the  RHF/3-
2IG level of theory was used for all compounds under 
consideration.  To  check  the  validity  of  the  results  in  
some  cases,  calculations  were  performed  on  RHF/6-
31G(d)  level  of  theory.  It  was  found  that  the  
geometries  of  pseudo-peptides  in their global  minima  
are determined  by  H-bonds.  
According  to  the  computational  results,  pseudo-
peptides,  in  general,  can  mimic  the  backbone  of  the  
parent  peptides,  as  shown  by  the  experimental  data  
[62,63].  Pseudo-alanine  was  shown  to  be  more  
flexible,  than  the  parent  alanine.  Fig.  34  shows  the  
topology  of  the  E  (<t>,  i¡i)  PES  which  is  analogous  to  
the  Ramachandran  map.  
8.  Non-peptidic  bioactive  molecules:  
8.1.  Antioxidants  
During  the  metabolism  of  foodstuffs,  carbon  is  
oxidized  to C02  with  the help  of  the  inhaled  oxygen.  
Parallel  to  that,  0 2  is  reduced  through  a  multistep  
process  to H20.  
• H,0 2 • 2H,0 (15) 
1 
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Somewhere  along  this  line,  hydroxy  radical  (HO )  is  
released  in  small  amounts.  Due  to  the  non-discrimi-
native reactivity of (HO),  it damages a number of key 
organic compounds  in the  human body.  Among  these  
are  DNA,  the  damage  of  which  leads  to  premature  
aging  as  well  as  numerous  including  cancer.  
Collectively,  these processes  are labeled as "oxidative 
stress" and can be relieved  by free radical  scavengers,  
called  antioxidants,  such  as  ilavones,  selenocysteine  
and lycopene.  It has also been recognized recently that 
certain  drugs  can  act  as  antioxidants.  
8.1.1.  Flavone  conformations  
Flavone  is  the  parent molecule  of  a broad  range of  
compounds  belonging  to  the  family  of  flavonoids.  
Flavonoids  are  polyphenolic  compounds,  which  
occur as yellow  pigments  in plants. They  are believed 
to  be  effective  against  HIV,  cancer,  coronary  artery  
disease  and  aging  [68],  
Conformational  analyses  were  performed  on  
flavone  and  three  other  related  compounds,  namely  
2-phenyl  pyranone,  p-phenyl  naphthalene  and  
biphenyl.  In  particular,  the  phenyl  rotation  with  
respect  to  the  rest  of  the  molecule  was  studied  using  
Hartree-Fock  (HF)  calculations  performed  on  
G a u s s i a n  94.  The  basis  sets  employed  were  STO-
3 G  and 3 - 2 1 G .  It was concluded that the hydrocarbons 
(biphenyl  and  P-phenyl  naphthalene)  are  noticeably  
different  from  oxygen  containing  heterocyclic  
analogues  such  as 2-phenyl  pyranone  and  flavone, as 
far  as  phenyl  rotation  is  concerned.  One  would  also  
expect  a  difference  in  their  reactivity  towards  free  
radicals.  It  seems  that  only  the  oxygen  heterocyclic  
analogues  can  be reactive  in nucleophilic  and radical  
attack because  they contain positively  charged atoms, 
as  shown  by  computed  Mulliken  charges.  Neverthe-
less,  the  topology  at  the  potential  energy  curves  
(number of  minima  and  transitions  structures)  is  the  
same  for all  four compounds.  
The  potential  energy  curve  of  flavone  is  shown  in  
Fig.  35.  The  antioxidant  mechanism  of  flavone  
skeleton  is  now  under  investigation.  
8.1.2.  Selenocysteine  as  antioxidant  
Selenocysteine  is involved in a variety of  biochem-
ical  interactions  and  has  recently  been  considered  as  
the 21st  amino  acid  used  by  nature for RNA  directed  
protein  synthesis  [69,70].  Several  selenoproteins  
containing  selenocysteine  at  their  active  sites  have  
been  identified  using  neutron  activation  analysis.  At  
the  end  of  the  20th  century,  possibly  28  of  these  
proteins  are  known  to exist.  At  present,  however,  we  
know  very  little  about  the  structure  and  function  of  
most of  these  proteins.  Those  that  have  been  charac-
terized and for which functions are known include the  
following: 
(a)  Four species of  glutathione  peroxidase  [71-73]  
(cellular  or  classic,  extracellular  or  plasma,  
gastrointestinal  and  phospholipid  hydroperoxide  
glutathione  peroxidase)  have  been  identified.  
Glutathione  (GSH)  peroxidase  catalyses  (Fig.  36)  
the reduction of a variety of hydroperoxides  includ-
ing  lipid hydroperoxides  (which,  in  the presence  of  
trace  metals,  can  form  toxic  lipid  radicals).  This  
mechanism  is  believed  to  protect  biomembranes  
and  other  essential  cellular  components  against  
oxidative  challenge  [74-76],  cancer  [77]  and  
gastric  ulceration  [78].  
(b)  Selenoprotein  P  is  an  extra-cellular  protein  
presumably  containing  10 Selenocysteine  residues  
that are encoded by the UGA stop codon in the open 
reading  frame  of  the  mRNA.  Some  indirect  
evidence  suggests  that  selenoprotein  P  acts  as  a  
free radical  scavenger  [79].  
(c)  Selenoprotein  W is  found  in  muscles  [80].  
(d)  Iodothyronine  deiodinase  catalyzes  the  de-
iodination  of  thyroxine  to  the  biologically  more  
active  thyroid  hormone  triidothyronine  [81].  
(e)  Thiroredoxin  reductase  catalyzes  the  NADPH-
dependent  reduction  of  the  redox  protein  thio-
redoxin.  Thioredoxin  stimulates cell  growth  and is  
over-expressed  in  a  number  of  human  cancerous  
cells  [82,83],  
(f)  Mitochondrial  selenoprotein  [84]  was  localized  
in  the  mitochondrial  membranes  of  endocrine  
organs. 
(g)  Prostatic  selenoprotein  and  testicular  seleno-
protein  were  found  in  spermatid  nuclei.  Recent  
findings suggest  that  it  takes  part  in  the  process  of  
replacing  and  condensation  of  the  DNA,  which  
occur  in  the  spermatid  nuclei,  and  thus  may  have  
an  important  function  in  sperm  development  
[85,86]. 
In  addition  to  the  above,  new  evidence,  based  on  
sequence  analysis,  suggests  that  HIV-1  encodes  a  
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Fig.  35.  Phenyl  torsional  potential  of  the  flavone  skeleton.  
protein  containing  selenocysteine  (Sec)  (87-89).  It  
has  been  observed  previously  that  plasma  selenium  
and glutathione  levels  are subnormal  in  HIV-infected 
individuals  [90]  and  that  specifically,  four  75Se-
containing  proteins  are  lower  in  HIV-infected  cell  
populations  than  in  uninfected cell  populations.  
8.1.3.  Lycopene  and free  radicals  
Lycopene is a very important free radical  scavenger 
[91,92].  It  is  a  polyene  with  15  conjugated  double  
bonds.  There  are  numerous  cis-  and  rrani-isomers  of  
lycopene  (c.f.  Fig.  37).  The  all  trans  isomer  is  the  
predominant  species  in tomatoes  and tomato products 
(=95%).  The  5  cis-,  13  cis-  and  9  cis-  lycopene  are  
H 2 o  g s h  
Fig.  36.  Putative  catalytic  mechanism  of  glutathione  peroxidase.  
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all-trans lycopene 
15-cia  lycopene  
13-cia  lycopene  
11 -eis lycopene 
9-cij lycopene 
1-cis lycopene 
5-cls  lycopene 
7,9,9',7-cw  lycopene  
(Zechmeister,  1941)  
Fig. 37. Geometrical  isomers  of  lycopene.  
found in human serum, making  up approximately  half  
the  total  lycopene  content.  Isomers  with  multiple  cis-
double  bonds  are  also  known.  For example  7,9,9',7'  
cii-lycopene  is  the  naturally  occurring  form of  lyco-
pene  in  fresh Tangerine-type  tomatoes  is  also  shown  
in Fig.  37.  
Two  isomers  of  1,3,5  hexatriene  were  used  to  
model  eis-  and  franj-lycopene.  The  central  double  
bond  (A  [4-6])  of  hexatriene  was  used  in  the  cis-
and  trans-forms.  For  the  computational  convenience,  
free  radical  fluorine  atom  CF)  was  used  instead  of  
the  biologically  more  important  hydroxy  radical  
(OH). 
Through  ab  initio  calculations,  using  ROHF/6-
31 + +G(d,p)  and  UHF/6-31G(d,p)  methods,  it  has  
been  found  that  if  C2  or  C3  of  the  1,3,5  hexatriene  
is  fluorinated,  both the  trans  and cis  isomers  have  the  
same relative energies.  On the other hand, fluorinating 
C1  makes  a  difference  of  3.7  kcal/mol  between  the  
trans  and  the  cis  isomer,  the  trans  isomer  being  
more  stable  Fig.  38.  
8.1.4.  Carvedilol  as  a  new  antioxidant  
The  Merck  Index  recognizes  Carvedilol  ( X X V I I I )  
as  a nonselect ive  ß-blocker  with  vasodilating  activity,  
MeO.  .¿v.  
H 
J U 
(-hydroxylated  Carvedilol  
4-[2-hydroxyl-3-[[2-<2-mc[hoxy-phenoxy)e[hyl]anuno|propoxyl] 
-9H-carbaa>l-Fol 
M.A.  Berg  et al. /Journal  of Molecular  Structure  (Theochem)  500  (2000)  5-58  
LYCOPENE  MODEL  
43 
-329.36  •  +  A V A  
\  ®  a  o  ® » ® u i  
-329.3634  -  ^  S  
TRANS  CIS  ft  
-329.37  \ \  
V, 
jr  v.  \  ;  
t  •329-38' f i i t \ \  / /  Vfc^fl  
S  . , «  •  \-329.3855  -329.3858/  •! ® V %  ^  C  TRANS2  T2  C2  ;;  9  QS2  
-329.39  • X l  \ \  . 3 2 9 . 3 9 3 2 /  
Q ®  "TRANS 3  %  \••-329.3951 T " r - O f  ;  p o  9 ^ 0  9  
-  O s  (  3.658 kcal/mol  )  1 6  i  a s ,  F°  TRANS I  V  er  us J 
Fig.  38.  Relative energies  of radical  addition  products  to  lycopene  models computed  at  RHF/3-2IG  level  of  theory.  
which  is  mediated  by  its  antagonizing  effect  on  
ct-adrenoceptors.  It  was  firstly  patented  in  Germany  
in  1979  and  subsequently  in  the  US  in  1985.  
Carvedilol  has  been  used  in  the  treatment  of  
hypertension  [93],  angina  pectoris  and  congestive  
heart  failure.  In  these  fields,  carvedilol  is  at  least  as  
effective  as  reference  drugs  (metoprolol  [94],  
enalapril,  verapamil  [95])  but  its  side  effect profile  is  
better,  and  it  has  more  beneficial effects. 
According  to  clinical  trials,  carvedilol  effectively  
reduced  the  morbidity  and  mortality  rates  in-
patients  suffering  from  chronic  heart  failure  to  
such  an  extent  that  the  US  Data  and  Safety  Moni-
toring  Board  stopped,  for  ethical  reasons,  the  inves-
tigation  before  its  completion  [96].  This  was  the  
first  time  in  the  history  of  drug  investigations  that  
a  clinical  trial  was  stopped  because  the  drug  was  
too  effective.  It  seemed  unethical  to  deprive  the  
medication  from  placebo  group.  Carvedilol  also  
reduces  the  frequency  of  reversible  myocardial  
ischaemic  events  after  thrombolysis  [97]  and  
prevents  cardiac  remodeling  in-patients  suffering  
from  left  ventricular  dysfunction  after  acute  
myocardial  infraction  [98].  This  latter  effect  has  
been  attributed  to  its  scavenging  action  of  oxygen  
free  radicals  and  preventing  the  lipid  peroxidation  
[97].  These  reactive  radicals  are  implicated  in  the  
process  of  programmed  cardiac  cells  death  (apop-
tosis)  [99]  and  the  concomitant  loss  of  myocardial  
cells  leading  to  progressive  decrease  of  left  ventri-
cular  mass  and  function  [100],  
Originated  from  this  antioxidant  property,  
carvedilol  may  also  prevent  the  development  of  
nitrate  tolerance  in,  patients  receiving  continuous  
nitrate  therapy  [101,102].  
Apart  from  carvedilol,  at  least  one  of  its  3-hydro-
xylated  metabolites  (XXIX)  has  marked  antioxidant  
properties.  The  metabolite  is  approximately  a  
thousandfold  more effective  than  vitamin  E in certain 
experimental  setups  and  more  effective  than  
carvedilol  itself.  Although  the  exact  antioxidant  
mechanism  of  these  compounds  is  not  known,  recent  
structure activity  relationships indicate  that its activity 
resides in the carbazol ring. A computational  mechan-
istic study on this exceptional  antioxidant capability  is  
now  in  progress.  
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8.2.  Medicinal  chemistry  and  drugs  
Most  of  today's  marketed  medications  were  found  
by chance  or  by  systematic  screening  of  large  collec-
tions  of  compounds  (called  "libraries")  either  from  
natural  or  man-made  sources.  Current  emphasis  on  
high-throughput  screening  and combinatorial  chemis-
try  suggests  that  an  educated  guess  is  pivotal  for  the  
discovery  of  tomorrow's  drugs.  Computer  assisted  
molecular  modeling  (CAMM)  is  a  relatively  new  
and rapidly  developing  tool  in drug design.  Computer  
graphics  techniques  allow  the  transformation  of  
complex  data  sets,  obtained  e.g.  from  theoretical  
chemical  calculations  or  X-ray  diffraction  patterns,  
into  an  image  on  a  computer  screen.  Chemical  
structures  and  their  properties  may  thus  be  
visualized,  manipulated,  and  matched  or  combined  
with  other  relevant  molecules.  The  availability  of  
the  three-dimensional  architecture  of  HIV  protease,  
thymidylate  synthase,  thrombin,  carbonic  anhydrase,  
and many  more has  led  to  at least  an equal  number of 
new chemical entities being evaluated and used now in 
clinics.  In  such  cases,  CAMM  has  certainly  led  to a 
more  rational  approach  toward  drug  discovery,  in  
particular  when  the  binding  domains  for  inhibitors  
and  substrates  are  known  from  cocrystallization  
experiments.  Knowing  the  "lock"  definitely  helps  in  
designing  the "key", although  the interaction  between  
newly  synthesized  ligands  and the  target  macromole-
cule  may  appear sometimes  unexpectedly.  
Locking  into  certain  stereochemically  important  
conformations  is  sometimes  achieved  by  heavy  
substitution,  such  as  o,o'  difluorophenyl  groups.  
This  principle  has  been  applied  in  one  of  the  anti-
HIV  drugs  where  o,o'  difluoride  substitutions  are  
used  [103],  
Calculations  of  the  barriers  and  associated  one-
dimensional  torsional  potential  are  performed  for  
the  internal  rotation  of  the  nitro-group  in  nitroben-
zene  as  well  as  for o-fluoro-  and  o,o'-difluoro-nitro-
benzenes  [104],  This  structure  is  related  to  certain  
drugs,  such  as  the  one  shown  in  XXX,  that  are  
under  investigation.  It  is  shown  that  the  presence  
of  substituents  in  ortho-positions  forces  the  benzene  
ring  to  rotate  about  the C - N  bond,  out  of  the  plane  
of  the  nitro  group.  In  these  conjugated  molecules,  
the  inclusion  of  electron  correlation  is  shown  to  be  
necessary  for  reliable  barrier  prediction.  The  poten-
tial  curves  at  HF  level  are  shown  on  Fig.  39.  
Corresponding  MP2  values  are  given  by  " + " 
symbol.  It  is  found  that  the  tr-slabilization  (reso-
nance)  is  of  relatively  small  contribution  to  the  
structure  of  the  nitroaromatics,  whereas  the  steric  
repulsion  between  the  orrho-substituents  and  
oxygen  atoms  of  the  NO,  group  is  rather  signifi-
cant.  The  interplay  between  them  accounts  for  the  
fact  that  for  o,o'-C6H3F2N02,  the  barrier  height  at  
0°  is  larger  than  that  at  90°,  when  electron  correla-
tion  is  included.  The  values  for  the  barrier  at  0°  
were  2.67  and  3.81  kcal/mol  computed  without  and  
with  electron  correlation  and  the  corresponding  
values  at  90°  were  1.42  and  0.91  kcal/mol,  respec-
tively. 
A  fairly  large  area  of  drug  design  is  related  to  G-
protein  coupled  receptors.  A  preliminary  structural  
analysis  of  the  |32  adrenergic  G-protein  coupled  
receptor  was  considered.  This  receptor  is  a  trans-
membrane  protein,  and  it  usually  consists  of  seven  
bundles  of  a-helices.  Each  of  these  seven  helices  
consists  of  approximately  21-24  amino  acids,  as  
required  to span  the cell  membrane.  In order to deter-
mine  the  type  of  interaction  between  the  helices,  an  
a-helix  made  up  of  seven  alanine  residues  was  built  
using  HYPERCHEM.  Two  other  helices  were  built  
in  the  same  manner,  except  one  of  the  amino  acids  
was changed  to  serine  and  tryptophan  respectively.  It  
was  found  that  amino  acids  arrange  so  that  many  of  
the  polar  amino  acids  can  face  the  cavity  and  non-
polar  amino  acids  can  face  away  from  the  cavity.  
This  is  expected  because  a  hydrophobic  lipid  
membrane  surrounds  the  outer  circumference  of  the  
bundle  of  seven  helices.  Interactions  between  resi-
dues  of  a  helix  such  as  that  between  tryptophan  
and  serine  are  practically  thermo-neutral.  Interaction  
between  the  Ala-Ala  helices  has  a  stabilization  
energy  of  —3.0 kcal/mol,  while  that  between  the  
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Fig.  39.  Phenyl  rotation  in  nitrobenzene,  o-fluronitrobenzene  and  o,o'-difluronitrobenzene.  
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Fig.  40.  Helical  structure  of  N-  and  C-prolected  polyalanines  HCO-(Ala)„-NH2  (n  =  6.8,10.12).  
Ser-Ser  helices  has  a  stabilization  energy  of  
- 8 . 2  kcal/mol  [105).  The  interaction  between  two  
serines  result  in  a  greater  stabilization  energy  than  
that  of  the  two  alanine  residues  interacting.  Thus,  
replacing  the  alanine  with  serine  resulted  in  larger  
stabilization  energy  but  replacing  serine  with  trypto-
phan  did  not  significantly  change  the  stabilization  
energy.  An  ab  initio  study  on  the  helical  structure  
of  For-(Ala)„-NH2  has  been  carried  out  for  n  =  
6,8,10  and  12 (c.f.  Fig.  40).  
Cell  cycle  inhibitors  or  modulators  that  halt  
uncontrollable  tumor  growth  are  regarded  as  highly  
promising  new  therapeutic  agents  against  human  
cancer.  Certain  sulfonamides  [106]  inhibit  micro-
tubule  assembly  owing  to  its  reversible  binding  to  
the  colchicine-binding  site  on  tubulin.  They  also  
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exhibit good in vivo antitumor activity against  various 
rodent tumors and human tumor xenografts. The focus 
on  making  a sulfonamide  compound  library  is  based  
upon  template  XXXI  ever  since  compound  XXXII  
was  found  to  inhibit  cellular  growth  and  mitosis  in  
vitro,  but  not  quite  potent  in  vivo.  In  the  design  of  
this template, the sulfonamide moiety  located between 
two aromatic rings was fixed as a basic  motif,  and the 
NH group at the orlho  position of the sulfonamide was 
considered  a key  functionality  for substantial  antipro-
liferative activity  in cell-based  assays  [106],  
A  substantially  different  aromatic  sulfonamide  
(XXXIII)  has  also  been  reported  [107]  to  interact  
with  microtubules  during  cell  division.  Concerning  
the  recently  reported  polyfluorodiarylsulfonamide  
(XXXIII),  we  are  now  involved  in  assessing  its  
mechanism  of  action.  
9.  Multidimensional  conformational  analysis  of  
allyl  methyl  disulfide:  a key  component  of  garlic  
Garlic  has  been  one  of  the  most  popular  medi-
cally  researched  plants,  with  over  1300  research  
articles  in  only  the  last  100  years  [108].  Organo-
sulfur  compounds  in  garlic,  like  allyl  methyl  
disulfide,  have  been  found  to  be  involved  in  anti-
mutagenic,  anticarcinogenic,  antithrombotic,  and  
lipid-lowering  activities,  and  it  has  also  been  
found  to  act  as  an  antioxidant.  Ab  initio  molecular  
computations  were  performed  on  allyl  methyl  
disulfide  (XXXIV)  
H2 
" 2 < \  / C \ / \  xxxiv  
C  S  CH,  
H 
with  respect  to  torsional  angles  Tj =  7fH3C2'CH2-
S - S C H 3 ) ,  T2  =  T ( H 3 C 2 C H 2 - S - S C H 3 ) ,  and  T3  =  
T(H3C2-CH2SSCH3).  Potential  energy  scans,  
resulting  in  potential  energy  curves  (PEC),  were  
performed  along  a,  b  and  c  as  shown  in  Fig.  40,  
at  the  HF/3-21G  level  of  theory.  All  conformations  
were  optimized  at  the  HF/6-31G'  level  of  theory  
and  their  energy  values  are  provided  in  Fig.  41  as  
well.  The  potential  energy  hypersurface  surface  
(PEHS)  of  XXXIV,  i.e.  E  =  £(r,,  T2, T3),  revealed  
six  lower  energy  pairs  of  enantiomeric  minima  (i.e.,  
[g_+g"Vlg~g~g~^  _ [ g V g + l  
g  g+_g  "]:  [g+g+g  |g  g~g+];  [g+<2g  |g  ag+];  and  
[g+g  g  lg  g + g + )  a s  w e ' l  a s  'hree  higher  energy  
minima  (i.e.  g + g + x | g ~ g g * a s \ g ~ a s } \  and  
[g+g"J |g"g+ 1])  w e r e  optimized  at  7"j =  ±90°using  
the  two  HF/6-31G"  and  B3LYP/6-31G'  methods  at  
this  level  of  theory  (Fig.  40).  In  our  previous  study  
on  the  multidimensional  conformational  analysis  of  
ethyl  benzene  [109],  we  found  that  very  often  two  
minima result  when a planar moiety  is  rotated against  
a  tetrahedral  moiety,  one  of  them  being  higher  (0°  
rotation)  and  the  other  being  lower  (90°  rotation)  in  
energy. 
As  illustrated  in  Fig.  41,  it  is  apparently  clear  
that  the  center  of  symmetry  of  the  PEHS  of  
XXXIV  is  at  r,  =  r2  =  r3  =  180°,  i.e.  at  the  fully  
anti-anti-anti  orientation.  Therefore,  if  an  imagin-
ary  line  can  be  drawn  through  this  fully  ami  center  
from  one  energy  platform  to  the  other  on  the  PEHS  
of  XXXIV,  then  the  structures  along  such  a  line  
are  enantiomers.  Conversely,  if  an  imaginary  line  
joining  two  conformers  cannot  be  drawn  through  
fully  ami  center,  then  the  structures  are  diastereo-
mers.  Therefore,  although  there  are  no  stereocentres  
in  XXXIII,  there  is  chirality  in  the  conformational  
twist  with  respect  to  the  fully  symmetrical  anti-
anti-ami  structure  [aaa]  through  t,  =  T2 =  T3  =  
180°. 
In order  to denote  the enantiomeric  relationship of  
each  pair  of  conformers,  a  convenient  notation  has  
been  adopted,  with  the  symbol  representing  a  
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Fig. 41. Topology of the conformational the PEHS of XXXIV (allyl methyl disulfide), where E  =  £(r, , r2, Tj). (A) The notation of the 6 pairs of 
lower energy conformers (along a, a', b and b'), the 3 pairs of higher energy conformers (along c and c') and the fully symmetrical ami structure. 
(B)  The  relative  energies  in  kcalAnol  of  the  6  pairs  of  lower  energy  conformers,  the  3  pairs  of  higher  energy  conformers,  and  the  fully  
symmetrical ami structure.  (All  energy  values obtained  at  the  HF/6-3IG'  level  of  theory).  Note  that  the centre  of  symmetry  is denoted  by a 
solid  dot  and  corresponds  to  the  r,  =  r ,  =  r ,  =  180°.  fully anil  conformation  (a a a)  as  shown  in  Fig.  42.  [Cross-sections  were  studied  at  
a.a'.b.b'.c  and c'].  All  conformations  were  optimized  at  the  HF/6-31G'  level  of  theory.  
mirror  between  two  enantiomers.  The  global  mini-
mum  was  determined  to  be  the  [g + g~g + |g~g + g~]  
conformer,  and  the  fully  symmetrical  anti  [aaa]  
conformer was determined to be a second order saddle 
point  (Fig.  42)  [126].  
Based  on  the  energies  and  MO  diagrams  of  
XXXIV,  the  HOMO  and  LUMO +  1  orbitals  were  
determined  to  be  involved  in  electron  donating  and  
accepting  activity  of  XXXIV.  The  putative  anti-
carcinogenic  and cholesterol  lowering  mechanism  of  
activity  of  XXXIV  is  presented  in  Fig.  43  [126].  
10.  Macromolecular  interactions  
10.1.  Protein-protein  interactions  
Molecular  recognition  forms  the  basis  of  protein-
protein  interactions.  Proteins  that  contain  covalently  
bound  oligosaccharides,  called  glycoproteins,  are  
often  tailored  to  be  specific  recognition  sites.  They  
form  a  diverse  group  that  includes  enzymes,  
hormones  structural  proteins,  and transport  proteins.  
The presence of one or more oligosaccharide chains 
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Fig. 42. Structures of the degenerate g'gg*  and g'g*g' conformers 
(A =  0). and the fully symmetric aaa  conformer  (A =  2). Note that 
the global minima conformers. g'g'g* andg'g*g', are enantiomeric 
and that this relationship is denoted with the symbol "I", indicating a 
mirror  plane.  
on  a protein  can  alter  its  physical  properties,  such  as  
its  size,  solubility  and  stability.  These  changes  can  
affect  biological  activities  such  as  immunogenicity.  
A  number  of  mammalian  hormones  are  dimers  of  
glycoproteins  whose  oligosaccharide  chains  assist  in  
the  assembly  of  the  dimer.  As  a  result,  they  confer  
resistance  to  proteolysis.  Another  role  of  glyco-
proteins  is  the  recognition  of  cell  by  another  cell  in  
processes  such  as  cell  migration  or  oocyte  fertiliza-
tion. These events  are dependent  partly  on the surface 
of  one  cell  binding  to  the  sugar  portions  of  specific  
glycoproteins  on  another cell's  surface.  Studies  of  a  
wide range of lectins have shown that oligosaccharide 
chains  of  proteins  are  always  located  on  the  outer  
surface  of  a  cell  membrane,  and  not  to  the  cystolic  
surface. 
10.2.  Prolein-lipid  interactions  
The backbone conformation of a polypeptide chain 
may follow some well-defined pattern, which could be 
drastically modified by various side chains. These will 
lead  to  side-chain  side-chain  or  side-chain  backbone  
interactions  in a polypeptide  chain,  which  very often 
involve  hydrogen  bonding.  Side  chains  of  arginine  
and  lysine  could  play  important  roles  on  many  
occasions. 
The overwhelming  presence  of  arginine  and  lysine  
(approximately  30  out of  the  170 residues)  in  myelin  
basic  protein (MBP)  is  crucial  in  the protein's  role  in  
stabilizing  myelin.  The positively  charged side chains 
can  interact  with  the  hydrophilic  head  groups  of  the  
lipid bilayer. Consequently,  MBP may  be involved  in  
bridging  distant  points  on  surfaces  of  myelin.  MBP  
exhibits  charge  microheterogeneity  as  a  result  of  
various  processes  such  as posl-translational  deamina-
tion, phosphorylation  and  the deamination  of  arginine 
to  citrulline.  Such  changes  lead  to  a  decrease  in  the  
stability of the lipid-MBPcomplex  [109], Eighteen out 
of  the  nineteen  arginine  residues  are  citruilinated  
(MBP Citl8)  in the fulminant form of  multiple  sclero-
sis (MS), known as Maburg's Disease [110]. The inter-
action  between  MBP  and  the  lipid  bilayer  could  be  
studied  experimentally  using  either  NMR  or  atomic  
force  microscopy  (AFM),  or  a  combination  of  both.  
It may be expected that the spectroscopic  pattern asso-
ciated with the complex  will  be different from the sum 
of the isolated components.  The altered observation of 
the  complex  could  be  regarded  as  diagnostic  of  the  
interactions  between  the two components.  
The  interaction  of  the  two  components  could  also  
be modeled  at the molecular level. The simplest  inter-
action  that one  can  imagine  between  the  guanidinium 
ion  functionality  of  the  arginine  side  chain  and  the  
carboxylate  ion  functionality  is  shown  in  XXXV.  
The  actual  interaction  is,  of  course,  far more compli-
cated because  phospholipids  (see  structures  XXXVI-
XXIX,  where X =  head group) have a number of elec-
tron acceptor  sites.  In particular,  binding could  occur  
between  the two  NH moieties  of  the  guanidinium  ion  
and one  of  the  following  three  pairs of  proton  accep-
tor,  as  illustrated  in  XXXV.  Binding  occurs  in  the  
fashion  shown  in  XXXV;  the  pairs  of  arrows  in  
XXXVII-XXXIX  indicate  the  locations  of  the  
binding  sites.  
10.3.  Protein-nucleic  acids  interactions  and  protein  
biosynthesis 
Protein-nucleic  acid  interaction  is  of  special  
importance.  It  occurs  even  at  the  birth  of  a  protein  
molecule  at its biosynthesis.  Translation of the genetic 
message  into  proteins  implies  the  precise  correspon-
dence  between  the 64 base triplets  and  the 20 canoni-
cal  amino acids.  In this process,  tRNA  plays a central 
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Fig. 43. Putative  mechanism  of  the (A)  anticholesterol  and  the  (B) anticarcinogenic  activity  of  XXXIV  (allyl  methyl  disulfide).  
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role  by  providing  the  nascent  polypeptide  with  the  
amino  acids  to  which  they  are  esterified  in  response  
to  codons  on  RNA.  In  this  step,  the  amino  acylated  
tRNAs  decipher  the  base  triplet  (codon)  using  
Watson-Crick  base  pairings  between  mRNA  and  a  
complimentary  region  on  the  tRNA.  The  anticodon  
is  independent  of  the  nature  of  the  amino  acid  ester-
ified  to  the  tRNA.  Therefore,  the  accuracy  of  the  
tRNA  aminoacylation  reaction,  ensured  by  the  
aminoacylation  tRNA  synthetases  aaRS  (a  given  
aminoaeyl-tRNA  synthetase  is  abbreviated  by  its  
cognate  amino  acid  three-letter  code  followed  by  
RS; e.g.,  GlnRS  stands  for glutaminyl-tRNA  synthe-
tase), is of  primary  importance in all living cells,  since  
it  will  govern  to  a  large  extent  the  fidelity  of  the  
translation  process  [111],  
Aminoacylation  of  tRNA  proceeds  through  a  two  
step mechanism.  The first step involves  the  formation  
of  a  stable  aaRS-amino  acyladenylate  complex  
resulting  from  the  specific  binding  and  reaction  with  
ATP:Mg2+  of the amino acid; pyrophosphate  is subse-
quently  released.  In the following step the 3'  terminal  
adenosine  of  enzyme-bound  tRNA  reacts  with  the  
aminoacyladenylate,  leading  to  both  the esterification 
of  the  tRNA  and  the  release  of  AMP.  Notably,  the  
binding  of  tRNA  occurs  in  the  presence  of  a  poly-
amine  or a divalent cation,  usually  magnesium  [112],  
aaRS  +  ATP  : Mg2+  +  aa  
—  aaRS  : aa ~  AMP  +  PPi; Mg  (16)  
aaRS  : aa -  AMP +  tRNA  
—  aaRS  +  aa -  tRNA  +  AMP  (17)  
where  aa  stands  for  amino  acid;  aa ~  AMP  for  
aminoacyladenylate. 
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Because the two steps involve  the specific  recogni-
tion of both the amino acid and the tRNA they  impose  
specificity  throughout  the  overall  reaction.  As  a  
general  rule,  there  is  one  synthetase  for  each  of  the  
20 canonical amino acids in a given organism or orga-
nelle. Two main functions are carried out by an  aaRS:  
the activation of the amino acid and the  recognition  of  
the  tRNA  molecule.  In  the  activation  of  the  amino  
acid,  the  carboxylate  of  the  amino  acid  becomes  
linked  to  the  AMP  moiety  of  an  ATP  molecule  to  
form  the  aminoacyladenylate,  which  remains  firmly  
bound  to the synthetase  [113].  
The mixed anhydride bond between the carboxylate 
and  the  phosphoryl  group  of  AMP  is  highly  suscep-
tible to  the attack  by  a hydroxy! group,  thereby  facil-
itating  further transfer of  the amino acid  moiety  onto  
the tRNA. Consequently,  the  reaction  of the  activated  
amino acid with tRNA can be viewed as the  result  of  a  
productive positioning of the 3'-terminal  adenosine  of  
the  nucleic  acid  within  the  active  center  of  the  syn-
thetase.  This  allows  the  attachment  of  the  amino  
acyl-AMP  by  either  the  2 '-  or  3 '  hydroxyl  group  of  
the terminal  ribose.  In this context, the accuracy of the 
activation  reaction  is  of  importance  in  the  further  
specificity  of  the  tRNA  amino  acetylation  reaction.  
In  all  cases  the  rapid  formation  of  a  ternary  complex  
of  the  enzyme  with  both  ATP:Mg2+  and  amino  acid  
was  evident.  The  amino  acid  acyladenylate  is  
produced  through  a  rate-limiting  isomerization  of  
this  ternary  complex  PP:-Mg,  one  of  the  products,  is  
then  released.  
The other function of the aaRS is the recognition  of  
the tRNA molecule. Many  recent  studies have  pointed  
out  that  the occurrence  of  discrete  nucleotidic  recog-
nition  elements  on  a  tRNA  molecule  dictates  the  
specificity  of  aminoacylation  by  the  corresponding  
aaRS.  Briefly,  three  major  recognition  sites  have  
been  identified:  
(i)  the  acceptor  stem,  including  the  "discriminator  
base"; 
(ii)  the three  bases  of  the  anticodon;  
(iii) the  D-loop.  
In  some  systems,  the  three  sites  are  important  for  
correct  aminoacylation  by  the  corresponding  amino  
acid,  whereas  in others, one site  is enough.  However,  
at least two sites appear to be  required  systematically  
for  achievement  of  maximal  aminoacylation  rates.  
Because  a  limited  number  of  recognition  sites  are  
present  on  the  tRNA  molecule,  it  appears  that  there  
may be a limited number of  recognition  sites (peptides 
regions)  on  the cognate  aaRS,  too. The  aaRS-amino  
acid interaction  is based on protein structure rules, but 
other  kinds  of  rules  govern  the  tRNA-aaRS  inter-
action. An unsolved question  in the molecular  biology  
of gene expression  is the determination  of  these  rules.  
Discrimination  between  tRNAs by the aaRS  enzymes  
is complex because all tRNAs are about 76  nucleotide  
residues  in  length  and  form  the  typical  tRNA  clover-
leaf  secondary  structure  [114-117],  
In  the process  of  investigating  protein  synthesis  in  
general,  an  exploratory  set  of  ab  initio  molecular  
orbital  computations  were  carried  out  on  the  various  
conformations  of  ribose  and  deoxy-ribose  model  
compounds  to  establish  the  nature  of  possible  inter-
actions between  the 5'-hydroxyl  and the oxygen of the 
ribose  ring.  Moreover, the investigation  was  extended  
to  the  hydrogen  bonding  between  the  two  adjacent  
hydroxyls,  2 ' -  and  3'-,  to  explore  their  effect  on  the  
stabilization  of  the  whole  system.  The  consistent  
presence  of  a  rather  unusual  weak  hydrogen  bond  
between  the proton of C 2 ' -H and the Oy of the  hydro-
xyl  methyl  group  for  the  g~g~  conformation  of  the  
-CH 2 -OH  functional  group  has  been  studied  using  
Bader's  atoms  in  molecules  (AIM)  method.  
Density  functional  calculations  coupled  with  
Bader's  Atoms  in  Molecule  (AIM)  method  are  
becoming  a  very  important  tool  in  examining  intra-
molecular  interactions  that  are  responsible  for  the  
system's  stabilization.  As  has  been  demonstrated  
[118],  an  unusual  hydrogen  bond  between  C y -
O y  -Hy  is  present  for  the  specific  g~g~  orientation  
of  the -CH 2 -OH  moiety  in  the  ribose  system.  
10.4.  Carbohydraies  and  molecular  recognition  
Carbohydrates are sometime  referred  to as  informa-
tion-molecules.  This  characterization  of  carbohy-
drates  is  due  to  the  fact  that  carbohydrates  have  a  
very  large  number  of  structural  variants.  First  of  all  
there are several hexoses and they can connect to each 
other to form oligosaccharides  in different sequences.  
The  chain  can  be  branched  or  unbranched  and  the  
connection  can  be  via  a -  or  (3-glycosidic  linkage.  
Furthermore,  the  numerous  OH  groups  can  assume  
g+,  a  and  g~  rotamers.  Such  tremendous  structural  
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variation  can  code  a great deal of  information.  Oligo-
saccharides are frequently attached to proteins  via  O-
or  N-glycosidic  linkage.  The  former  one  involves  
either  serine  or  threonine  while  the  latter  utilizes  
almost  exclusively  asparagine.  These  carbohydrate  
antennas  are  involved  in  molecular  recognition  
processes.  During  the molecular  recognition  process,  
hydrogen  bonds change from intramolecular  to  inter-
molecular  type. These  processes  could  be  studied  in  
terms  of  glycopeptides.  However,  before  embarking  
to  the  field  of  glycopeptide  research  one  must  under-
stood  the  conformational  intricacies  of  carbohydrate  
conformations. 
We  have  modeled  hydrogen  bonding  between  
adjacent  OH  groups  in  ethylene  glycole  [119,120].  
We  have  also  investigate  internal  hydrogen  bonding  
in  a 6-dehydro hexose:  L-fucose [121,122].  D-glucose  
[123,124]  as  well  as o-mannose  [124] have also  been  
studied  in  some  details.  An  explanatory  study  of  an  
oligosaccharide:  the  Lewis  X  trisaccharide  [125]  has  
just  been  completed.  We  are  now  engaged  to  study  
glycopeptides. 
11. The  mystery  of  protein  folding  
Protein  synthesis  occuis  sequentially,  one  amino  
acid  at  a  time.  Initially,  it  was  tacitly  assumed  that  
once  the  synthesis  of  the  primary  sequence  is  
completed,  the  nascent  macromolecule  is  folded  to  
its  bioactive  conformation.  Originally,  it  was  further  
assumed  that  the  folded  structure  is  the  global  mini-
mum,  and  thermodynamics  will  drive  the  structure  
to  this  uniquely  folded  structure.  Relatively  soon,  it  
became  obvious  that  it  takes  an enormous  amount  of  
time  "to  search  the  entire  conformational  space  
available  for  a polypeptide  chain"  [8]. This  principle  
became  known  as  the  Levinthal's  paradox  [7].  
Latter,  it  was  envisaged  that  the  bioactive  form  
may  not  be  the  global  minimum,  but  in  fact  it  
could  be  one  of  the  local  minima.  Thus,  thermody-
namics  could  not  be  treated  as "Maxwell's  demons"  
to  guarantee  such  a  specifically  folded  structure,  
even  if  the  necessary  time  was  available.  At  that  
time,  chapetones  were  invoked  as  an  explanation  
of  post  biosynthesis  folding.  This  view  effectively  
allows  the  interaction  between  the  chaperone,  
and  the  nascent  polypeptide  while  it  is  being  
synthesized.  Thus,  the  folding  could  in  fact  occur  
while  the  synthesis  is  in  progress.  
Nowadays,  it  is customary  to look  upon  folding  in  
teims of statistical ensembles of states. However,  such  
ensembles  of  states  are  nothing  more  than  energeti-
cally  and conformationally closely spaced  minima  on  
a  rather  complex  multivariable  potential  energy  
hypersurface  (PEHS).  Professor  Honig  greets  the  
"light  at  the  end  of  the  tunnel"  with  the  following  
acclamation  [8]:  
It is likely  that  a complete solution to all  aspects  
of  the  protein  folding problem  will  require  that  
the  information  available  from  the  analysis  of  
large  structural  and  sequence  databases  be  
combined  with  the  principles  and  methods  
of  physical  chemistry  and  computational  
chemistry. 
We concur with his view. However, we wish to add 
that  computational  chemistry  should  go  beyond  
currently  used  empirical  force  fields.  It  must  start  
with  ab  initio  molecular  computations,  which  will  
eventually  lead  to  an  accurate  analytic  function  that  
encompasses  all  possible  protein  conformers  as  the  
roots  of  the  gradient  of  such  an  analytic  function.  
The search for the secret of folding patterns can  really  
start  in  the  possession  of  such  roots.  The  mystery  
associated  with  protein  folding  will  gradually  fade  
in  the  light  of  new  understanding.  
12. Proposal  for  a  millennial  mega-project  and  
conclusion 
Once  a complete  set  of  data exists for all 21  amino  
acids and all of their ' found' backbone conformations, 
a  database  may  be  constructed.  This  large  data  set  
may  then  be  used  in  the  construction  of  di-,  tri-  and  
even  large  arrays  of  peptides,  with  the  ability  of  
accepting  changes  at  any  time.  However,  as  the  
number of units in a polypeptide chain grows  linearly,  
the  number  of  possible  combinations  and  conforma-
tions  grows  exponentially.  Therefore,  without  ques-
tion,  an  automated  procedure  is  necessary  for  both  
the construction of input  files as well for the extraction 
and  tabulation  of  relevant  output  parameters.  
Even with  a successful and efficient digital script  or  
program  to  perform  these  tasks,  the  current  problem  
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of  insufficient  computational  power  and  other  hard-
ware resources would still exist. This is the largest and 
omnipresent  limitation  in  computational  chemistry,  
amicably  referred  to  as  the  'limiting  reagent'  in  the  
synthesis of  ab initio solutions to chemical  problems.  
The  present  solution  of  continually  upgrading  to  
larger  and  faster  hardware  will  not  bring  about  the  
elimination  of  this  low  yield.  
The  implication  of  truly  parallelized  software and 
more  efficient optimization  algorithms  is one part  of  
the solution. The other lies in the creation  of a distrib-
uted network, through which calculations may be sent 
out  to  various  individuals,  institutions  and  organiza-
tions willing to donate free CPU  down-time.  
As PC's  have  come  to  the  forefront of  the  cost  to  
performance  ratio,  many  nodes  are  now  available  to  
run  large  arrays  of  computations,  both  quickly  and  
efficiently. All  that  is  required  is  a  means  to  manage  
the incoming  and outgoing data,  in  an organized  and  
error-free  manner.  The  fragmentation  of  jobs,  for  
parallelization,  may  be  accomplished  by  sending  a  
copy  of  the  electron-density  and  Fock  matrices  to  
each  node  in  the  array.  Portions  of  the  Hessian  are  
then  constructed  and  assembled  into  a  complete  set  
afterwards. 
This  may  be  accomplished  using  a  standardized  
numbering  method  for  the  molecules  to  be  studied.  
With  this  common  input  parameter  definition,  poly-
peptides  may  be  constructed  without  error  and  opti-
mized  quickly.  
A novel  and  sound proposal  has been made to opti-
mize  all  possible  tri-peptide  (IV)  combinations  and  
conformations.  The  reason  for  choosing  tri-peptides  
lies  in  that  fact  that  all  W-acetyl  and  W-methyl  inter-
actions  and  resultant  conformations  possible  with  a  
central  peptide  would  be  evaluated.  Hence,  once  
completed,  two  tri-peptide  blocks  could  then  be  
bound  together  and  optimized  more  quickly  than  a  
single  calculation  of  a  hexapeptide.  This  is  due  to  
the fact that  the internal  structure  of each  tri-peptide  
unit would not change dramatically,  upon biding  to a 
second  one.  These  'blocks'  could  subsequently  be  
used to give  insight  into  the most stable geometry  of  
much  larger  polypeptide  chains,  both  quickly  and  
efficiently. 
For  the. automation  of  this  input  generation  and  
subsequent  data  extraction  from  the  log  files,  the  
numbering  of  the  atomic  sequence  in  the  peptides  
must  be  standardized.  In  this  way,  scripts  and  
programs  may  be  used  to  reorganize  immediate  
patterns  necessary  for  one's  chemical  analysis.  As  
an example,  we use Arginine XL for this: 
H „ 
C , ! — N ^ 
C o -
« 
\ 
H» 
H i i -
XL r  ^  / < r  
^ t  I  f  N.  
H..  "5  0,  H j j  
As  all  amino  acids  contain  the  same  backbone  
sequence,  the  numbering  is  started  from the  nitrogen  
attached  to  the  alpha  C,  following  through  to  the  
carbonyl  carbon  all  the  way  to  the  carbonyl  oxygen.  
The groups on the nitrogen and subsequently the alpha 
C are numbered next, with the side chain the hydrogen 
attached  to  the  alpha  C. The  W-Acetyl  or  N-Methyl  
groups  are  defined  separately  and  then  added  at  any  
time, as their coordinates do not disturb the definitions 
of  the  internal  parameters  specific  to  the  core  (i.e.  
amino acid  residue).  
In  the  case  of  di-peptides  or  larger  polypeptides  
lengths,  the  numbering  is  left  'open',  in  the  form  of  
variables, so that the files may be modified at any time 
at any of these groups without disturbing the structure 
of  the  remaining  coordinates,  or the  molecular  envir-
onment  it  defines. As  the  internal  coordinate  system  
relies  on  fixing  subsequent  atoms  to  previously  
defined  ones,  the  next  amino  acid  would join  to  the  
carbonyl  carbon  of  the  first. Hence,  any  of  the  stan-
dardized  amino  acids  in  this  database,  numbered  
beginning  at  the  N  attached  to  the  C„,  would  then  
'mesh'  with  the  internal  coordinates  of  the  first  
without  problem.  In fact, any  of  the groups or  atoms  
attached to the backbone may be denoted by a variable 
of  choice  and  modified  or  truncated  accordingly.  
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Although  an  extensive  explanation  of  the  above  
numbering  sequence  would  be  required  to  show  all  
the  inherent  benefits  of  this  system,  the  reader  is  
encouraged  to attempt  trials on various input  files.  
In  this  way,  it  is  possible  to  make  an  additive  or  
integrateable database for the 20 amino acids, with the 
point  of  attachment  in  a  polypeptide  chain  being  
defined  as  the  #1  atom,  in  the  coordinate  system  
used.  Other previously  optimized  structures can  then  
be  added  to the database,  including  the  W-acetyl  and  
W-methyl  portions,  or  even  long  chain  fatty  acids,  
provided they use the standardized numbering system. 
Simply  adding  the  coordinate  definitions  onto  the  
internal  coordinate  system  of  that  original  structure  
may  then  extend  an  optimized  structure.  Any  poly-
peptide  combination  of  any  possible  conformation  
can  be  easily  created  and  submitted  for  optimization  
efficiently and can be easily automated. With the new 
millennium,  a  massive  mega-project  is  proposed  to  
use  the  above  process  to  explore  the  large  number  
of  potential  energy  surfaces created  by  this  gigantic  
number  of  peptide  structures.  For  example,  a  tri-
peptide  sequence  would  contain  many  millions  of  
possible  combinations  and conformations to  be  opti-
mized;  this  number  grows  exponentially  with  the  
extension  of the polypeptide  chain.  
To  create  a  surface  large  enough  to  help  in  the  
unraveling  of  the  protein  folding problem,  one  must  
continue  to explore  such  surfaces  with  progressively  
larger  sections  of  the  amino  acid  polymer.  This  
creates  a  massive  demand  for  both  CPU  time,  hard  
storage  space  and  data  management  and  extraction;  
the  latter  being  a  much  less significant  obstacle.  The  
all  too  common  problem  of  CPU  power  being  the  
'bottle  neck'  in  the  creation  of  meaningful  ab  initio  
results  may  be  solved  via  a  different avenue.  Rather  
than throwing massive amounts of hardware in  tightly  
coupled  networks  at  the  challenge,  instead  it  is  
proposed  to  farm-out  the  CPU  time  to  the  millions  
of  stand alone PC's  and  workstations  residing  on  the  
loosely coupled  network  of the  internet.  
Some  computational  problems  and  data  analysis  
ventures  have  indeed  used  this  approach  with  much  
success. SETKShome is one example, whereby  radio-
telescope  data  from  Afescebo  in  Puerto  Rico  are  
analyzed  by  millions  of  individuals  in  their  homes,  
using their PC's. At last count, over  1.3 million people 
were  contributing  computer  time  toward  this  effort.  
The  process  is  automated  to  use  'down  CPU  time',  
whereby  the  individual's  computer  usage  is  not  
affected  by  the  running  program,  nor  are  they  
buidened  by  any  direct  responsibility  of  managing  
their  chunk  of  the  data.  Once  the  user  needs  their  
computer,  the  calculating  program  is  stopped  and  
the  CPU  is  entirely  free for the  user.  Another , such 
venture  is  the  DES/RC5  project,  whose  goal  is  to  
show  how  US  export  limitations  on  the  strength  of  
cryptographic  algorithms  is  naive.  They  are  under-
taking  this  by  having  contributors'  computers  try  
every  possible  decryption  key  in  sequence  against  
a  cipher.  With  over  100,000  CPUs  working  on  the  
job,  cracking  such  encryption  is  relatively  easy.  
The  megaproject  could  indeed  make  use  of  a  simi-
lar  such  automated  and  'loosely  coupled'  network,  
whereby  surfaces  of  the  many  independent  vari-
ables  may  be  analyzed.  Those  who  wish  to  parti-
cipate  may  register  at  the  following e-mail  address:  
protein@velocet.ca. 
It  is  part  of  human  nature  to  ask  what  good  will  
come out  of  a  project  that  aims  to decode  the  secret  
of  protein  folding.  Such  a  discovety  may  well  be  
regarded  as  the  greatest  human  achievement  in  
history.  Its  social  impact  would  be  greater  than  the  
combined  social  impact  of:  
the discovery  of fire; 
the discovery  of  writing;  
the discovety  of the  wheel.  
Even though this topic is very important for the whole 
human  race,  it  cannot  be  done  due  to  lack  of funds 
unless individual contributions come from millions of  
people. 
The deciphering of the law of protein folding would 
open  new  dimensions  to  all  life  sciences,  including  
medicine.  For  example,  the  drag  discovery  process  
would  be  shortened  dramatically,  by  a  more  cost-
effective method for the production of  pharmaceutical  
products.  Not  only  would  the cure  be  found  reason-
ably soon (say by the year of2025) for cancer, HIV, as 
well  as  other  diseases,  preventive  medicine  would  
also  reach  new  heights  whereby  pathogen  infections  
(bacteria,  viruses and prions) could  be  eliminated.  
Anyone,  who has  lost  a  loved  one to  an  incurable  
disease,  appreciates  the  prospects  of  eliminating  all  
human  sufferings. This  heartache  includes  the  pain  
of  the  ill,  as  well  as  the  anguish  of  those who  would  
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mourn after the patient has passed  away. Needless  to  
say, a person lost prematurely  by a family is also lost  
by  society  as  a  whole,  with  all  of  his/her  talents  and  
productivity.  Global  hunger could  also be  eliminated  
by  improved  agricultural  and  food-processing  tech-
nologies,  in  which  the  knowledge  of  protein  folding  
also plays  a significant role. 
The peptide folding project, which one can  partici-
pate in,  at the  above e-mail  address, does  not  offer a 
quick  fix,  but  gradually  it  will  lead  to  a  new  under-
standing of protein folding, which in'turn will produce 
a  healthier  society enjoyed by generations  to  come.  
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Abstract 
Ab initio conformational analysis has been carried out at the RHF/3-21G level of  theory. Computations  were performed on a 
tail-end lycopene (Model B).  Both the all-trans  and the 5-cri-isomers were studied. The fully planar structure turned out to be a 
second-order  saddle  point,  which  indicated  that  lycopene  itself  is  not  planar.  Most  of  the conformers of  the 5-cis-isomer  are  
more stable  than the corresponding  conformers of  the all-ira/ix-isomer.  This stability is  in agreement  with the observation  that  
even  though  lycopene  is biosynthesized  in plants  as  the all-irons  form,  in  the  human  body  over  65% exists  in one of  the  cis-
forms  and  less  than  35% remains  in its  all-trans  form.  ©  2001  Elsevier  Science  B.V.  All  rights  reserved.  
Keywords:  Conformational  analysis;  All  irans-lycopene  tail-end  model;  Selected  Ci.s-isbmers  of  lycopene  tail-end  model;  Conformational  
potential  energy  surfaces;  2D  scans; Ab  initio MO  theory  
1.  Introduction  
1.1.  Biological  background  
Several  chronic diseases, amongst  which are cancer 
and  cardiovascular  diseases,  are  related  lo  oxidative  
stress  which  is  now  recognized  as  an  important  etio-
logical  factor.  Antioxidants  are  effective  in  reducing  
the damaging effect of oxygen containing radicals and 
radicaloids  such  as  OH,  Oo ¿HjOr  as  well  as  that  of  
singlet  oxygen  'Oft, Lycopene  is  a  carotenoid  type  
antioxidant,  present  ih torhatoes  and  other  fruits  and  
vegetables.  Studies have-shown  that  lycopene  acts  as  
*  Corresponifipg  author.  Address:  Velocet  Communications  Inc.,  
210  Dundas  St.  Wi,  Suite  800  Toronto,  Ont.,  Canada  M5G  2E8.  
Tel.:  +1-416-978-3598;  fax:  +1-416-978-3598.  
E-mail  address:  gchasse@fixy.org  (G.A.  Chasse).  
0166-1280/01/$  -  see  front  matter I  
rights  reserved.  
an  antioxidant  in  vivo,  providing  protection  against  
the  oxidation  of  lipids,  proteins  and  DNA  [1,2].  A  
recently  published  review  [3]  indicated  a  significant  
inverse  correlation  between  the  intake  of  lycopene  
and  therefore  the  serum  concentrations  of  lycopene  
and  the  risk  of  several  diseases  including  cancer.  In  
the absorption  and bio-availability  the isomeric forms 
of  lycopene  appear  to play  an  important  role.  
2001  Elsevier  Science  B.V.  All  
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1.2.  Structural  background  
The  skeleton  of  lycopene  [C4oH56] consists  of  eight  
isoprenic  units,  thus,  it  is  related  to  tetraterpenes  
[CztoH«]  even  though  it  contains  fewer  hydrogens  
and  therefore  more  double  bonds.  Its  composition  is  
shown  in  I  in  its  fully extended  form which  is  the  all  
rraris-lycopene. As such, lycopene  is closely related  to  
|3-carotenes. 
1,4 interactions  as shown  by  the  following  structures.  
Clearly,  on  the  basis  of  relative  group  sizes,  the  -
C H 3 - H -  interaction  (type  C)  appears  to  be  the  most  
destabilizing  (Scheme  1).  
No  X-ray  structure  of  lycopene  has  been  deter-
mined  as  yet.  There  are,  however,  two  X-ray  struc-
tures  of  3-carotene  in  the  literature  [15,16].  
1.3.  Computational  background  
Type  A'  
&5 6-trans  or E- isomer  A5'6 cis  or Z-  isomer  
Sometimes,  the  structure  of  lycopene  is  presented  
in  a  pre-folded  form  (II)  to  show  its  structural  simi-
larity  to  (3-carotene.  Due  to  the  internal  molecular  
symmetry,  it  has  been  traditional  to  number  the  
chain  from the  two  ends  as  shown  in  I  and  II.  
In  fruits  and  vegetables  .Lycopene  is  present  
mostly  in  its  all-/rans  isomeric  form.  However,  
cw-isomers  constitute  the  predominant  form  
present  in  the  serum  andssiissues  [17,18].  This  
observation  suggests:::  that  at  least  some  of  the  
The  history  of  lycopene  [1-14]  reveals  an  interest-
ing  story  from  the  initial  curiosity  of  a  colourful  
substance  in  the  1910s  to  the  medical  application  in  
the  1990s  as  an  antioxidant.  
In  1943, Pauling pointed out [14] not all  cis-isomers  
may  be  of equal  stability  due  to  a number  of  possible  
cii-isomers  may  be  energetically  comparable  to  
the  stability  of  the  all-trans  isomers.  Fig.  1  
shows  the  all-trans-  and  selected  c/'s-isomers  of  
lycopene.  The  all-frans-  and  the  selected  six  cis-
isomers  (5-,  7-,  9-,  11-,  13-  and  15-)  are  yet  to  be  
explored  computationally  in  their  molecular  
Scheme  2.  
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All  trans  
15-cis  lycopene  
1 3 - m  lycopene  
11 -cis  lycopene  
9-cis  lycopene  
7-cis  lycopene  
5-cis  lycopene  
Type  A  
T y p e C 
Type  A '  
Fig.  1. Geometrical  isomers  of  lycopene.  
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entirety  (containing  296  electrons  and  96  atoms,  
which  corresponds  to  282  geometrical  parameters  
to  be  optimized).  Thus,  lycopene  may  well  be  
among  the  largest  organic  molecules  to  be  inves-
tigated,  using  ab  initio  molecular  computation,  
with  the  current  computational  technology.  The  
relative  energies  for  the  four  types  of  structures,  
are  depicted  in  Fig.  1,  are  expected  to  exhibit  four  
categories  of  stability.  Consequently,  we  may  
anticipate  four  energy  ranges.  
Type  A1  involves  the  5-c/s-isomer.  
Type  A  involves  the  9-cis  and  13-c/s-isomers.  
Type  B  involves  the  15-c/s-isomer.  
Type  C  involves  the  7-  and  11-cis-isomers.  
Type  A'  is  extremely  similar  to  Type  A  (see  
H  H  H  H  
Scheme  3 as Model  A, Model  B,  Model  C, Model  D,  
etc. 
For  the  present  study,  we  have  chosen  Model  B  in  
order  to  be  able  to  mimic  conformationally,  the  tail-
end of the  n\l-trans  isomer,  as well as the 5 - c i s  isomer,  
as  depicted  in  Scheme  4.  
3.  Method  
In  order  to  learn  about  the  conformational  beha-
viours  of  the  two  tail-end  conformations  of  lyco-
pene,  Model  B  (III)  was  studied  in  mofe  detail.  
This  truncated  lycopene  model  ( C ' - C 3  segment)  
contains  of  the  first  three  double  bonds  Of  lyco-
pene.  Structure  III  shows  the  fully  extended  form  
of  Model  B.  
X,: 
X2: 
X3: 
X4: 
Xs: 
X6: 
H 
Me-C'-C2-C3 
C'-C2-C3-C4 
€2-l3-C4-C5 
C3-C4-C5-C6 
c4-c5-c6-c7 
C5-C6-C7-C8 
C6-C7-C8-H 
III 
Fig.  1)  except  that  the  hydrogens,  involved  in  
1,4  interactions  (attached  to  carbons  4.  and  7),  
are  not  eclipsed  but  staggered.  This  is  illustrated  
in  greater  detail  by  Scheme  2.  ,,>••••.  
2.  Scope  
The  presence  of  three  consecutive  carbon-carbon  
single  bonds  ( C 2 - C v~C4 -<|5)  suggests  conforma-
tional  flexibility  of  the  tail-ends  of  lycopene.  It  was  
deemed  desirable  therefore  to  study  the  conforma-
tional  intricacy  of  the  tail-end  of  lycopene  by  choos-
ing  some  model  compound.  If  one  looks  at  the  
lycopene structure, one can cut out from the full mole-
cule shorter segments  and  terminate  them  with  hydro-
gen  atoms.  These  model  compounds  are  labelled  in  
When  a planar moiety  is rotated  about  a  tetrahedral  
carbon,  it  may  be  either  eclipsed  with  a  tetrahedral  
bond  or  perpendicular  to  that  bond.  This  has  been  
revealed  by  the  study  on  ethyl  benzene  [19].  These  
idealized  conformers  are  illustrated  by  Scheme  5.  
Single  scans can  be carried  out  to study the  rotation  
about  the  C 2 - C 3 ( * 2 ) ,  C 3 - C 4 ( * 3 )  and  C 4 - C 5 ( * 4 )  
single  bonds  of  I II .  However,  the  conformational  
problem  is  better  studied  in  the  form  of  a  potential  
energy  hyper-surface  (PEHS),  which  involves  all  
three  torsional  angles.  
E = f ( X i ! i x M x  ( 1 )  
Since  the  rotation  about  the  single  C - C  bond  
(^3)  is  expected  to  be  in  g+,  a,  g~  configurations,  
therefore  three  potential  energy  surfaces  (PES)  
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•trans  or E-  isomer  
Scheme 4. 
may  be  generated  at  these  three  orientations  of  
E=f(X2&X4)  ^  *3  =  + 6 0°&  (2a]  
E=f(X2&X4)  at  X3 ~  +180°â  
E=fixi*xa)  at  =  +300°(—60°)ae  (2q)  
The  levels  of  these  2D  cross-sections  are  shown  in  
Fig.  2.  
One  may  also  generate  1D cross-sections  such  as  The  location  of  these  conformational  potential  
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Fig.  2.  A  schematic  representation  of  the  conformational  PEHS,  
E  =  of lycopene Model  B. The heavy  dot, at the  centre,  
illustrates  the  location  of  the  fully  symmetric  conformation  as  
drawn  in  I I I .  The  three  levels  indicate  the  three  2D  cross-sections  
(PES)  and  the  three  perpendicular  heavy  broken  and  solid  lines  
specify  the  locations  of  the  three  I D  cross-sections  (PEC)  investi-
gated. 
energy  carves  (PEC)  are  indicated  by  three  heavy  
solid  lines  and  three  heavy  broken  lines  in  Fig.  2.  
The compulations  were carried  out  using  the  GAUS-
SIAN  98  program  system  [20].  Standard  geometry  
optimizations  were  performed  on  the  all-trans  as  
well  as  six  selected  cis-isomers.  
4.  Results  and  discussion  
4.1.  Molecular  confonfiiMotm^^  
The  conformational  PEHS,  as  specified  by Eq.  (1),  
illustrated  schematically  in  Fig.  2,  is  applicable  for  
both  the  all%fln$-  and  for  the  5-c/s-isomer  of  lyco-
pene  Model  B l a i l  
4.1.1.  The  all-trans-structure  
The  all-trans-lycopene  Model  B  (III)  was  
subjected  first  to conformational  analysis. The  confor-
mational  PEHS  (1)  of  three  independent  variables,  
was  investigated  in  terms  of  three  PESs  (2)  of  two  
independent  variables.  These  three  PESs  are  depicted  
in landscape  and contour representations  in Figs.  3-5 . 
For  Fig.  3,  Xi  w a s  kept  in  its  anti-position  (2b),  for  
Fig. 4,  xt, w a s  kept in g+  and for Fig. 5,  was kept  in  
g~  position.  Clearly  the  central  level  of  Fig.  2,  for  
which  the  PES  (2b)  is  depicted  in Fig.  3, is  the  most  
symmetric.  By  inspection,  we  may  anticipate  the  
presence  of  nine  minima  on  the  PES. These  are  listed  
in  Scheme  6.  
Those  minima  located  at  the  edges  are  repeated  
twice  and  the  structure  at  the  comer  is  repeated  
four  times.  These  repeated  structures  are  shown  in  
square  brackets,  leaving  nine  unique  conformers  
(which  are  not  in  square  brackets).  Since  there  
are  three  levels,  as  shown::  in  Fig.  2,  the  three  
PESs  (Figs.  3 -5)  may  {»ntaia  up  to  3 X 9 =  27  
stable  conformations.  The  I D  scans  leading  to  the  
three  PECs  (shown  ait  the  left-hand  side  of  Fig.  6)  
indeed  suggest  the  existence  of  three  unique  
minima,  on  each  of  the  three  PECs.  This  recon-
firms  that  3  == 27  minima  may  be  anticipated.  
However,  sometimes  expected  minima  are  annihi-
lated  frqm  the  PES.  Geometry  optimizations  have  
been  initiated  on  these  27  conformations.  
The  optimized  torsional  angles  are  summarized  in  
Table  1.  Indeed  a  few  minima,  involving  some  syn-
orientations,  were  annihilated.  The  torsions  about  the  
single  bonds  (xi ,  and  xs)  are  shown  in  bold.  A1  
other  torsional  angles  are  associated  with  double  
bonds.  Since  this  is  the  al\-trans  form,  these  double  
bonds  should  have  dihedral  angles  in  the  vicinity  of  
±180°.  The  last  double  bond,  however,  is  ending  in  
CH2,  so  one  of  the  two  hydrogens  are  trans  (xi)  and  
the  other  is  cis.  In  Table  1,  the  last  three  dihedral  
[s(a)s) [*+(a)S ] [£"(a)s] [s(a)s] 
s (a )g- 8-(a)g- [sW] 
s(a)8+ 8-( [s(a )g+] 
s(a)s S+(a ) s £"(a)s [s(a)s] 
Scheme  6.  
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Fig. 3. AJI-/ran,s-lycopene  Model  B PES, E  flXi&Xs)at  Xi  —  anti  position. Top:  Landscape  representation.  Bottom: Contour  representation.  
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Fig.  6. Conformational  PECs  of  lycopene  tail-end  Model B f  =  g(x2)&E  = / ( y 3 ) a £  =  according  to  Eq.  (3a)-<3c),  respectively.  Left-
hand  side:  all-mm.s-isotners.  Right-hand  side:  5-ctt-isomers.  
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Table  1  
Torsional  angles  of  the  optimized  al\-trans  lycopene  Model  B  conformers  
Conformer  ATi  *3  Xi  Xs  Xi  Xi  Xi  Xi  Xia  
XI Xs X4 
s g+ s 175.825 8.219 73.456 - 2 . 6 9 6 178330 179.109 -180.118 -1.567 155.285 179.822 
s « + NOT FOUND GOES TO s W 
s g NOT FOUND GOES TO 
s 180.620 132366 70.240 13.795 178.533 180.080 -179.996 0.201 178.837 185.729 
+ 
g 
+ 
g 180.030 99.689 59.014 79358 180359 180.113 -180.005 0.247 179.439 172.338 
g+ g' 180.584 117.884 66.164 253.403 179337 180.202 -180.009 0.358 179.405 179.754 
g 
+ 
g s 180.784 -167 .031 68.838 - 0 . 2 9 1 179.071 179.299 -180.081 -0315 -179.499 
g 
+ 
8 
+ 
g 181.444 -114 .775 69.896 84.896 181.140 180.181 -179.979 0.441 185.744 183.034 
g' 
+ 
g g 178.865 -105 .966 74.625 - 9 8 . 9 6 9 179.045 180.560 -179.990 0.277 176.476 ,#173.688 
s a s 179.961 - 1 . 0 7 2 180.693 - 0 3 5 0 180.039 179.983 -180.001 0.016 179.745 179.679 
s a NOT FOUND GOES TO +  +  g  a «  
s a g NOT FOUND GOES TO g  a «  k 
a s 180.835 103.795 177.115 0.315 179.902 179.969 -179.998 -0.037 179314 180.142 
a 181.065 106356 176.434 100.248 181.363 180.202 -179.961 0.069  >  ?i:i':'f79,791 176.165 
+ 
g a g' 181.088 104305 177.254 - 1 0 1 3 3 8 178.588 179.917 -180.049 0.018 I 179.623 181.733 
g' a s 179.149 -103 .829 182315 - 0 3 5 7 180.099 180.038 -180.001 0.083 180374 179.863 
g a 
+ 
g 178.912 -104 .659 182.837 101.431 181.412 180.089 -179.959 :0.006 180.344 178.335 
g~ a g~ 178.956 253326 183.549 259.703 178.637 179.818 -180.037,,. 183.768 
s g~ s 184.130 - 8 . 1 4 3 - 7 3 3 6 3 2 3 1 6 181.474 180.903 180.116 1.77,7 155.308 -179.569 
s g 
+ 
g NOT FOUND GOES TO  a  fg'g'g* 
s g~ g NOT FOUND GOES TO ,.g+g  g  
+ 
g g s 179.087 167376 -68 .605 - 0 . 0 9 3 180.981 180.528:;; «"119.921 "
5>  0.683  179.219 180.034 
+ 
g g 
+ 
g 181.140 105.930 - 7 4 . 6 5 5 98.949 180.966 179.429 -180.010 -0.234 183.711 173.668 
g+ g g' 178.624 114357 - 6 9 . 9 1 5 - 8 4 . 9 2 2 178.840 179307 i -  180;014  -0.341 174.794 183.126 
g g s 179.388 -131 .690 - 7 0 3 6 9 - 1 3 . 8 4 0 181.446, 179.922 %f9.997 -0.460 180.771 174.221 
g g 
+ 
g 179.402 -117 .654 - 6 6 . 1 8 5 106.482 180.131 179.865 ¿A-179.996 -0.269 180.616 179.818 
g' g~ g' -180.001 - 9 9 . 7 5 7 - 5 8 3 6 5 - 7 9 . 9 0 6 179.135 179374 -179.997 -0.381 180.530 187.383 
angles  \ 9  and  measure  the  spatial  orienta-
tions  of  the  three  methyl  groups  of  III.  
T h e  four  central  m i n i m a  shown  in  Scheme  6  
represent  the  two  most  s table  confo rmat ions .  
They  are  pai rwise  equivalent ,  bu t  they  all  pract i-
cally  have  the  same  stabili ty  as  shown  in  te rms  of  
A E  ( k c a l m o l - 1 )  in  S c h e m e  7.  T h e  rela t ive  ener-
gies,  together  with  the  compu ted  dipole  momen t s ,  
are  summar ized  in  Table  2.  
In  addition  to  the  pine  structures  in  Scheme  6,  
g+(a)g"  g'(a)g"  0.071  0.000  
\  •  
g+(a)g+  g (a)g +  0.000  0.071  
Scheme  7.  
::iiii: where  the  central  letter  in  paren theses  represents  
anti  orientation,  (a),  a long  xi,  there  are two  additional  
sets  of  9  structures;  one  set  with  (g+)  and  the  other  
with  (g~).  
It  is  interesting  to compare  Figs .  4  and  5.  They  are  
centrosymmetric  to  each  other  through  the  fully  
symmetric  (a,  a,  a)  focal  point ,  denoted  as  a  heavy  
dot in  Fig.  2. For  this  reason,  the  t w o  sides  of  the  I D  
cross-section  (3b),  cor responding  to  the  central  lef t-
hand  side PEC,  in Fig. 6, a long  with  the  heavy  vertical  
line  in Fig.  2,  are  not  completely  symmetr ica l .  The  g  +  
and  g~  minima  di f fer  slightly  because  the  two  
surfaces  at  Xi  =  X4~  9 0 ° i are  not  ident ical .  
The  centrosymmetr ic  a r rangement  can  also  be  seen  
f rom Scheme  8.  
The  discrepancies  (1 .063  versus  1.062  and  1.301  
versus  1.302)  are  the  result  of  regu la r  opt imizat ion,  
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Table  2  
Dipole  moments,  total  energies  and  relative  energies  of  the optimized  all-trans  lycopene  Model  B  conformers  
Conformer  Dipole  Energy  (haitree)  A£  (kcal  mo l - 1 )  
Xi Xi X4 
s 
+ 
g S 0.7430 -424.6006056 7.381 
s g + Not  found  GOES  TO  g
+g+g  +  N/A 
s g+ g~ Not  found  GOES  TO  g V g - N/A 
+ 
g 
+ 
g s 0.8374 -424.6089342 2.155 
+ 
g 
+ 
g 
+ 
g 1.0844 -424.6102939 1 J 0 1 
g+ g 0.6797 -424.6118287 0.338 
g 
+ 
g s 0.6463 -424.6093099 1.919 
g 
+ 
g 0.8069 -424.6106742 1.063 
g' 
+ 
g g' 0.5608 -424.6110997 0.796 
s a s 0.8259 -424.604468 4.957 
s a g + Not  found  GOES  TO g + ag  +  N/A 
s a g Not  found  GOES  TO  g  a g "  N/A 
g + a s 0.8872 -424.6108053 0.9805 
a 0.6568 -424.6123678 0.000 
a g' 0.9860 -424.6122554 0.071 
g~ a s 0.8869 -424.6108055 0.980 
g' a 0.9861 -424.6122554 0.071  '  
g~ a g 0.6571 -424.6123677 0.000  i:;  
s g' s 0.7423 -424.6006059 JrMè7  ;  
s g Not  found  GOES  TO  g ~ g " g
+  
t f 
s g g Not  found  GOES  TO  g
+ g " g ~  N/4 
g s 0.6492 -424.6093103 1.919 
+ 
g g g' 
+ 
g 0.5602 -424.6110997  €  0.796 
s + g~ 0.8070 -424.6106747?  \  1.062 
g g s 0.8412 -424.6089341  #  2.155 
g g 
+ 
g 0.6794 -424.6118286 0.338 
G " g g 1.0843 -424:6102937  S  5 i 1.302 
which  are  expected  to  disappear  when  the  optimiza-
tions  are  performed  to  a  tight  convergence  threshold.  
4.1.2.  The  5-cis-structure  
The  conformational  PEHS  (1)  of  three  indepen-
dent  variables,  shown  schematically  in  Fig.  2  for  
the  all-mms-isomer,  is  also  valid  for  the  5-cis-
isomer.  In  the  case  of  the  5-(;i,y-fsomer,  just  as  
before,  three  PESs  of  two  independent  variables  
were  generated  for  the \i  a i  g +  and g~  orienta-
0.338  0.796  gV)g"  g'(g*)g"  \  <  
1.301  1.063  g + (gV  g ' ( g V  
Hons.  These  are  shown  in  Figs.  7 - 9 ,  respecHvely.  
The  ID-scans  produced  three  PECs  (shown  at  the  
right-hand  side  of  Fig.  6,  Table  3).  
The  centrosymmetric  arrangement  can  be  seen,  
analogously  to the all-frany-form, in  the case for \ i  —  
antik  in  Scheme  9.  
Similarly,  the  centrosymmetric  character  of  the  
PEHS  can  be  further  demonstrated  by  comparing  
energies  for  the  xi  — g+  and  =  S~  cases.  This  is  
illustrated  by  Scheme  10.  
gV)g~  g"(g")g  1.062  1.302  
• 
g+(gV  g"(gV  0.796  0.338  
Scheme  8.  
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Fig.  8.  The  
sentation. 
fiXi^Xn)  at  X3  =  S*  conformation.  Top:  Landscape  representation.  Bottom:  Contour  
' • • t o 
B^te 
repre-
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Fig.  9.  The  5-ci'.?-lycopene  Model  B P E S , % : = )  at  y 3  =  g  conformation.  Top:  Landscape  representation.  Bottom:  Contour  repre-
sentation. 
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Table  3  
Torsional  angles  of  the  optimized  5-els  lycopene  Model  B  conformers  
Conformer Xi Xi XÎ XA Xs X6 Xi XR X9 XIO 
Xi X3 XA 
s + g s 176.805 - 9 . 0 8 0 88.036 - 8 3 2 0 -4.471 170.478 -181.311 -1.685 163.845 178.980 
s g+ NOT F O U N D GOES TO sg
+s 
s g+ g NOT F O U N D GOES TO 
+ 
g 
+ 
g s 180.452 1 7 0 3 5 9 6 7 3 9 7 8.997 -3.028 170.953 -180.864 -0.132 179.930 182.914 
+ 
g 180.041 99.783 58.797 7 9 3 7 1 1.400 182.284 -179.580 0.255 179.460 175.630 
g* g' 180.717 115.906 67.994 258.053 0.596 181.810 -179.796 1.003 179.588 181.870 
g~ 
+ 
g s NOT FOUND GOES TO 
g g+ 181.120 247.018 68.508 80.618 0.963 182.754 -179.686 0.296 185.079 ,5178.317 
g~ 
+ 
g s" 178.111 - 1 0 5 3 6 1 75.434 - 1 0 0 . 1 2 7 -0.038 181.286 -180.039 - 2 3 4 9 -182.219, -177.214 
s a s NOT F O U N D GOES TO 
s a + g NOT F O U N D GOES TO 
+  +  g  A g 
s a g~ NOT F O U N D G O E S TO g
+ a  g*  % '''  
a s 180.860 102.780 174347 4.853 0.122 180.257 -179.872 -0.077 179,099 1  181.457  
g* a g* 181.099 1 0 4 3 7 5 175366 91.422 1.315 181.324 -179.966 -  0.001,#  179.400 176.023 
+ 
g a g' 181.052 103.802 179.675 - 9 1 . 9 1 9 -1.255 179.048 -180.005 0.009: 179.441 183.829 
g a s 179.155 - 1 0 2 . 8 6 5 185316 - 4 3 7 5 -0.114 179.658 -180.125 a  129  5  181.131 178.668 
g~ a 178.939 - 1 0 3 . 9 6 2 180368 91.951 1.255 180.915 -179.994 0.014 180.608 176.131 
g~ a g 178.916 - 1 0 4 3 3 1 184.418 - 9 1 . 4 5 9 -1.320 178.750 -180.030 -0.021 ''  180.516  184.011 
s g' s 183.218 9.068 - 8 8 . 1 0 4 8 3 9 1 4.444 189.461 181.309 |  1.637  196.198 181.053 
s g 
+ 
g NOT F O U N D GOES TO  ' % , g'  g~g'  
s g g~ NOT F O U N D GOES TO g  g  g  
s + g s NOT FOUND GOES  :  TO g  g  «  +  
g 
+ 
g 181.885 1 0 5 3 2 5 - 7 5 3 7 3 100.166 0.061 178.649 -179.960 -2.389 181.962 176.975 
+ 
g g g~ 178.875 113.110 -68.478 - 8 0 . 6 1 0 -0.968 177.3Z5 5,-180320 -0.360 174.822 181.661 
g g s 179.535 - 1 7 0 3 2 4 - 6 7 . 4 9 0 - 8 . 8 2 2 3.006  ,  188.995 %i;i79.135 0.295 180.655 177.220 
g~ g 
+ 
g 179.289 - 1 1 5 3 1 5 - 6 8 . 0 0 5 101.908 - 0 3 9 8 178  149  f—180.201 -0.988 180.411 178.083 
g~ g g 179.946 - 9 9 . 7 6 5 - 5 8 3 3 6 - 7 9 3 9 5 1773J12 -180.418 -0.159 180.651 184.473 
The  optimized  torsional  angles  are  summarized  in  
Table  4  and  the  computed  properties  are  given  in  
Table  4.  
4.2.  Molecular  configurations  '%.  
It  is  of  considerable  interest  to  optimize  the  fully  
symmetrical  a,a,a  ~  Xi  =  X4  180°)  conforma-
tion.  This  is  done  for  both  the  ail-trans  and  the  5-cis  
structures,  in  two  steps.  Fifst,  these  three  dihedral  
g"(a)g'-  g W  -0.157  -0.314  
.  •  
g+(a)g+  g (a)g+  -0.314  -0.157  
Scheme  9.  
angles  were  kept  frozen  and  then  subsequently  
relaxed.  In  addition  to  the  optimized  torsional  angles  
(Table  5),  the  energies  and  the  imaginary  frequencies  
(Table  6)  were  also  tabulated.  These  fully  symmetric  
points  (marked  as  a  solid  dot  at  the  centre  of  Fig.  2)  
are  second  order saddle  points.  All  these  indicate  that  
neither  the  all-frans,  nor  the  5-cis  isomers  are  ever  
fully  symmetric.  Consequently,  neither  the  zil-trans  
nor  the  5-cis isomers  are  planar.  
It  is  interesting  to  compare  the  relative  stability  of  
the  a\l-trans-  and  the  5-c/r-isomers.  A  graphical  
comparison  of  the  relative  energies  given  in  Tables  
2  and  4,  is  shown  in  Fig.  10.  Intuitively,  one  would  
have  guessed  that  all  5-c/r-conformers  have  to  be  of  
higher  energy  than  their  corresponding  a\l-trans-
conformers.  However,  this  is  not  the  case.  
Only  four  conformers  of  the  5-c/s-isomer  (sg+s ,  
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0.140  0.796  
0.795  0.518  
g V ) g '  E"(g*)8"  
g W  g ( g V  
E*(g)g  g'(g")g~  0.518  0.795  
g + ( g V  g ' f e V  0.804  0.140  
Scheme  10.  
Table  4  
Dipole  moments,  total  energies  and  relative  energies  of  the  optimized  5-cis  lycopene  Model  B  contemners  
Conformer Dipole Energy  (hartree)  AE  (kcal  mol" 1 )  
Xi X3 X4 
s + s 0.8089 -  424.5945699  11.168 
s + NOT  FOUND  GOES T O  s  g *s N/A 
s + g NOT  FOUND  GOES T O  g a g "  N/A 
+ 
g s 0.8657 -  424.6023298  6J2989 
+ 
g 
+ 
g 1.0293 - 4 2 4 . 6 1 1 1 0 1 3 # 6 . 7 9 4 7 
g+ g+ g 0.7313 -  424.6121441  0 1 4 0 4 
g 
+ 
g s NOT  FOUND  GOES TO g^a  g *  N/A  '  .  
g g+ 
+ 
g 0.7078 - 4 2 4 . 6 1 1 5 4 2 8 . J ?  0.5177  
g' 
+ 
g g 0.5608 -  424.6110997  0.7957 
s a s NOT  FOUND  GOES TO  g + a  " % / A 
s a NOT  FOUND  GOES TO  g+a;f+  ' % .  N/A 
s a g NOT  FOUND  GOES  T O J  N/A 
+ 
g 
g+ 
a 
a 
s 0.9719 
0.6513 
-  424.6Ö4Ö333  
-  424.6128689  
5.2300 
— 0.3140 
g+ a g 0.9975 -  424.6126178  -  0.1570  
g' a s 0.9716 -  414-6040331  5.2301 
g a 0.9976 -  424.6126178  -  0.1570  
g~ a g 0.6515 1  -  424.6128689  — 0.3140 
s g' s 0.8091 -  424.5945699  11.1680 
s g 
+ 
g NOT  FOUND  '>  (jfÔES T O  g~  g~  g*  N/A 
s g g NOT  FOUND  #  GOES T O  g  g  g  N/A 
+ 
g g s NOT BOtlND  \  f  GOES TO g - g - g
 +  N/A 
+ 
g g~ 0.6145 -  424.6110874  0.8035 
g+ g g' 0.7079  \  -  424.6115427  0.5178 
g' g s -  424.6023291  6.2994 
g' g ...  <>-7314  - 4 2 4 . 6 1 2 1 4 4 1 0.1404 
g~ g g % , 1 0 2 9 6 - 4 2 4 . 6 1 1 1 0 1 3 0.7947 
TableS 
Torsional  angles  of  the  symmetric  second  order  TS  lycopene  Model  B  isomers  
Conformer  :  y r i Xt X3 *4 Xs Xs Xn Xt Xi X to 
Trans 
5-Cis 
179.973 
180.001 
180.000 
180.000 
180.000 
180.000 
180.000 
180.000 
180.000 
- 0 . 0 0 0 8 
179.996 
180.001 
180.000 
- 1 7 9 . 9 9 9 
0.181 
0.025 
180.124 
180.005 
180.121 
179.981 
Journal of  Molecular  Structure (ITieochem)  -  Model  3 -  Ref style  1  -
a ^ s i a i  f i  dm  
A ET O PAG1N ATi O N 2 Alden 
18 G A.  Chasse et  ai  / Journal of Molecular Structure (Theochem) 00 (2001) 000-000  219  
Table  6  
Imaginary  frequencies, dipole  moments,  total  energies  and  relative  energies  of  the  symmetric  second  order  TS  of  lycopene  Model  B  isomers  
Conformer Imaginary  frequencies  (cm  ')  Dipole Energy  (hartree)  A £  (kcal m o l " l  )  
Trans 115.5Î 51.0i 1.1343 -424 .6036305 5.4827 
5-Cis 77. Ii I9.6i 1.0753 -424 .6055073 4.305 
a l l  -  t r a n s  5 -  eis  
523  8-"  
< 
^  3  
0-
-1 
"  g" » »  0.98  
g+»g—g-»g+  0.07  
-0.15  g + » g - - g  «g-t  
g+»g+ -  0.00-
--0.3I  '  E-»g  
Fig.  10. Relative  energy  of  the  all-rran.ç  and  5-cw-isomers  of  lycopene  Model  B  at  the  =  a  conformation.  
7  -
M 
5 
S 
3  -
•52  -
1  .  
a l l  -  t r a n s  
g - g + «  1.92  
g + g + g +  1.30-
g - g + g +  1.06-
g- g+ g-  0.80  
g + g + g -  0_34-
5 - c i s 
- 6.30  g+ g+ » 
0.80/0.79  g-g+g-=  g+g+g+  
g - g + g + 
.  0.52  
0.14 g+g+g-
Fig.  11. Relative  energy  of  the  al\-trans  and  5-cir-isomers  of  lycopene Model  B  at  the  =  g  conformation.  
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7 " 
*  6  -
S  -
< 
a  3  
E-
all  -  trans  5 - cis 
6.30  g- g- ' 
g-g-'  2.16-
g+g-s  1.92  
g-  g" g"  1.30_  
g+g-g-  1.06—  
g+g-g+  0.80  
g-g-g+  0.34-
0  80/0  79  g+g-g^  -  g-g-g-
0.52  g+ g- g-
0.14  g-g-gf  
Fig.  12.  Relative  energy  of  the  all-fra/i.s and  5-c«-isomers  of  lycopene  Model  B  at  the  f i g''  conformation.  
g~g+s,  g'as,  g~g~s)  had higher energy  than the  corre-
sponding  all-rran.?  isomer.  Two  conformers  (g~g+g~  
and  g+  g~g*)  had  practically  the same  energies,  while  
in  the  case  of  the other  conformers,  the  5-c/s-isomers  
were  slightly  more  stable,  than  their  corresponding  
all-fraru-isomers  (Figs.  11  and  12).  
5.  Conclusions  
Type  A'  1,4 -interaction  (Scheme  4).  The  conforma-
tional  study  revealed  that  the  fully planar  structure  of  
lycopene  Model  B,  is  a  second-order  saddle  point.  
Such  fully  symmetric  (i.e.  planar)  structure  of  lyco-
pene  would  be  expected  to  become  a  fourth-order  
critical  point on  its PEHS,  because  there  are two  nega-
tive  eigenvalues  at  both  ends  (;y2,  X4  as  well  as  x i  
X4')-  X  
Epidemiological  studies  have  supported  the  
hypothesis  that  consumption  of  heat  processed  toma-
toes,  such  as  in  the  Mediterranean  diet,  may  reduce  
the  risk  of  coronary  heart  disease  by  preventing  the  
oxidation  of  the  low-density  lipoprotein  [1,2].  
Giovannucci  et  al.  have  also  suggested  that  only  the  
intake  of  processed  tomato  products  was  related  to  
reduced  risk  of  prostate  cancer  probably  because  of  
their  high  cis  isomer  content  of  lycopene  [21].  The  
observation  that  high  concentration  of  cis  isomers  are  
present  in  human  serum  anil  prostate  tissue,  also  
suggests  that  cis  isomers  might  be  biologically  more  
active  than  the  alf3ran.y  isomer.  
In  contrast  to  previous  results  [22],  according  to  
which  the:c/s-isomer  is  less  stable  than  the  corre-
sponding  rran.v-isomer,  the  present  study  suggests  at  
least  the 5-ct s-isomer is more stable than the  all-rra/w-
isomer.  Such  stability  may  be  due  to  the  favourable  
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Abstract 
Lycopene  is  an  effective  antioxidant  in  vivo.  Although  lycopene  is  present  in  its  all -trans  isomeric  form  in  fruits  and  
vegetables,  serum and tissue  samples  show  a predominance of  various ci.s-isomers of  lycopene.  The present  study  was  under-
taken to investigate the molecular  structure of several c/.v-isomers of lycopene using an ab initio molecular modeling  procedure.  
The  relative  stability  of  selected  cis-isomers  of  lycopene  with  respect  to  the  all-trans  isomer,  was  studied.  The  following  
sequence  of  stability  was  observed.  
5-cis  >  all-trans  >  9-cis  >  13-cis  >  15-cis  >  1-cis  >  11-eft  
The  first  four  of  these  isomers  had  relative  energies  within  — I  kcal  mol"1,  but  the  fifth  isomer  (i.e.  15-cA)  was  within  
3 kcal mol"'.  However,  the  last  two isomers were less  stable than the all-rranr-isomer  with  more than 5 kcal  mol"',  difference 
in energy. The optimized molecular conformational study structures indicated  that the central conjugated  part of every  lycopene 
isomer  is  planar.  However,  the  two  tail  ends; of  the  molecules,  each  containing  three  single C - C  bonds,  avoid  coplanarity.  
©  2001  Elsevier  Science  B.V.  All  rights  reserved.  
Keywords:  All  rra/u-lycopene;  Selected  c/'.c-isomers  of  lycopene;  Thermodynamic  stability  of  lycopene  isomers;  Computations  of  lycopene  
isomers;  Ab  initio MO  theory  ^.vix...  
1.  Introduction  et iological  fac tor  in  the  causation  of  several  chronic  
diseases,  amongs t  which  are  cancer  and  cardiovascu-
1.1.  Biological  background  lar  diseases.  Ant ioxidants  are  effective  in  mitigating  
the  damaging  effect  of  free  radicals.  Lycopene  is  a  
Oxidative  stress  is  now  recognized  as  an  important  carotenoid  antioxidant ,  present  in  tomatoes  and  
other  fruits  and  vegetables.  Recent  studies  have  
• •  ..  _  .  „ , , „ . „ , „  „  . .  „ . ,  shown  that  it  acts  as  an  antioxidant  in  vivo,  providing  
*  Corresponding  author.  Tel.:  +1-416-598-3229;  fax:  +1-416-  '  y  6  
598-7797.  protection  against  the  oxidation  of  lipids, proteins  and  
E-mail  address:  gchasse@fixy.org  (G.A.  Chasse).  D N A  [1,2].  A recently  published  paper  [3] indicated  a  
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significant  inverse  correlation  between  the  intake  of  
lycopene  or serum concentrations  of lycopene  and  the  
risk  of  several  concerns.  The  isomeric  forms  of  lyco-
pene  have  been  suggested  to  be  important  factors  
influencing  its  absorption  and  bioavailability.  
1.2.  Structural  background  
Lycopene  [C4oH56] consists  of eight  isoprenic  units,  
so  its  skeleton  is  related  to  tetraterpenes  [QoH^],  
even though  it contains fewer hydrogens.  Its  composi-
tion  is  shown  in  I.  
The  spectral  characteristics  of  stereoisomers  caro-
tenoids,  including  lycopene,  were  studied  [9] in  1943.  
The  ease  of  isomerization  of  the  C40H56 carotenes  has  
been noticed  by Zechmeister  and Tuzson  [10]  as early 
as  1938.  An  isomerization  equilibrium  can  only  be  
reached  very  slowly  but  the  process  starts  immedi-
ately  after  the  crystalline  carotene  is  dissolved.  This  
indicates  that  the  all-frans-  and  various  c/s-isomers  
are  very  close  on  the  free-energy  scale,  but  neverthe-
less require appreciable  energy of activation for such  a  
non-catalyzed  inter-conversion.  Subsequently,  trans  
to  cis  isomerization  of  lycopene  [11]  and  other  
H,C - -c— 
HJ 
-c— 
H2 
•  c  c=  
H 
r - C - ; — c — c = =  c -
Ha  •  H  
As  such,  lycopene  is  closely  related  to a - ,  (3-,  and  
y-carotenes.  Sometimes,  the  structure  of  lycopene  is  
presented  in  a pre-folded  form  (II)  to  show  its  struc-
tural  similarity  to  (3-carotene.  Due  to  the  internal  
molecular symmetry,  it has been  traditional  to  number  
the  chain  from the  two  ends  as  shown  in  II.  
compounds  were  studied  using  iodine  as  the  catalyst.  
[11-13],  In  1943,  Pauling  pointed  out  [14]  that  trans  
to  cis  isomerization  could  be  a  result  of  the  overlap-
ping  of  the  methyl  group  of  a carbon  atom  adjacent  to  
a  double  bond  and  the  hydrogen.  Not  all  c/r-isomers  
may  be  of equal  stability  due  to  a  number  of  possible  
The  all-trans  lycopene  has  also  been  presented,  
traditionally,  in  its  fully  extended  form  (III).  
»9.'"• ;::..  20  
III 
All  of  thèse  representations  imply  a  planar  mol-
ecular  form.  
Isolation  procedures  for  lycopene  were  first  
reported  in  1910  [4]  and  its  structure  was  determined  
during  the  period  of  1928-1931  [5-8] .  
1,4 interactions  as shown  by  the structures of  Scheme  
1. Clearly,  on  the  basis  of  relative  group  sizes,  the  -
CH3- •  -H— interaction  (type  C)  appears  to  be  the  most  
destabilizing. 
There  are  a  number  of  possible  geometrical  
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Scheme  1.  
96 atoms,  which corresponds  to 282 geometrical  para-
meters  to be optimized).  Thus, lycopene  is among  the  
largest  organic  molecules  being  investigated  using  ab  
initio  molecular  computation  with  the current  compu-
tational  technology.  
4.  Results  
isomers.  Zechmeister  indicated  [13]  the  possible  
presence  of  20  (3-carotene,  32  a-carotene,  64  y-
carotene  and  72  lycopene  geometrical  isomers.  No  
X-ray  structure  of  lycopene  has  been  determined  as  
yet.  There  are,  however,  two  X-ray  structures  of  (3-
carotene  in  the  literature  [15,16].  
2. Aim  of  study  
Although  lycopene  is  present  in  its  all-trans  
isomeric  form  in  fruits  and  vegetables,  c/r-isomers  
constitute  the  predominant  form  present  in  the  
serum  and  tissues  [17,18]. The  biological  significance  
of lycopene isomerization  is not  well  understood.  The  
aim  of  our  study  was  to  investigate  the  structure  and  
stability  of  different isomeric  forms of lycopene  using  
ab  initio  molecular  modeling,  and  to  gain  a  better  
understanding  of  lycopene  isomerization  require-
ments.  In addition  to geometrical  cis/trans  isomerism,  
the  conformations  of  the  two  tails  of  the  molecule  
were  also  analyzed.  
3.  Method  ..  ....  
This  computational  study  involved  semi-empirical  
(AMI)  geometry  optimization,  which  was  followed  
by  an  ab  initio  study  carried  out  at  the  HF/3-21G  
level  of  theory.  
The  computations  were  carried  out  using  the  GAUS-
SIAN  94 program  system  [19].  Standard  geometry  opti-
mizations were performed on the all-trans- as well as six 
selected  c/r-isomers.  The optimized  molecular  confor-
mations were also Compared to the results obtained from 
a lycopene  model  compound  [20],  
Fig.  1 shows  the  all-trans-  and  selected  c/r-isomers  
of  lycopene.  The  all-trans-  and  the  selected  six  cts-
isomers  (5-, 7-, 9-,  11-,  13-  and  15-)  were explored  in  
their molecular  entirety  (containing  296 electrons  and  
The  relative  energies,  which  measure  thermody-
namic  stabilities  of  the  lycopene  isomers,  computed  
at  the  HF/3-21G  level  of  theory,  are  summarized  in  
Table  1.  The  expected  stability,  on  the  basis  of  
molecular  structures,  are given  in Table  2. The  values  
of  the  torsional  angles  (p  2'  3  as  well  as  .ft,2',3) of  the  
three  pairs  of  single  bonds  (C 2 -C 3 ,  C 3 - C 4 ,  C 4  - C 5  as  
well  as  C 2 - C 3  C 3 ' - C 4 '  C 4 ' - C 5 ' )  are  summarized  in  
Table  3,  
5.1.  Molecular  configurations  
The  relative  energies,  which  measure  thermo-
dynamic  stabilities  of  lycopene  isomers,  are  summar-
ized  in  Table  1 and  are  depicted  in  Fig.  2.  We  notice  
four Categories  for c/r-isomers,  which  are  summarized  
in  Table  2.  The  computed  relative  stabilities  of  the  
four categories  of  the  c/r-isomers,  are  listed  below.  
Type  A'  involves  the  5-c/r-isomer.  This  is  the  only  
c/r-isomer  which  is  slightly  more  stable  (within  
—0.5 kcal mol" 1)  than  the  all-rranr  form.  
Type  A  involves  the 9-cis and  13-c/r-isomers.  These  
c/r-isomers  are slightly  less stable (within  1.0 kcal  -
mol" 1 )  than  the  all-rrarjr-form.  
Type  B  involves  the  15-c/r-isomer,  which  is  only  
about  3 kcal mol"1  less  stable  than  the  all-rrawr  
form. 
Type  C  involves  the  7-  and  11-c/r-isomers.  These  
c/r-isomers  are  about  6 kcal mol" 1  higher  on  the  
energy  scale  than  the  all-rranr-form.  
C/r-isomers  of  lycopene  in  Types  A'  and  A  and  the  
trans  lycopene  have  similar  energies,  since  we  are  
dealing  with  triply  substituted  double  bonds  as  
shown  in  Table  2.  
Type  A  structures  (see  Fig.  1)  are  only  slightly  
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Fig.  1. Geometrical  isomers  of  lycopene.  
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Table  1  
Computed  total  energy  and  Relative  Energy  Values  of  Various  
Isomers  of Lycopene,  at  HF/3-21G  level  of  theory  
Isomer Energy  (Hartree)  Relative  energy  (kcal  mol  ')  
All-trans - 1 5 3 8 3 7 3 1 2 4 9 0.000 
S-Cis - 1 5 3 8 . 5 7 3 7 5 4 8 -  (0.395)"  
1-Cis - 1 5 3 8 . 5 6 3 6 8 9 9 5.921 
9-Cis - 1 5 3 8 . 5 7 2 2 4 6 0 0.552 
11  -Cis - 1 5 3 8 . 5 6 3 4 7 8 9 6.053 
13  -Cis - 1 5 3 8 . 5 7 2 1 3 3 8 0.622 
15  -Cis - 1 5 3 8 . 5 6 9 3 0 9 8 2.394 
'  Global  minimum.  
higher  on  the  energy  scale  (see  Fig.  2)  than  the  all-
rrani-isomer.  Type  A1  is extremely  similar to Type  A,  
except  that  the  hydrogens  on  the  1,4  positions  
(denoted  as  carbon  4  and  7)  are  not  eclipsed  but  
staggered.  This  is  shown  in  Scheme  2.  
Type  B,  there  is  only  one  example-  the  \5-cis-
isomer.  The  1,4  interaction  involves  the  cis  double  
bond  which  has  only  two  alkyl  substituents  as  
shown  in  Table  2.  
Type  C has  the two least  stable  structures,  the 7-cis  
and  11-c/s-isomers.  In  accordance  with  Fig.  2,  the  
NB:  Clearly,  on  the  basis  of  relative  group  sizes  ,  the  -CH 3 —H-  interaction  (type  C)  appears  to  be  the  most  
destabilizing.  The  order  of expected  stability  is the following:  A'>A>B>C.  
Table  2  
Classification  of  various  cw-lycopene  isomers  according  to  1,4-non-bonded  interactions  and  extent  of  substitution  about  the  carbon-carbon  
double  bond involved. NB: Clearly, on the basis of relative group  sizes, the -CH 3 - • H-interaclion  (type C) appears  to be the most  destabilizing.  
The  order  of  expected  stability  is  the  following: A '  >  A  >  B  >  C  
I 
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Table  3  
Optimized  torsional  angles  and  selected  orbital  energies  for various  isomers of  lycopene,  calculated  at  RHF/3-21G  level  of  theory  
Parameter' Dihedral all-trans 5 -cis 1-cis 9-cis 11-cir 13-cis 15-cis 
Ad D5 -106.596 103.040 -106.539 -106.605 -106.440 -106.409 -106.393 
X7 D6 -176.424 176.517 -176.567 -176.479 -176.430 -176.524 -176.473 
X3 D7 -100.364 90.063 -100.548 -100.368 -100.340 -100.393 -100.459 
X,' D31 106.368 106.440 106.515 106.460 106.394 106.474 106.475 
Xi' D30 176.452 176.460 176.480 176.460 176.4637 176.504 176.456 
X,' D29 100.377 100.406 100.468 100.415 100.448 100.415 100.421 
<t> D# N/A 1.388 -5.854 -0.016 5.945 -0.0005 0.016 
HOMO - -0.23712 -0.23320 -0.23387 -0.23347 -0.23508 -0.23422 -0.23459 
LUMO _ +0.06964 +0.05102 +0.05144 + 0.05255 +0.06867 +0.05331 +0.05284 
A - 0.30676 0.28422 0.28531 0.28602 0.30375 0.28753 ,#0.28743 
'  x  denotes  the dihedral  angle  value  for the  single  bonds,  from the outsides  inwards  , corresponds  to  the  first  single  bond, closest  to  the  
terminal  end  of the molecule).  <p  corresponds  to the value  of  the dihedral  angle about  which  the isomerisation  has occuredj for each  particular  
cù-isomer.  Thus,  4> measures  deviation  from  coplanarity  of  the  cis  double  bond.  HOMO  is  highest  occupied  MO  energy,  measuring  the  
ionisation  energy  (IE)  in  terms  of  Koopman's  theorem. LUMO  is  lowest  unoccupied  MO  energy  and  A  is  the  différence LI."MO-  HOMO  in  
Hartree  atomic  units.  
TypeC 
Type  B  
Fig. 2. A schematic  illustration of the relative energies (kcal  mol  ' )of the various ctv-isomers of lycopene studied relative to the all-trans form. 
All-trans o r  E- isomer 
Scheme  2.  
5-cis or  Z-isomer  
Type  A'  
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ciS'  trans>  9~cis>  lJ~cis>  ÍJ~cis>  '~cis>  1 '"cis 5-, 
relative  energy  
n-r 
•4 
15- / - IO,  l ' r  
stability 
11 -, 
Scheme  3.  
relative  energies  measuring  stabilities  are  therefore  as  
follows  in  Scheme  3  
In  view  of  the  foregoing,  one  only  may  wonder  if  
the  thermodynamic  stability  of  the  lycopene  isomers,  
as  well  as  the  kinetic  stability  of  the  isomerization  
transition  states,  will  predetermine  the  relative  
concentrations  of  these  isomers  in  tissues  and  plasma.  
5.2.  Molecular  conformations  
When  a planar moiety  is rotated  about  a  tetrahedral  
carbon,  it  may  be  either  eclipsed  with  a  tetrahedral  
bond  or  perpendicular  to  that  bond.  This  has  been  
revealed  by  the  study  on  ethyl  benzene  [21].  
In  the  case  of  lycopene  isomers,  in  most  cases,  the  
olefinic  moiety  seems  to  favor  a compromising  posi-
tion, having  1 and  in the range  of 90-107°.  Thus,  
it is either roughly perpendicular  to the C 3 - C 4  bond  or  
near  to  a position  of eclipsing  with  one  of  the two  C—  
H  bonds  of  the  CH2  moieties  of  C 3  and  C4.  These  
conformers  are  shown  in  Scheme  4.  The  optimized  
values  of  the  torsional  angles  are  summarized  in  
Table  3.  
Fig.  3 shows the optimized  structures of lycopene  in  
the  al[-trans  as  well  as  in  the  selected  c/r-isomeric  
forms.  The  results  (see  Fig.  3  and  Table  3)  clearly  
indicate  that  while  the  conjugated  double  bonded  
segment  of lycopene from C 5  to C5  is planar or  nearly  
planar,  the  two  terminal  positions  of  the  molecule  
(from C 1  to C5  as  well  as  from  C1  to C 5 )  are  rotated  
out  of  plane.  
5.3.  Deviation  from  coplanarity  
Sometimes  the  reactivity  of  an  unsaturated  
compound  is  related  to  its  not  completely  planar  
forms.  This  is  particularly  true  for err-double  bonds.  
Deviation  from  coplanarity  is  within  about  6°  at  the  
HF/3-21G  level  of  theory  as  shown  by  the  data  in  
Table  3  by  the  entry  3>. The deviation  from  coplanar-
ity  (A <t>) at  the corresponding  double  bonds  in  the  all  
trans-form  is  considerably;  smaller  as  shown  by  the  
data  given  in  Table  4.  Such  non-planarity  implies  a  
weakening  of  the  ir-bond.  which  in  turn  is  related  to  
reactivity.  Such  an  enhanced  reactivity  is  certainly  
related  to  trans-cis  isomerization.  However,  it  is  not  
clear  at  this  time  if  such  structural  differences  may  
also  imply  enhanced  radical  scavenging  ability.  
6.  Perspectives  
Lycopene  from  natural  plant  sources  exists  predo-
minantly  in  the  all-franr  configuration.  For  this  
reason,  it  may  have  been  assumed  to  be  the  thermo-
dynamically  most  stable  form.  However,  all  one  can  
conclude  is  that  the  biosynthesis  in  the plants  leads  to  
C1 
90-
H 
3d = o-
Scheme  4.  
5d=90- i  =  120*  
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Fig. 3. (continued) 
the  all-rra/is-form  and  this  is  independent  of  its  ther-
modynamic  stability. Ihhuman  plasma, lycopene  is  an 
isomeric  mixture,  containing  Ot least  60%  of  the  total  
lycopene  as  cfktsbmers  (Table  5).  All-trans,  5-cis,  
9-cis,  13-cis  ahd  iSrp's  are  the  most  commonly  iden-
tified  isomeric  forms  of  lycopene  [18].  The  relative  
biological  significance  in  terms  of  absorption  and  
effectiveness  of  various  geometric  isomers  of  
lycopene  is  unclear  at  present.  
Epidemiological  studies  have  supported  the  
hypothesis  that  consumption  of  heat-processed  toma-
toes,  such  as  in  the  Mediterranean  diet,  may  reduce  
the  risk  of  coronary  heart  disease  by  preventing  
the  oxidation  of  the  low-density  lipoprotein  [1,2].  
Giovannucci  et  al.  [22]  have  also  suggested  that  
only  the  intake  of  processed  tomato  products  was  
related  to  reduced  risk  of  prostrate  cancer,  prob-
ably  because  of  their  high  content  of  lycopene  
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Table  4  
Torsional  angles  for  the  fran.v-peptide  bonds  in  the  all-iran.s  lyco-
pene,  computed  at  RHF/3-21G  level  of  theory.  
Bond Dihedral  (<f>)  <t> A <t>' 
c'-cJ D4 178.955 1.045 
C5-C6 D8 178.645 12355 
C7-C8 D10 179.943 1.057 
c'-c10 D12 -179 .999 -0.001 
c"-c13 D14 179.999 0.001 
CI3-CM D16 179.998 0.002 
c,5-c15' D18 180.000 0.000 
C|V-C13' D20 179.997 0.003 
C2'-C"' D22 180.000 0.000 
Cltf-C®' D24 180.000 0.000 
cs'-c7' D26 179.060 0.940 
c6'-c5' D28 -178 .623 - 0 . 3 7 7 
c7'-c'' D32 -178 .925 -0 .075 
'  Deviation  from  coplanarity  measured as  follows:  
A 0  =  180°  -  4>  (íoi<f>  >  0),  A<f>  =  - 1 8 0 °  -  4>  (for  <j>  <  0).  
Table  5  
7.  Conclusions  
As  far  as  configuration  stability  is  concerned,  the  
following  sequence  has  been  established  at  the  HF/3-
21G  level  of  ab  initio  computations.  
5-cis  >  all-trans  >  9-cis  >  13-cis  >  15-cis7-c/r  
>  11-c/r  
The  conformational  analyses  indicated  that  the  
central  skeleton  of  conjugated  double  bonds  is  practi-
cally planar for all seven isomers. However,  the tail-end 
with C - C  single bonds are  flexible  and  theirconforma-
tions avoid  coplanarity  with the central  skeleton.  
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Computational  analyzes  were  undertaken  to  investigate  the  geometrical  isomerization  mechanism  of  a  truncated  tail-end  72  
model  (C | -C | 0 )  of  the  full lycopene  molecule,  the products  of  which  are  the 5-cis  and 7-ci'iforms. The  global  conformational  73  
minima  were  identified  for  the  neutral  all-trans  reactant,  the  cationic  isomerization  intermediates  and  that  of  these  two  cis-  74  
isomeric  products.  Energies  and  stabilities  were  compared  during  different  stages  of  the  isomerization  mechanism  of  the  7 5  
segments.  The  C4  allylic  hydride  affinity  values  of  the  all-trans  to  the  5-cis,  and  the  7-cis  isomers  of  this  lycopene  model,  
are  in  the  range  of 255-260  kcal  mol ~1,  which  are  within  the  expected  limits  of  such  hydride  affinity values  (210  kcal  mol"1  
for  weak  and  360 kcal  mol"1  for  strong  hydride  affinity)  at  the  RHF/3-21G  level  of  theory.  The  bond  lengths  involving  
alternating  single  and  double  carbon-carbon  bonds  roughly  coincide  with  the  expected  changes  along  each  intermediate  of  
the putative  isomerization  pathway. The following sequence  of  stability was observed  in the  tail-end  model  of  neutral  lycopene  
isomers: 
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For  the  cation,  the  order  of  stability  was  different:  84  
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Fig.  1. Structure  and  numbering  of  lycopene  and four experimental  models.  
1.  Preamble  
Lycopene  (Fig.  1)  belongs  to  a  family  of  natural  
lipophillic pigments, known  as carotenoids.  Carotenoids,  
present  in  various  fruits and  vegetables,  are  fundamental  
constituents  of  plant  photosystems.  Perhaps  the  most  
extensively  studied  functions  of  carotenoids  are  their  
light-harvesting  abilities  during  photosynthesis  
and  protective  effects  against  photosensitization,  
which  could  lead  cancer.  Today,  approximately  700  
carotenoids  have  been  identified  in  nature  [1],  and  
their  chemical  structures  have  been  unveiled.  All  
carotenoids  are  characterized  by  an  extended  system  
of  conjugated  double  bonds  that  account  for  their  
color  and  antioxidant  activities.  Carotenoids  can  be  
classified  into  hydrocarbon  carotenoids  containing  
solely  carbons  and  hydrogens,  and  oxocarotenoids,  
which  include  oxygen  atoms  in  their  structure.  
Pre-folded fo rm of  lycopene  
Beta-carotene 
Fig.  2. Similarity  in  structure between  lycopene (pre-folded) and beta-carotene.  
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Fig.  3. Energy  level diagram showing  the energy transfer during  02  scavenging (left side) the spin forbidden de-excitation  of  triplet  lycopene  
(right  side).  
Another  method  of  classification  is  based  on  the  
presence  or  absence  of  provitamin  A  activity.  
Originally,  carotenoids  were  considered  important  
only  as  precursors  of  vitamin  A.  More  recently,  
there  has  been  significant  interest  in  evaluation  
of  carotenoids  for  roles  that  are  unrelated  to  their  
conversion  to  vitamin  A.  Beta-carotene  has  been  the  
primary  research  focus  of  earlier  studies  because  of  
its  role  in  cancer  prevention  and  its  potential  vitamin  
A  activity.  Although  both  lycopene  and  beta-carotene  
have  very  similar  chemical  structures  (Fig.  2), and  the  
former  is  even  the  precursor  of  the  latter  in  the  bio-
synthetic  pathway  [2],  the  effects  of  lycopene  and  
beta-carotene  on  health  differ  drastically.  It  is  only  
recently  discovered  that  instead  of  protecting  humans  
against  cancer,  the  supplement  form  of  beta-carotene,  
when  ingested,  can  increase  the  risk  of  lung  cancer  
and  heart  disease  [3].  Thus,  the  relationship  between  
molecular  structure  and  health  is clearly  demonstrated  
-  even  a  diminutive  difference  in  chemical  structure  
can  lead  to  unpredictable  effects on  health.  
Although  used  as  a  natural  food  colorant  for  many  
years,  it  was  only  recently  that  lycopene  became  the  
subject  of  intense  study  with  respect  to its  antioxidant  
activity  and  potential  in  alleviating  chronic  diseases  
such  as  prostate  cancer  [4],  A  growing  body  of  
scientific  evidence  indicates  that  antioxidants  are  
important  in  the  human  body ' s  defences  against  
harmful  free  radicals,  which  induce  structural  
damages  to  cells  and  possibly  contribute  to  aging  
and  diseases  that  occur  more  frequently  with  
advancing  age.  Lycopene,  an  antioxidant  in  vivo,  
provides  protection  against  the  oxidation  of  lipids,  
proteins  and  D N A  by  free  radicals.  The  collective  
degenerative  effects  of  these  free  radicals  are  termed  
'oxidative  stress'.  
In  fact, the  most  dangerous  free radicals  come  from  
oxygen,  known  as  the  reactive  oxygen  species.  They  
include  superoxide  (02~),  hydrogen  peroxide  (H 2 0 2 ) ,  
hydroxyl  radicals  ( •  OH)  and  singlet  oxygen  ( ' 0 2 ) .  
Singlet  oxygen  is  a  very  high  energy  form  of  oxygen  
with  a shorter  life than  an  oxygen  radical,  but  damage  
cells  and  tissues  much  more  quickly.  Lycopene  may  
well  be  the  most  potent  of  all  singlet  oxygen  
quenchers.  Its efficiency for radical  quenching  resides  
in  its  extended  system  of  conjugated  double  bonds.  
The  greater  the  number  of  conjugated  double  bonds,  
the  higher  the  ability  of  a  carotenoid  to  quench  free  
radicals  [5].  Lycopene  antioxidant  activity  begins  
with  the  transfer  of  energy  of  singlet  oxygen  to  the  
carotenoid,  yielding  a  triplet  ground  state  oxygen  and  
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Fig.  4.  Absorption  of  carotenoids  (lymphatic  pathway).  
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Fig.  6.  Interaction  between  a  methyl  group  and  hydrogen  group  in  lycopene.  
a  triplet-excited  carotenoid  (Fig.  3). Subsequently,  the  
carotenoid  returns  to  ground  state  by  dissipating  its  
energy  through  interaction  with  the  surrounding  
solvent  [6].  In  fact,  lycopene  acts  like  a  catalyst  
since  it  is  left  intact  in  this  quenching  process;  also,  
once  its job  is  finished,  the physical  quenching  process  
begins  again  when  lycopene  further  quench  another  
singlet  oxygen  molecule.  Furthermore,  lycopene  may  
also  undergo  isomerization  during  quenching,  via  the  
lowest  triplet  state  of  the  molecule  [5],  
Together  with  dietary  lipids  and  bile  acids,  lyco-
penes  are  incorporated  into  lipid  micelles  in  the  
small  intestine  via  the  lymphatic  pathway  when  it  
is  taken  into  the  body  (Fig.  4).  It  is  possible  that  
configurations  of  different  lycopene  isomeric  forms  
determine  the  ease  of  micelle  formation,  thus,  aiding  
absorption  of  carotenoids  into  the  intestinal  mucosa  
cell.  However,  whether  an  in  vivo  isomerization  
mechanism  exists  is  still  unknown.  The  intact  
carotenoid  is  subsequently  incorporated  into  
chylomicrons,  which  are  released  into  the  lymphatic  
system  for transport  to  the  liver. The  highest  levels  of  
lycopene  have  been  found  in  the  testes,  adrenal  glands  
and  prostate  [7]. The  bioavailability  of  lycopene  after  
its  absorption  and  distribution  in  the  body  depends  
on  various  factors:  food  processing  and  presence  of  
dietary  lipids.  Interestingly,  processing  such  as  
heating  has  traditionally  been  considered  as  
contributing  towards  the  loss  of  nutritional  quality  
of  foods.  In  contrast,  research  confirmed  that  
processing  breaks  down  cell  walls,  which  weakens  
the  bonding  forces  between  lycopene  and  tissue  
matrix,  thus  making  lycopene  more  easily  absorbed.  
Isomerization  occurs  during  processing,  converting  a  
portion  of  the  all-trans  isomers  to  a  mixture  of  cis-
isomers.  Lastly,  since  lycopene  is  a  fat-soluble  
substance,  it  must  be  consumed  with  some  fat  in  
order  to  be  absorbed  through  the  intestine  to  achieve  
best  results.  
2.  Introduction  
2.1.  Structural  background  
Lycopene  has  a chemical  formula of C4 0H5 6 .  It is  an  
acyclic  and  internally  symmetrical  molecule  with  11  
conjugated double bonds.  Zechmeister  [8] pointed  out  
the  possible  existence  of  72  geometrical  isomers  of  
lycopene.  However,  the  most  predominant  species  in  
tomatoes  and  tomato  products  is the  all-trans  isomer.  
Lycopene  is  present  naturally  in  human  plasma  as  an  
isomeric  mixture  containing  over  60%  of  the  total  
lycopene  as  cis  isomers  [7],  
The  a\\-trans,  5-cis,  9-cis,  13-cis,  and  15-as  
lycopene  (Fig.  5)  are  commonly  identified  in  human  
serum.  Not  all  c/s-isomers  are  of equal  stability  due  to  
a  number  of  possible  1,4  interactions  between  
neighbouring  methyl  and  hydrogen  groups  (Fig.  6).  
Pauling  called  attention  to  the  fact  that  trans-  to  cis-
isomerization  can  be  a  result  of  overlapping  of  the  
methyl  group  of  a  carbon  atom  adjacent  to  a  double  
bond  and  the  hydrogen  [9].  Apparently,  the  steric  
interaction  between  a  methyl  group  and  hydrogen  
atom  (Fig.  6)  is  the  most  destabilizing  which  is  
based  on  their  relative  group  sizes.  
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2.2.  Computational  background  
Conformational  analysis  has  been  performed  on  a  
truncated  ( C i - C g )  tail-end  model  (see  Model  B  
in  Figs.  1  and  8)  of  lycopene  [10].  The  global  
minimum  on  the  conformational  Potential  Energy  
Hyper-Surface  (PEHS):  E  =  E(x2,^3,^4),  corre-
sponds  to  the  (g +,  a,  g+)  structure,  or  its  degenerate  
pair  (g~,  a,  g~),  for  both  the  all -trans  and  5-cis  
isomers.  For  the  full  lycopene  isomers,  the  sequence  
of  stability:  
5-cis  >  all-trans  >  9-cis  >  13-ct's  >  15-ct's  >  1-cis  
>  11 -cis 
has been observed  from previous  ab initio  calculations  
[11].  Apparently,  the  5-cis  form  is  the  energetically  
most  stable  of  all  isomers  not  only  in  the  case  of  the  
full  lycopene,  but  also  its  truncated  tail-end  model  
(Model  B)  [10].  
2.3.  Scope  
The  aim  of  the  present  research  is  to  study  the  
isomerization  mechanism  (Fig.  7)  of  a  truncated  
( C , - C , 0 )  tail-end  model  (Model  C)  of  the  full  
lycopene  (Figs.  1 and  8),  the  products  of  which  are  
two  cis  forms  (5-cis  and  1-cis).  The  use  of  this  
truncated  tail-end  model,  which  is  considerably  
smaller  than  the  full  lycopene,  permits  more  
convenient  and  manageable  molecular  computations  
as  well  as  a  detailed  examination  of  the  two  terminal  
portions  of  lycopene  (from  C]  to  C5  and  from  
C']  to C ' 5 )  that  rotate  out  of  plane.  Previous  studies  
concluded  [10,11]  that  lycopene  has  a  rigid  central  
skeleton  (from C5  toC ' 5 )  and  two  flexible  tails  (from  
C,  to  C5  and  from C ' ,  to  C ' 5 ) .  
As  it  can  be  seen  f rom  the  proposed  mechanism  
(Fig.  7),  the  cation  formation  converts  C 4  f rom  its  
nearly  tetrahedral  (sp3),  to  a  trigonal  planar  (sp2)  
geometry.  Since  the  positive  charge  is  dispersed  
throughout  the  rr-network,  C3  now  has  two  trigonal  
planar  carbons  attached.  
H  H  
+ H:(") 
For  this  reason,  it  became  necessary  to  study  the  
conformational  pattern  of  divinyl  methane  
(1,4-pentadiene),  before  the  cationic  intermediates  
were  investigated.  
3.  Methods  
Completely  relaxed  geometric  optimizations  
were  performed  at  RHF/3-21G  level  of  theory  for  
the  neutral  all-trans  as  well  as  the  5-cis  and  1-cis  
isomers,  of  lycopene  Model  C  (Fig.  8)  using  the  
conformational  information  of  Model  B,  published  
earlier  [10].  The  three  cationic  intermediates  (i.e.  the  
all-trans,  the  5-cis  and  1-cis  form) were  also  subjected  
to  the  same  analysis.  
An  ab  initio  (RHF/3-21G)  2D-scan  was  carried  out  
to  generate  the  E  =  E(f>,  <//) potential  energy  surface  
of divinyl  methane,  where  cf) and  1ft represent  rotations  
about  the  C(sp 2 ) -C(sp 3 )  and  C(sp 3 ) -C(sp 2 )  single  
bonds,  respectively.  The  visually  observed  minima  
were  subjected  to  geometry  optimizations  at  the  
RHF/3-21G  level  of  theory.  The  results  were  used  in  
studying  the cationic  reaction  intermediates.  GAUSSIAN  
94 has been used  to carry out  all  the computations  [12].  
4.  Results  and  discussion  
4.1.  Conformations  of  divinyl  methane  
Divinyl  methane  (1,4-pentadiene)  has  been  studied  
first,  as  a  conformational  model  of  the  cationic  inter-
mediates.  The  essential  question  here  is  whether  the  
two  unsaturated  moieties,  joined  to  the  central  C H :  
unit,  are  coplanar  or  not.  In  other  words,  do  minima  
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Molecule  1  Molecule 2 
H  H  
NAD(+) NADH 
Molecule 2" Molecule 2' 
Twist about C5-C6  bom 
NADH 
Molecule 3 
Me  Me  
-NAD ( + ) 
Me / Y , 
Molecule 5 
Molecule 6 Me 
Fig.  7. Putative  mechanism  for lycopene  isomerization.  
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MODEL  B  
Me  Me  
H 
MODEL  C  
ATn Me-Ci-C2-C3 
Xy.  CI-C2-C3-C4  
Xy. c2-c3-c4-c5 
X4'.  C 3 - C 4 - C 5 - C 6  
X5:  C4-C5-C6-C7  
X(,:  C5-C6-C7-C8  
X f .  C6-C7-C8-H  
X\.  Me-Ci-C2-C3  
X2.  Ci-C2-C3-C4  
AT3:  C 2 -C 3 -C 4 -C5  
X4'.  C3-C4-C5-C6  
X s ' .  C 4 - C 5 - C 6 - C 7  
X$:  C5-C6-C7-C8  
Xy".  C6-C7-C8-C9  
X&:  C7-C8-C9-C10  
X<)\  C8-C9-C10-H  
Fig.  8. Structure  and  numbering  of  the  tail-end  models  of  lycopene.  Model  B includes  the  first eight  carbons  of lycopene's  carbon  backbone.  
Model  C  includes  the  first  ten  carbons  of  lycopene's  carbon  backbone.  
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occur  either  in  the  syn/syn,  syn/anti,  or  in  the  anti/anti  
form. 
and  maxima  along  the  torsional  mode  of  motion.  The  
results  are shown  in Fig.  10A and  B,  respectively.  
H H  H  
(0°, 0°) (0°,  18 0°) 
The  conformational  PEHS  of  divinyl  methane  
is  shown  in  Fig.  9.  The  eight  minima  located  
were  optimized  and  the  results  are  summarized  in  
Table  1.  
The  minima  occurred  in  the  vicinity  of  ± 1 6  and  
±120° .  That  means  that  the  unsaturated  moieties  
are  ei ther  nearly  perpendicular  (corresponding  to  
± 3 0 ° )  to  one  or  the  other  of  the  C - H  bonds,  or  in  
al ignment,  i.e.  ecl ipsed,  ( ± 1 2 0 ° )  with  one  or  the  
other  of  the  C - H  bonds.  However ,  no  minimum  
was  observed  at  0  or  ± 9 0 ° ,  when  the  olifinic  
groups  would  be  ecl ipsed  with  or  perpendicular  
to  the  C - C  bond.  
Torsional  potential  energy  curves  (PECs)  of  the  
type 
E  =  E(tP),  
were  generated  at  4> — 0°  as  well  as  cb =  120°  
and  4>—  —120°,  to  see  the  alternation  of  minima  
anti anti 
( I 80°,  18 0°) 
4.2.  Structures  and  stabilities,  along  the  isomerization  
mechanism  pathway  of  lycopene  Model  C  
The  trans-cis  isomerization  mechanism  (Fig.  7)  of  
Model  C  (Fig.  8B),  as  well  as  the  conformational  
torsional  angles  and  relative  energies  of  its  intermedi-
ates  have  been  examined  in  detail.  The  geometries,  
energies  and  stabilities  of  all  species  involved  are  
presented  in  Table  2.  
Results  obtained  here  for  the  neutral  compounds  
are  expected  to  follow  the  sequence  of  energy  and  
stability  of  the  full  lycopene.  The  observed  order  of  
stability  is  clearly  in  agreement  with  earlier  results  
obtained  in  the  case  of  full  lycopene  [11]:  
5-cis  >  all-trans  >  1-cis  
For  the  cationic  intermediates,  however,  the  order  
of  stability  is  different:  
all-trans  >  5-cis  >  1-cis  
Table  1  
Optimized  dihedral  angles,  bond  lengths,  total  energies  and  relative  energies  of  various  conformers  of  divinyl  methane  
Conformer <t> CJ-H 9 C3-H10 Energy A E  (kcal  m o F 1 )  
a 116.85982686 116.8582153 1.08566470 1.08566516 -192 .8732017 0.00000 
a' -116 .86066755 -116.85996391 1.08566521 1.08566492 -192 .8732017 0.00000 
b 119.87843183 -119 .87227647 1.08815294 1.08353286 -192 .8718829 0.82756 
b ' -119 .87318394 119.87789676 1.08353187 1.08815307 -192 .8718829 0.82756 
c 16.10175702 -115.86964444 1.08760599 1.08673326 -192 .8720363 0.73130 
c ' - 16 .10317418 115.87135594 1.08673431 1.08760496 -192 .8720363 0.73130 
d -115 .86972268 16.1032023 1.08673701 1.0875990 -192 .8720363 0.73130 
d ' 115.86753178 -16 .10561373 1.08759825 1.08673763 -192 .8720363 0.73130 
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Fig.  9.  Conformational  potential  energy  surface  of  divinylmethane;  H 2 C = C H - C H 2 - C H = C H 2 ;  E  =  E(tf>.  <10  where  <f>  and  ip are  the  rotations  
about  the  two  single  bonds.  Top:  Landscape;  Bottom:  Contour  representation.  
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The  rotation  PEC  along  ip,  of  divinyl  methane  is  
structurally  analogous  to the rotational  potential  along  
in  the  cationic  intermediates  of  Model  C.  For  the  
three  cationic  intermediates  (i.e.  for  the  all- trans,  the  
5-cis  and  1-cis  cations),  the  
E =  E(Xi)-
PECs  are  shown  in  Fig.  11.  It  is  interesting  to  note  
that  the  cationic  intermediates  show  a  somewhat  
different  torsional  potential  (Fig.  11)  with  respect  to  
that  obtained  in  the  case  of  divinylmethane  (Fig.  10).  
Although  the  increased  size  of  Model  C  may  be  a  
factor,  nevertheless  it  is  more  likely  that  the  presence  
of  the  positive  charge  redistributes  the  electron  
density  sufficiently, which  in turn  translates  to  a  some-
what  different  conformational  PECs.  
4.3.  Bond  length  interpretations  
One  of  the  structural  features  of  the  isomerization  
process  is  the  changing  carbon-carbon  bond  length.  
During  the  reaction,  a  double  bond  may  change  to  
a  single  bond  and  vice  versa.  Key  bond  lengths  
at  various  stages  of  isomerization  are  summarized  in  
H 
, C O N H ; 
v v 
N 
f rom  C 5  to  C8  are  neither  genuine  single  or  
genuine  double  bonds.  Thus  rotations  may  occur  
relatively  easily  along  the  C 5 - C 6  and  C 7 - C 8  
bonds.  The  results  (Table  3  and  Scheme  1)  
roughly  coincide  with  the  expected  changes,  but  
they  are  somewhat  different  from  conventional  
resonance  hybrid  representation  (c.f.  Structures  2,  
2 '  and  2"  in  Fig.  7).  
4.4.  Energetics  of  isomerization  mechanism  
The  rotational  potential  energy  curves  associated  
with  the  isomerization  processes  
All-trans  cation  —• 5-cis  cation  
All-trans  cation  —• 1-cis  cation  
are  shown  in Fig.  12. The  barriers  to  interconversions  
are  different  for  the  two  processes.  The  two  PECs  
clearly  indicate  that  the  isomerization  to  the  5-cis  
cation  is  kinetically  more  favourable  than  that  to  the  
1-cis  cation.  However,  the  cations  have  to  be  formed  
in the  first place. Hydride transfer to N A D ' + 1  may  lead  
to  the  formation  of  allylic  cations.  
C O N H j 
Table  3.  The  C - C  single  and  C = C  double  bond  
lengths,  obtained  at  this  level  of  theory,  are  
given,  for  the  sake  of  comparison,  in  the  footnote  of  
Table  3.  
Three  types  of  CC  bond  lengths  were  identified:  
double  bond  (approximately:  1.32  A),  
conjugated  single  bond  (approximately:  1.47  A),  
genuine  single  bond  (approximately:  1.54  A).  
On  the  basis  that,  a  conjugated  stabilization  
pattern  has  emerged,  which  is  shown  in  Scheme  
1.  The  broken  line  —  passing  through  three  bonds  
The  relative  ease  of  hydride  [H: ( " ' ]  removal  is  
measured  by  the  hydride  affinity  of  the  molecular  
system.  Hydride  affinity  values,  as  computed  at  the  
RHF/3-21G  level  of  theory,  are  summarized  in  
Table  4.  These  data  suggest  that  the  easiest  removal  
of  an  allylic  hydride  is  from  the  all -trans  isomer  
and  the  most  difficult  to  remove,  is  f rom  the  5-cis  
isomer.  These  results  are  illustrated  graphically  by  
Fig.  13,  in  the  form  which  preserves  the  mechanistic  
considerations  given  in  Fig.  7.  
As  far  as  the  thermodynamics  of  the  reaction  are  
concerned,  a great  deal depends  on  the hydride affinity 
of  the  hydride  acceptor.  This  is  clearly  shown  in  
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Table  2  
Torsional  angles,  total  and  relative  energies  for the reactant,  intermediates  and products  of  lycopene  Model  C  isomerization  
I s o m e r C h a r g e Xi X2* Xs * 5 b ATe AT,b Xt AT9 AC to' AtuC Xn E n e r g y tSE 
( H a r t r e e ) ( k e a l  m o l  ~ ' )  
A l l - t r a n s 0 -  1 7 8 . 9 1 9  1 0 6 . 0 9 0 1 7 6 . 4 1 4 1 0 0 . 2 1 1 -  1 7 8 . 6 2  -  1 7 9 . 7 7 3  -  1 7 9 . 9 4 2  1 7 9 . 9 7 7 1 7 9 . 9 9 6 1 7 9 . 8 5 3 1 7 5 . 9 1 7 -  1 7 9 . 0 0 6  -  5 3 9 . 8 9 2 7 0 5 7  0 . 0 0 0 0 0 0 
5-cis 0 -  1 7 8 . 9 1 8  1 0 3 . 0 5 8 1 7 6 . 4 4 8 9 0 . 1 8 6 1.362 -  1 7 8 . 1 4 6  1 7 9 . 9 0 5 -  1 7 9 . 7 7 9  -  1 7 9 . 9 9 0  1 7 9 . 1 9 7 1 7 5 . 8 7 1 -  1 7 9 . 9 4 3  -  5 3 9 . 8 9 3 3 2 9 1  -  0 . 3 9 1 1 9 0  
1-cis 0 1 8 1 . 0 6 9 1 0 6 . 4 2 7 1 7 6 . 3 5 1 9 9 . 6 0 0 1 8 1 . 6 3 3 1 8 2 . 0 2 1 0.772 1 8 1 . 4 5 4 1 8 0 . 2 7 4 1 7 9 . 9 9 1 1 7 3 . 9 4 3 1 7 7 . 5 8 5 -  5 3 9 . 8 8 3 3 6 7 0  5 . 8 6 0 1 2 7 
> All-trans  + 1 1 7 9 . 1 6 1 9 7 . 9 5 8 9 9 . 2 8 4 -  1 7 7 . 5 9 7  -  1 7 8 . 3 2 7  1 7 9 . 6 7 3 -  1 7 9 . 9 5 8  1 7 9 . 9 7 9 -  1 7 9 . 9 7 1  -  1 7 9 . 7 4 1  - 2 . 3 1 8 1 7 9 . 9 8 0 -  5 3 9 . 0 8 5 3 8 0 8  0 . 0 0 0 0 0 0 
5-cis +  1  1 7 9 . 0 3 0 9 7 . 3 7 0 1 0 0 . 0 8 7 -  1 7 7 . 3 6 2  2.951 -  1 7 9 . 4 0 6  1 8 0 . 0 0 0 - 0 . 0 0 3 - 0 . 0 0 1 -  1 7 9 . 9 3 3  -  1 7 8 . 2 8 8  1 7 9 . 8 9 4 -  5 3 9 . 0 7 9 0 7 0 4  3 . 9 5 9 8 3 9 
1-cis + 1 1 7 9 . 1 0 2 9 8 . 4 4 3 9 8 . 9 9 4 -  1 7 7 . 6 4 2  -  1 7 8 . 2 3 5  1 7 9 . 7 1 3 0.098 -  1 7 9 . 9 6 8  1 7 9 . 9 9 5 -  1 7 9 . 6 6 7  -  2 . 4 1 3  1 7 9 . 8 7 5 - 5 3 9 . 0 7 5 0 1 7 0 6 . 5 0 3 3 8 8 
'  Conformational  torsional  angles,  in  bold.  
b  cis-isomeric  torsional  angles,  in  italics.  
c  Methyl  rotations.  
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Fig.  11. Torsional  potentials  for  the  three  cationic  intermediates  of  lycopene Model  C  isomerization.  Top:  all-trans,  middle:  5-cis, bottom:  7-ci's.  
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Table  3  
Variation  of  carbon-carbon  bond  lengths  along  the  isomerization  pathway  of  lycopene  Model  C  (conjugated  single  bonds  in  italic,  double  
bonds  in  bold  R [ C - C ]  in  ethane  =  1.542,  in  butadiene  =  1.467, R[C=C]  in  ethylene  =  1.315,  in  butadiene  =  1.320)  
Molecule Charge R(Me-C,) R ( C , - C , ) R(C 2 -C 3 ) R(C 3 -C 4 ) R(C 4 -C 5 ) R ( C j - C i ) R ( Q - C , ) R(C,-C g ) R ( C , - C , ) R(C,- i 
All-trans 0 1.517 1.321 1.510 1.556 1.518 1.328 1.462 1.328 1.472 1.325 
5-cis 0 1.517 1.321 1.510 1.556 1.517 1.328 1.463 1.328 1.472 1.325 
1 -eis  0 1.517 1.321 1.510 1.556 1.518 1.329 1.463 1.332 1.478 1.326 
All-trans 1 1.516 1.322 1.529 1.495 1.359 1.410 1.393 1.364 1.335 1.516 
5-cis 1 1.516 1.323 1.531 1.495 1.358 1.412 1.399 1.362 1.334 1.515 
7-eis 1 1.516 1.322 1.529 1.495 1.360 1.412 1.394 1.368 1.337 1.516 
1 4 8 9 
1 4 9 0 
1 4 9 1 
1 4 9 2 
1 4 9 3 
1 4 9 4 
1 4 9 5 
1 4 9 6 
1 4 9 7 
1 4 9 8 
1 4 9 9 
1 5 0 0 
1 5 0 1 
1 5 0 2 
1 5 0 3 
1 5 0 4 
1 5 0 5 
1 5 0 6 
1 5 0 7 
1 5 0 8 
1 5 0 9 
1 5 1 0 
1 5 1 1 
1 5 1 2 
1 5 1 3 
1 5 1 4 
1 5 1 5 
1 5 1 6 
1 5 1 7 
1 5 1 8 
1 5 1 9 
1 5 2 0 
1521 
1 5 2 2 
1 5 2 3 
1 5 2 4 
1 5 2 5 
1 5 2 6 
1 5 2 7 
1 5 2 8 
1 5 2 9 
1 5 3 0 
1 5 3 1 
1 5 3 2 
1 5 3 3 
1 5 3 4 
1 5 3 5 
1 5 3 6 
-539.03  "  
-539.04 
-539.05 
<D 
O 
t 
-539.06 
O) 
0) 
C 
LU 
-539.07 
-539.08 
-539.09 
'  33.8  
/  »  .  \  
\ 
J  \  
1  \  
:  \  
1  \  .  t  
c 
25.3 
* 
< # 
i 
\ 
\ 
\  31.8  i 
\ i « 
r " • 
i i 
0  A  
1  /  
i  /  
i i 
\ i i i 
\  Q  \  »  \  \  \  %  
\  \  
;  \  
;  *  
!  /  \  »  
»  /  \  x  
\ 
b o  /  
y ' ' [ y  1 2 / 7  
\  \  V  »  \  \  \  \  \  \  \  \  
\  \  
L  \ b  r 
i  J  \  \  '  T  V * * /  •  \  
!  \  
i !  V  
/ / 
-0--
—I— 
- 6 0 60  120  180  240  300  
Torsional Angle  (Degrees)  
360 420 
Fig.  12.  Torsional  potentials  for  the  two  isomerization  processes  Solid  Line:  all-trans  —»  5-cis,  broken  line:  all-trans—>  7-eis.  
Table  4  
Energy  components  (E[H (~']  =  —0.4004207 Hartree)  for hydride  affinities of  selected  compounds  
Molecular  system  Total  energy  (Hartree)  Hydride  affinity  (kcal  mol  ')  
Cation Neutral 
Weak  hydride  acceptor  -7 .1870945  Li (+  '  - 7 .9298426  L i - H  214.813866774 
Strong  hydride  acceptor  — 39.0091291  HjC< + l  -39 .9768768  H , C - H  356.00336577 
All-trans  Model  C  -539 .0853808 -539 .8927057 255.336454542 
5-cis  Model  C  -539 .0790704 -539 .8933291 259.687483380 
7-cis  Model  C  -539 .0750170 -539 .8833670 255.979715043 
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Fig.  13. Energy  level  diagram  (kcal  mol  ')  for  trans-cis  isomerization  mechanism  of  the  truncated  lycopene  model.  
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Fig.  14.  Side-by-side  comparison  of  hydride  affinities (kcal m o F  ) for  several  small  cationic  systems.  
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Fig.  14  where  a  weak  hydride  acceptor  [Li ( + ) ]  is  
compared  to  a  strong  hydride  acceptor  [H3C(+)]>  as  
summarized  in  Table  4.  The  overall  reaction  may  be  
endothermic  for  a  weak  hydride  acceptor  [Li ( + )] ,  or  
exothermic  for  a  strong  hydride  acceptor  [H3C ( + )],  as  
shown  in  Fig.  15.  
No  attempt  is  made  here  to  study  N A D ( + ) ,  because  
it  is believed  that  the hydride  affinity of  NAD< + ) is  not  
just  the  hydride  affinity  of  the  pyridinium  ring.  It  is  
quite  likely  modified by  the  carbohydrate  attached,  as  
well  as  by  the  remaider  of  the  N A D ( + )  molecule.  
5.  Conclusions  
All  of  the  results  obtained  suggest  that  the  isomer-
ization  mechanism  proposed  is  indeed  plausible.  
The  following  sequence  of  stability  is  observed:  
5-cis  >  all-trans  >  1-cis  
for  the  neutral  tail-end  (Ci-Cio)model  of  lycopene  
(Model  C).This  is  in  line  with  the  results  from  
previous  studies  [11]  on  the  various  isomers  of  the  
entire  lycopene.  The  relative  stability  of  the  inter-
mediate  cations  generated  from  Model  C,  however  
exhibited  a  different  stability:  
all-trans  >  5-cis  >  1-cis.  
6.  Uncited  reference  
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